	   SnapGene      ƒGTTAGGCGTTTTGCGCTGCTTCGCGATGTACGGGCCAGATATACGCGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCTGGCTAGCGTTTAAACTTAAGCTTGGTACCGAGCTCGGATCCACTAGTCCAGTGTGGTGGAATTCgccaccatgatgcttatccccacccatcacttccgagacattgagcggaaaccagagtacctccagccagagaagtgtgccccacctcccttccctggtcctgcgggagccatgtggtttatccgagatggctgtggcattgcttgtgccattgtcacctggtttctggtcctctatgcggagtttgtagtcctctttgtcatgctggttccatcccgagactacgcgtacagcatcatcaacggaattgtgttcaacctgctggccttcttggccctggcctcccactgccgggccatgctgacggaccccggggcagtgcccaaaggaaatgccactaaagagttcatcgagagccttcagctgaagcctgggcaggtggtgtacaagtgtcccaagtgctgcagcatcaagcccgaccgggcacaccactgcagtgtttgtaagcggtgcattcgcaagatggatcaccactgtccttgggtcaacaactgtgtcggcgagaacaaccagaagtactttgtcctattcacaatgtacatagctctcatttccttgcacgccctcatcatggtgggattccacttcctgcattgctttgaagaagactggacaaagtgcagctccttctcgccgcccaccacagtcatcctgctcatcctgctgtgctttgaggccctgctcttcctcattttcacatcagtgatgtttgggacccaagtacactccatctgcacagatgagacgggtattgaacgcctccaacgaacaaaacagcccagggagcagtcgggcagctggaagtcggtccaggaggcttttggtgggaacttttccctgaactggttcaaccctttcaccagaccttgtcaaccagagacacccattgataagggcttggtacgtcaagtgtcatctctgtcagacgtggacaacatggaaacagctgagagccaattggaggcgacaaaagacagggactctgtggaggtgctggatgaaCTCGAGTACCCATACGACGTACCTGATTATGCAACTTATCCTTATGATGTACCTGATTATGCTAGCTATCCTTATGATGTCCCAGACTACGCATAGTGAGGGCCCGATATCTCGACAATCAACCTCTGGATTACAAAATTTGTGAAAGATTGACTGGTATTCTTAACTATGTTGCTCCTTTTACGCTATGTGGATACGCTGCTTTAATGCCTTTGTATCATGCTATTGCTTCCCGTATGGCTTTCATTTTCTCCTCCTTGTATAAATCCTGGTTGCTGTCTCTTTATGAGGAGTTGTGGCCCGTTGTCAGGCAACGTGGCGTGGTGTGCACTGTGTTTGCTGACGCAACCCCCACTGGTTGGGGCATTGCCACCACCTGTCAGCTCCTTTCCGGGACTTTCGCTTTCCCCCTCCCTATTGCCACGGCGGAACTCATCGCCGCCTGCCTTGCCCGCTGCTGGACAGGGGCTCGGCTGTTGGGCACTGACAATTCCGTGGTGTTGTCGGGGAAGCTGACGTCCTTTCCATGGCTGCTCGCCTGTGTTGCCACCTGGATTCTGCGCGGGACGTCCTTCTGCTACGTCCCTTCGGCCCTCAATCCAGCGGACCTTCCTTCCCGCGGCCTGCTGCCGGCTCTGCGGCCTCTTCCGCGTCTTCGCCTTCGCCCTCAGACGAGTCGGATCTCCCTTTGGGCCGCCTCCCCGCCTGGAAACGGGGGAGGCTAACTGAAACACGGAAGGAGACAATACCGGAAGGAACCCGCGCTATGACGGCAATAAAAAGACAGAATAAAACGCACGGGTGTTGGGTCGTTTGTTCATAAACGCGGGGTTCGGTCCCAGGGCTGGCACTCTGTCGATACCCCACCGAGACCCCATTGGGGCCAATACGCCCGCGTTTCTTCCTTTTCCCCACCCCACCCCCCAAGTTCGGGTGAAGGCCCAGGGCTCGCAGCCAACGTCGGGGCGGCAGGCCCTGCCATAGCAGATCTGCGCAGCTGGGGCTCTAGGGGGTATCCCCACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGCAGCGTGACCGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTCTTCCCTTCCTTTCTCGCCACGTTCGCCGGCTTTCCCCGTCAAGCTCTAAATCGGGGCATCCCTTTAGGGTTCCGATTTAGTGCTTTACGGCACCTCGACCCCAAAAAACTTGATTAGGGTGATGGTTCACGTAGTGGGCCATCGCCCTGATAGACGGTTTTTCGCCCTTTGACGTTGGAGTCCACGTTCTTTAATAGTGGACTCTTGTTCCAAACTGGAACAACACTCAACCCTATCTCGGTCTATTCTTTTGATTTATAAGGGATTTTGGGGATTTCGGCCTATTGGTTAAAAAATGAGCTGATTTAACAAAAATTTAACGCGAATTAATTCTGTGGAATGTGTGTCAGTTAGGGTGTGGAAAGTCCCCAGGCTCCCCAGCAGGCAGAAGTATGCAAAGCATGCATCTCAATTAGTCAGCAACCAGGTGTGGAAAGTCCCCAGGCTCCCCAGCAGGCAGAAGTATGCAAAGCATGCATCTCAATTAGTCAGCAACCATAGTCCCGCCCCTAACTCCGCCCATCCCGCCCCTAACTCCGCCCAGTTCCGCCCATTCTCCGCCCCATGGCTGACTAATTTTTTTTATTTATGCAGAGGCCGAGGCCGCCTCTGCCTCTGAGCTATTCCAGAAGTAGTGAGGAGGCTTTTTTGGAGGCCTAGGCTTTTGCAAAAAGCTCCCGGGAGCTTGTATATCCATTTTCGGATCTGATCAAGAGACAGGATGAGGATCGTTTCGCATGATTGAACAAGATGGATTGCACGCAGGTTCTCCGGCCGCTTGGGTGGAGAGGCTATTCGGCTATGACTGGGCACAACAGACAATCGGCTGCTCTGATGCCGCCGTGTTCCGGCTGTCAGCGCAGGGGCGCCCGGTTCTTTTTGTCAAGACCGACCTGTCCGGTGCCCTGAATGAACTGCAGGACGAGGCAGCGCGGCTATCGTGGCTGGCCACGACGGGCGTTCCTTGCGCAGCTGTGCTCGACGTTGTCACTGAAGCGGGAAGGGACTGGCTGCTATTGGGCGAAGTGCCGGGGCAGGATCTCCTGTCATCTCACCTTGCTCCTGCCGAGAAAGTATCCATCATGGCTGATGCAATGCGGCGGCTGCATACGCTTGATCCGGCTACCTGCCCATTCGACCACCAAGCGAAACATCGCATCGAGCGAGCACGTACTCGGATGGAAGCCGGTCTTGTCGATCAGGATGATCTGGACGAAGAGCATCAGGGGCTCGCGCCAGCCGAACTGTTCGCCAGGCTCAAGGCGCGCATGCCCGACGGCGAGGATCTCGTCGTGACCCATGGCGATGCCTGCTTGCCGAATATCATGGTGGAAAATGGCCGCTTTTCTGGATTCATCGACTGTGGCCGGCTGGGTGTGGCGGACCGCTATCAGGACATAGCGTTGGCTACCCGTGATATTGCTGAAGAGCTTGGCGGCGAATGGGCTGACCGCTTCCTCGTGCTTTACGGTATCGCCGCTCCCGATTCGCAGCGCATCGCCTTCTATCGCCTTCTTGACGAGTTCTTCTGAGCGGGACTCTGGGGTTCGCGAAATGACCGACCAAGCGACGCCCAACCTGCCATCACGAGATTTCGATTCCACCGCCGCCTTCTATGAAAGGTTGGGCTTCGGAATCGTTTTCCGGGACGCCGGCTGGATGATCCTCCAGCGCGGGGATCTCATGCTGGAGTTCTTCGCCCACCCCAACTTGTTTATTGCAGCTTATAATGGTTACAAATAAAGCAATAGCATCACAAATTTCACAAATAAAGCATTTTTTTCACTGCATTCTAGTTGTGGTTTGTCCAAACTCATCAATGTATCTTATCATGTCTGTATACCGTCGACCTCTAGCTAGAGCTTGGCGTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCAATGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGGACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTGACGTCGACGGATCGGGAGATCTCCCGATCCCCTATGGTCGACTCTCAGTACAATCTGCTCTGATGCCGCATAGTTAAGCCAGTATCTGCTCCCTGCTTGTGTGTTGGAGGTCGCTGAGTAGTGCGCGAGCAAAATTTAAGCTACAACAAGGCAAGGCTTGACCGACAATTGCATGAAGAATCTGCTTAGG  =      "      #      #   !                   $      -   "               "                                    &                                  $                #         !   (             3      '   0      %      /            $                                 !                     4                                                         #               $                               
                              $   (   (            "   "                   /   '                                    !               #          !               "      -   +   !      !   0                   $   %      "               !   '   (   $         "                                 &   5             (            !             (               +   "       0      
                /   $      %      (            1   )      $   %   ,      *          1       .         Y áóužn	o	à	
g
Œ
•
–
:dÏ�®�Q�Ÿ" á xâ b#ú‚Èô‹-ŸØp	­ëðs‘îž›vFåPÑ Z ÷ œ¥Ä	Ë	á	H
—
À
Hzgb¯R÷e #  ÈNßô/`Ò8vƒW	î	
U
h
�
;�-eÁ Ð©_1ãJ¦Ž% t û c$nÉçz•Æq	‡	¶„�®žGÒ-# ´é®ÚõeP h	ƒ	“	—	ÞVmµì¢8f˜ï©ÎTœÑb¢æ.! Îãž‹ûž$dÍK	ÃÕÛöž·K’Ÿ�Z1w’QžxÌ â y!ìƒ\Œ.pÙ	Ì�ñÀkwt6¥  ø ¬_±47{÷ñ˜ç•Å	I
Á
Æ
{h°‰5c°%ËtŠ+ø Œ MR’¦>@˜
Ão„¾.Si°Ýþ> ´Õ.[‰³	â	É
I�¡$m[É%ŒSˆÇf¡ [ fb�áÌ	ç	õ©ZZÑS~Ú·•ç0$  ÉOV­}âMi
¯
½
fÂPóhŸ¢O"2h�ç(G¤qc/E�& ]‡ºBõ0aÓÚ„¨	ó	l
<^…Í.£Fìù#Í
Y- œ {<ê9“w|µ	t	ï	V
Ž
!yÁ<‡™#>W«´öBSfÑì^ƒª`{bõä˜K€C^"   “ TÂËÑà]	Îò	$	X	
O
p
ŽY_“
¸?Z¾ÉÛ�W§² d[è{–Är	W]‚…‘Ù¡ #g÷H. Ý 7”° 'oˆ		
Ï1:„p ®Ó u ü ño¨ÇF	·öŸº#}ØÐîf
67 t˜å%Êq/o¯Ž’Ç™ I“¾k¶c«ûtB" (»Û¡„	”	L
‰Ñzæí£Ä–™U�…¢Á:³£²ç¨Xr êf4i	|	n¶3�9Woðª+Ò)g€’/�µ µ¯·	IW‘,¥g—"7„u ²¬¹ö¢Q˜	ßí•ß®Ïðch  ¯Ã9ˆ{�ŸÒð~ÖóGFŸ¸€öº % Ï3eþ	š� @‚8AhRy 7 äü½Û%8ÎOu4é÷LÒ<B[x†‡ ŸŒL	
ÄÉÜa²»	ƒ“ç2=E“Ÿ]o�Ÿ°ÔÍÕÝ ¹ Å î AJûEé¢W´ú§ÚC	¥	ž°ž¾ÚÁ ó&uXÃÉ 1 ß)]€‡qŠŠ	³	Ñ7x23¦ß)g > ã zÚ"–�ù</Í@)òTL78(ë   « pí\„	
Ø
f|€vl®=qr2c& ù Ì`¯²,@5øòZ“bÌàå“Ä
Ç
‹ÊTk³²6Xf&¢ˆ‹`µ) ­y2J
Ö
|€‹m¼´õù  #Y­´8@o¨Hèñ–ÁÆ	Â
[]i±Pdk£Ìè3,¹'&( LùI|$T™êUŠÔº±ú`êu^|sÈº< Suª
ˆ}»ÎnÞÿ5ô9 M � Õ N2uR¥…Ô/TÒð«ò½ È þ %•§A{�¨™
ŒÔµ7Ä#3,p¿jª±È?)ˆ  3j‹¾[“óž:¾Ó‹?ª·Õ˜ó . O´ÉÓ
€˜ÃÈ	³Ý€\	ÓáÚ!ßy¡¯8«4*   C ~ Ê
%cÊu�Èqãÿh‰»Èg  µÖ‚/\qq~óÐ	%
¢àl¶d&êJ¶:ñ$ c w Ì Š¶Ô	ã	D
J‚¿Ô%RnÅäø¡^lÇÕù÷T†¶¢ /ªÏÞ›H	Í	û	d
¯:ë÷[Ò07Æè1  \ ¼ ñ D›þT�ž@CJSÖ+_¥í[wà[.¤æH ígº0	öª/TÛÔm ¨cxB–ÅâóªÝêè	¹rºú…‰%¸–# ²ÓPç!lyNÖÿ	"	Þ	j
­
»
¾
©éNQi Ž#fm‚r†-v  ®~G�£$i)end0�'@  , | ÊW€œã.	#
Ô
Ã~PÑ*ßèH Fï!  Ôž	„
£
°
¹
Ï
é
ñ
_g§ÌÖôöÚŒÖ3Tb¥	·$­
[§>( ˆ»qö1Nl&ÌÔ[
m
|
†
Ñ
‚†ÊÎTÿaš¤Î×½¦GJ`&¯¶Îe H„ÃÛý©	�©Øñ IÖ¸Ãíc�½~ýDZ  ^C£Q~	ÿ²
=•™ÝáåW‰ÉøÜÜóœ$ÖÜ[n bè˜ì…À	ô	_û/”ìúÑÊ©3  � =†¿æ%KQ×l›j·÷jm}¤¶	ð	‰
1=?XµÑ÷CT_“«|›a Qcä¸àå¾û`¨4 ¡|áå]‚åu	 	Ü
q$¬úgp„EÀw™êO'  ŽÆHVë:mˆ”6 "Wˆš±]%C›²¼aÀKã=z§ìLDù"_{0 všÚ)HcR#x¹	W
�
÷
0zÂ§BÖ(ÒíÌ|Ø5EVvöXd²Ù¹á[y�3N�;uü Ü3Z	Y	Z`JM	.¦Ü)@[ÉKx•ÜwŸ¨â³% ! Ú .»ü'NásHÆ
^
v
å
�¹Øè2ü¿Ê@MÄ›ûë]¼ ˜ YÃÒ+°u]a½	%	6	\	d	ci”!áëNª³�Ž$É/ j ” ¤ ² 7Ue=	ÌûXì6^Ã
Ïfó<	
P
q
¥
ë
ó
•©ÿ *5iŒnü)¨ßûþXA à Ç7Ští	T
”
Gy
fcïÎœuI¥$dž æÅ†	–	ƒÔÚœ¶v¨Í5Y¤0‘� e3—¯Z$½Ðh/$  U\é|Ùs	N
o
x„ÀÌX^†’˜¢ëò!€½ÈÚôFpø"b	X] sðÿ&pVÎÆ˜H"b|×í ±º¶	ˆÐy2–­¡(9±§!gŽt $ 8‡œ7~
ò;?<…ž7†õ¯Ô Þ•¡(V†øB	‰	²	

�Ð6{2q "¬ø?Hn#xGTŠÉ¢»‡_ô]´¸&r¹; L Ô ý 2iŠ½ò½Š©‹Ó|6©ÇÑïóªò8 B b v pÈC
b$÷ Æ~ÇÙµâ öþg®7µ šì§w?ÎÝG	¸q¤¹ìùê$Ó Òæxþ¬
¸
Ó
è
ð
^¦è~�}Ù#‹lŸd¬…îu p¢PË{
�”¨ÉÜð“ÈÕÛò›·ÂI_�ÐdÛüZC! u�™$Ù(Ökä"£ˆ
/0p¦°Ðš¿DJ`¿ÿuWßàéMŒN i û&*WÂr]
¥Û”©ýLÃšž  6…	•	M
	îñY¼ÇÙ£/t�¤aœ#W\ †…6±	ÍñzÅ—¬>1Ö8;ôs !1ë>G¼"‰ÜFB
pŠ¸Ò{5¡†´Æ³ò©­q¸ oŒ)Vw¢·
.“Û¥ç}¤"Ôñš¨VžÞÂè„YM ÿ!„5°	o’·Ú¤4XÓð §~«»ÆØ=Õ.�Åƒp·4 *½ƒ+®	¯	»	lmn()*<=¢£:ºÅÖ×ÓÔ*+,-h�Ž­®€�‚o�“ÿ �‘¶F � P+J,¬5+>;Ïãìp¨¯»0’šG 	†ë¾gj	}	¼	Ú	oÙ‚ñ,ïóiÔ•‚”– � Â ô GQÅ,KÐr,X’K<¦Æ ·¯°ée1… I ¿ Ý �	«	¸	
Æ-ÐØí‡’#KU 8O“› S ¶°v-�?JN èDäq‚Í©ÛÚHj O ­ù6:hT˜¼Àð÷v ¨ × «­¶Ýk	½	Û	a
D£dZƒ 4¡³º¿`h~	àã9î3ƒŒ¯Vð—T … 
7‡¤÷£ÅIRx	pÚ–à±Ã’jÕ;¿i•Ð ìº¶"ÿ™	ê«ó-òÐ-ñ)ô–¿ r ‘ õ RvªÆL:‰õc‘³:ô@ 3=§ÇXAÅËå Ã HnÁž ÐîÂ£	-×ç'“¹U�¸	‚±Îfmrp  Ê -*Ñ|ÓñM`Y!-²lw»2† ,c°Äj„äÁßs€Ž—ÖßRHGLú™°êé÷+ J g Ò Þ Ð×y
›Ç÷{Ù^ò$bœ	 ƒ À m4ª¬	¹	Ø	ÄÑîž¡;9“ØS!” & n p *k·.ŽÊÌP~ ( °fŽ	ÿ	
Y5�ˆAƒBiLV9?z# 4 ; ¶ ë >øBâEQ±©0w9…E
!êøý�ºrÎ.Ü|Ujk 8 F T _ `—¤¾Ü&´
vK¡éÊ\‡ªØR  åàm.šP5@EN½=åõ¬yˆ]€Š­I ·€ÊýCŽÏúO.trMÓCƒIÛ žW7’Ý;¯†‹QÆÞèi=&žÎ$ P 'ÂÔ¥¨S�òu}Ê=³Ë0s5Þ*Ur™
Š½ñŒ^¾ya  �”MM	€
ð›ãÅ¼
”%Á³3F”Á 	S ÕÞÖøw  Ê3�CLÊè®ú›
?¹9b„x�è> ÅÏpî±Þ  W Š Kß]¬ê£Kl	�	¦	Â	\Ÿ¿ÁŠ–ODN,Ê © ·²D	Ÿ¼Âô8‘î6e?[ º Æ ï B“üAXµÞ¨Ûèb
†±½Û–o„Ä * Ø 5Fšê®ý[hû¾	Ü	
¡
Í
Eý['v¤¶"Yw1  =šÀiˆr´	Ò4”3Wz§à  5<¢´Î»^�)‹‹	á:ï18Íáê€Šñ˜õRUh 2 � l�ÀàÕsa„y�È°k`|«
 d�*	ß
äˆ4œ* Ùi“¥=î‡y	Û*—ãóáUþÜICPÓãÑ ? ¤—úJA8“ž< † ä {ƒ#ˆ×ÀøÆ0á
q²9ÖÀjå Û8�Ž¤Sö	ÎæšÄMzk)Á–Ä;Aì ¡ •]�	
Ù
}m¯H7Ñ~øk}3X¥d §¾íf�·:#¬ôwzCõæP—ë qõW»¹×É	a�#j.>ó…Ëšü¿ ¬ óÐî…,¬ š	

6
;
gë‡¬.rò*sÀÌ ö wÇMa.›ù�ó‚V	Ê	
‹
Œ,ÿa¨^­0âö$ s ú Í³ŠÙ[dy”�#coÌg	µËÝUl´�õ¡¿7J~�Sa~,( «‘°-Zaˆ6öð=?²æ”Å
È
€#4ÈYR‰¯Üý}Ù¶*=Ææ( ’ › S\†¹z;AÁÊÐ’Íá´ò	;³·õA>Yg‚žNæ'£EŒVB±Ì äZŸnÃ.n�Øÿ¹½µ"ƒÏö	­ús6 '«¡3{	K
ì�”å•Vn
„À²6Wƒq 6 ®Âz2¼ÑÚït}™3ÈèFE`ºŒ‚æDgnÓ " 0 = Ÿ ¸ Ä í @IoÙúDè;ù‰¦¤	×
¯?(­òKWÞ'Âb" ®+?K³§S’1aËéðÀÃ
SZ\j²ÓWejl³çé{ %'  $Zt9tÒÔz§©
´"2¤ºÍm4(¼‡ Ë µp}Nò—ÂÇ	Ó	ÓQãµctkÞxºª3)  .S€A•©ÄIRò¹Õšú	^Zv„ß®.öˆ-£ål  ± kÓ!	ƒ
ËMÐÕ)Sea¶	,= Mk}ç%—Âë�˜×àSŸú™HV¼ ëb¼}ÕÉm/  ÅG…¾åJGPUbšàQl�‡¶öl¸ä	VAÕù'$’»šã±v½ë_ø:tû!z' -dMÛútG`eÅ	u
ä
hI‹-mû (1²Þûv#áê@»  ß T“
Fxe—ó¼Ïo�~ œG �6ì� A K a Ó ™¦vS‰È£ëø~õ%
: h Ñ~Øãz
«
ï
|ÚC_^ß ‹c n‹v5¶
0sñ¬ó"L Ž O…«­	º	Ù	4'ÒïŸ¦Õ<§¬ºÄÓ”n• H N Á qÅMCÅS¶Ì†ïÚÙT „ Ö 3Hw	8CÂ¢U‘:¾ q É +buiÀÏÞíL_�Á¢	�ÕQ&TkÍ@Ê*ä ' o jl©¶Ã4:ÉË : E ÿ =–£É¨B„Dù Msü�¹-«×QTi‰! &É2Éç|š
ï¸®8/rÅç$)wq�À<²‰ÿ‹Ä½`  ) V ‰ 4’\™@±üZgç
Ì
[ZÀ�‰•!N>CM € kŒ¿Ÿ;ÔŒ(Þ
Ìy›j{ôQ ‚¿™âä:@ ¦”ô«¸Ö�	 
i†6B}„ÊåOjW¤# …¸�Éš€ï<x�U	É	
´"Žþ��]M/®Û|Ø<°}+ / 5 < · ì ?ØùCãYª1:s® ë_ñ!ƒåC¬5V‚a  
JRs²sÃ0y¦ÊÔ™Ò	Ò³uÞ­´
sÝz¢k$! 
 FæP†µõFdÄã
žùÊ&'‘»ÏÔ(â"à9?l  ` ˜ERwd¢ê]ŠŒ} G „ŠGpµ
Ä&7BLËr¦«¹îÙ mK 9 D atÈ1¿ÈÎÝìÀLP¸Â(vŽ;ˆŠÃ¼ÉS_h U  ˆ ¥'YË
Z¿Ë|É äNiá£ã" 	 ·×	r~rÂXî/xôT	Ñ	­ÿ��t'­B{;� ƒ0Xo¿DQYÃ6AKO¾·¥¸‰Âlâ^‹J-  ¶níúW›.
£¤þFGHIJŠ‹Œœ¾rsEmö÷øùëì	
Iz¤·ûáIJ+ æ }æ%]áoû–œ(28®&
/
ü
$¥¿áF>næúeåíK�©JüçòK®!  ¸�3ï3	9	ä	E
ý
¦Àâ såÔ?c¥_˜ÈÖÎø’Š· d ·!Ëp	—Õ	ƒNçûú—FJØèL! ^Æ.D�Ðá'
ÀûP/oGäîùüQ¢‘ª€KÜý‡ó0 x Í ç ~ç&Ù‹âþgüŠ)9�¯	
	*	*
0
%KÕ&uSÆ´Dof„æ9?îLmUE£¯ œ«ÐßzœðI	å	F
e
8óÁ!<œdìX`™ÉÏ“‹Ï ¦ü	dØtŒ°R@;¸Çé 0Î	Þ°¸jø\^Ó1'58ŸÆ   Ÿ¹‚14X»4	:	Y
þ
“§ã‡ÔæÇÕßé¦CO×>ù2 "vT× @	`¦î\´Ìtsš Äû]ò�K¥Ùbð$ Q ½ ò EÃÿ©¸TŸ
 D÷,èžæËxï|­6‹¾_IšM% ] e (œ‚¦ÞðóAJkK~˜UÖ	>1O—+V\€GÃçwz=p ÝÕUŽÌq„á!6ßèü~ÆÚGx´m˜{/¿é" x_•P�!Ñâ	ø	�
QflÆD½Hý	0´»UÜ
Tþôùþx �hg‘
2÷åRALÂÕ |ÇeE½(	1	(
ÁÐüp«ïú£&7�ãG•ß=ˆ¡ÖßC îÜ/Nž»N	ñœä0•f’«Â4Ý˜n×î y :Ú4*�+	L'2T†cpy:ønŠéÆPšï¤! è èð'¡©øŒÿ‘³ã°ûºÖvº:Eˆ…ç‘ïÛ&ƒÌÐ²' dy—Æã+DMhËéT £¯%«Þ	+
ù
Ç*µ…g@h?¡¹�—F( Î Ë�ÕCýô‹:@ë	P	_	é	1
œ
&@s|»Äû©ÎMZ”+Vq°Ùß$  X à"Þò_¤Ñ,�×m	Ã	ß	G
f
¿
9¬Àêr�íšPEäOŒÐ �èm­ëO 	J	‚	’	Â�je—€Ð¡-wË ‹ L³ÔQ^zàæ	 ôlˆ¨Â$Ynƒ‹Ê-sR‡”" ¬L{ñ		#	§	k
®
¼
 ]	"=VªORe]¡zag—ë.D —Ü6“¯§E	
\ 0�‘õ9’jfoªe5A ¸H€ÃÞ+¤*ïf‘´  ý	N±ÑA@\œ¹Ü ª [³e½ÙuÿS%<1p71(Èêf ËXYßä’Õ
O±Š¹ù_¡2(Ç Ç ”1�¶Ž‡—Q+Óñ  - } �ÒÏ	$
²¾ßÄÜkÒ]àéIÔøp9 …ð » ð CýB©Üé/	c
*9/6GÅ  + { ›Õ	-	�	Ý	"
¢
º
Î
F¨Õõ�Þ#mZ¦? Gƒþü¿	Z
…
±
Ð
äþ`Íˆ÷ÖÛ¥%®µ¨&   \i5iŸ	Û
ö
ÿ
\Bo±Ë{×â4<DPUcy¦·Ø¸úZx2§35 — £ ± Ù 6X<ºë25¯Y\¼5	;	[	c	
¤
ê
ò
”¨þ
)4bLh×çÈàê(JMw§úŒ
?Èú\  2Æå‰Øsì	S
n
wƒ®¿ËÓ b›µÍêu›§Ì4EX!c # rïþ¹›%U÷A	µ	}
‡ÏUx5•!a{'…°¦f h‰¼«÷m>wÍa#éÅ¨Æ^áó\Òý·´ñ( ú¡#O'ÁÕj!ý\
‡
Ò
ç
€§Èï]¥ÏÚØŠ¾þtÁüHKŽ™�LÏÚí  0ê=FU…ˆEA
-Ìðy|ð!Ý7`›V[ )Iþ ¼‚*kØ;‘Ù¡Îâë}¹ÄîòŒþ™E R ¾ Ü ó FÄ ÏuŒøŒ	ª	
Ÿç9J×�®¿èd‘JNöi! § 6ª¹ £µµ!_ÄÜþ`
âéªò2,°‹(¾YÏS m©À)ƒãôb²–Þ9æ?ù2˜,W±�lvÄèqo f m ‚ Ñ )Ö¯ ×	x
öXz]Ž�ñ×a>}  3 ^ µ ê _÷AáDPß
l/™
³
-¼qôÉH{\¬( Ž�ÁÓŽ¤§RñBKt“LV>‘šâ<…ŠÊPÝ4Ý	RÎ%íxÝ ÞéJ€	Á	 
…¼ü»•7µí5nv0+ cÍ<r™0àé‡‰Ç“_ª £ÖØ
h’Ží†õ	à
åâýÛHyBO�ÀÒÃ ò½ÏVe�9+È
5
:
`"yG«÷™û|Ëê¾+ š [yY`‡ÀÏ-Øœ">±nËf	ñ	Š
Ü+¶ô¾I`
}œ¬åRáDQüUõ" ž ç& m»Ùøˆ¥z	˜2>mÇE�äD”¬þJ¿VÝ&ÒÁÿ5  >”¦RQ‘¸ï~¿ù	¨
RYƒÒâV1biõj‡¹æäÿ©0  ½ÚLjFOa–k_k·Òã		 	t
‚
g@˜ø,Ul#0ÿÝRduµ¼a»Ôú y @ }¥â’
î
–BFŸœë
 v	3BµÁ�Ã <¢ihÈæK^ƒC¡	îør%­ûqæS9þÖã �‘˜ûæÝ
h…x”šM=P  „�IÈ™å;¥câ
rÑ²É%^¬&œð³L ‚ä×>#` ‡ s‰ÇÇÍëFÁ'{:íMà¢|/ å |$}ÁWìùVnw•¾'17­S	-
û
#CX¬Âý‰›qD½ä�¨AH£ÁúkàæH$  ØÅ -f‰àî			)	2	8	)

³ãíûPb¤8>—Í–E‘‰×D ›0¥yºX
cò×›Ó·BNW]4Å% ÜÝïIjTö?	ç�å î–}ÅÙFw{¬³Ã5\lzÂv™<oï wf{ÛdO� ¼	'	÷	�
1ÏekC@6eºâÞ<—Bíý( ï9÷Ô*�²SŸ¢$?O	^	ø
{Ã1¨)Í‡÷Yg“Ú*‚ËOŽ™Ø Ýñ^+	‘	«Uk‡
d§\qy–,ê~ ãQC –Û5’Z
M[~/Ýþ*Ð0o ©›4³Ûe �Ñ‘)N‰8Ò÷.ð1 z – ¢ ° W;4[h	,	Z	b	œ	!
Ú
õ
ý	(3aKAn°ÊILzá;Ýùx‹ùlÇ´Y¦¥) " gªîùý¸Åä$öüë	R
æ
v­¾Ç"wÙé‰èýÀËDÅ[„˜œÑü³ì ¦ Û /é(ýE‡´t
@
_
j×{ +¯Ü'çXÎ$ l ´ Ð é ¨ö@¿Ò(O�â’.®±
w
�õ,8»;p3ðQÍuì% ñ¢¼Î×	g‘ 8;IÇ
4
9
Ÿ
»ºxFª†’ANöu^Â½, ™ ZX¼Î,EN`ÿºØ°^¾Ê	e	s
§
—‚Ž+k"/h«ô Qit†%ºÀ ;€ÇBí
í•´�›ýâ* rÄ˜ä,ÌêUv¤&b¬ßí		7	R	,
ú
	B«È$âìOŽ–Ì@¢�G öezÓîi±¡>õ&	>	]	bdj¶†?A\Ê˜  • ¯ V‘ðYŒÐg	a	›	 
ô
(üªjýˆÏà/öÿ+-B²Ú1 k ¥ ³ Ï fõ?ÍÑÖüD7†Ä-­õê	

3
8
?
Q
ž
iu~½Æ!+7o*©®ZtWtÁÍ  :Íí_þ=Aìô=	Q	r
¦
ì
A–ªì�ÿP[s•á. ­ ® 89ô>Ì
ï;<`	

2
7
<
=
>
�
'ht}¼Å 6­üýþNOóôõ,Yrs±à  .à  qGACNNNNNNGTC,CCAGGCCTGG,GATCCGGATC,CCWGGTACCWGG,CCANNNNNTGG,CCAGGNNNTGG,CCANNNCCTGG,CCAGGNCCTGG,GCACNNNAACGTTNNNGTGC,CACNNNGTG,CCNNNNNNNGG,AACNAACRYGTGCGTGC,GCACGCACRYGTTNGTT,GCACNAACRYGTTNGTGC,AACGCACRYGTGCGTT,GACNNNNNGTC,GAANNNNNNNTTGG,CCAANNNNNNNTTC,CACNNNNGTG,AACACNNNNGTGC,GCACNNNNGTGTT,GCANNNNNNTGC,GAACNNNNNNTCC,GGANNNNNNGTTC,CAGNNNCTG,CCAGGNNCTG,CAGNNCCTGG,CCWGGGCCC,GGGCCCWGG,CCWGGGCCCWGG,AACNNNNNNGTGCACNNNNNNGTT,GACNNNGTC,GAANNNNTTC,CCWGGTACC,GGTACCWGG,CCWGGWCCWGG,ACNNNNGTAYC,GRTACNNNNGT,CCWGGYRCCWGG,GAAGNNNNNNTAC,GTANNNNNNCTTC,AACGGCNNNGTGC,GCACNNNGCCGTT,GCACGGCNNNGTT,AACNNNGCCGTGC,CGANNNNNNTGC,GCANNNNNNTCG,CGATCNNNNTGC,GCANNNNGATCG,TGANNNNNNTCA,TGATCNNNNTCA,TGANNNNGATCA,TGATCNNGATCA,AACCTGCNNGTGC,GCACNNGCAGGTT,GCACCTGCNNGTT,AACNNGCAGGTGC,GCCNNNNNGGC,AACNNNNNNGTGCMC,GKGCACNNNNNNGTT,CCWGGNCCWGG,AACTGGGNNGTGC,GCACNNCCCAGTT,GCACTGGGNNGTT,AACNNCCCAGTGC,GACNNNNGTC,GAGNNNNNCTC,CCWGGTCTC,GAGACCWGG,GATNNNNATC,GATCNNNATC,GATNNNGATC,GATCNNGATC,CCWGGCGCCWGG,ACNNNNNCTCC,GGAGNNNNNGT,AACNNNNNNGTGCAG,CTGCACNNNNNNGTT,GATCATGATC,CCWGGNNCCWGG,AACTGGNNNGTGC,GCACNNNCCAGTT,GCACTGGNNNGTT,AACNNNCCAGTGC,AACNAACCGGTGCGTGC,GCACGCACCGGTTNGTT,GCACNAACCGGTTNGTGC,AACGCACCGGTGCGTT,GCANNNNNTGC,GCACNNNNNNGTTCGAACNNNNNNGTGC,CCTNNNNNAGG,GCNNNNNNNGC,CCANNNNNNTGG,CCAGGNNCCTGG,CCTGGCCAGG,CAANNNNNGTGG,CCACNNNNNTTG,TTTAAACNNNNNNGTGC,GCACNNNNNNGTTTAAA,GCACNNNNNNGTTTAAACNNNNNNGTGC,CCAGGNCCY,RGGNCCTGG,CCWGGGNCCTGG,CCAGGNCCCWGG,AAGNNNNNCTT,GAYNNNNNVTC,GABNNNNNRTC,GAYNNNNNRTC,GATCNNNNVTC,GABNNNNGATC,GAYNNNNGATC,GATCNNNNRTC,GATCNNNGATC,GTYAACNNNNNNGTGC,GCACNNNNNNGTTRAC,GCACNNNNNNGTTAACNNNNNNGTGC,GATCNGATC,TAACTATAACGGTCCTAAGGTAGCGA,TCGCTACCTTAGGACCGTTATAGTTA,CTCTCTTAAGGTAGC,GCTACCTTAAGAGAG,TAGGGATAACAGGGTAAT,ATTACCCTGTTATCCCTA,GTTAACNNNNNNGTGC,GCACNNNNNNGTTAAC,AACNAACGCGTGCGTGC,GCACGCACGCGTTNGTT,GCACNAACGCGTTNGTGC,AACGCACGCGTGCGTT,TCCAACNNNNNNGTGC,GCACNNNNNNGTTGGA,CAYNNNNRTG,AACAYNNNNGTGC,GCACNNNNRTGTT,GTTTAAACNNNNNNGTGC,GCACNNNNNNGTTTAAAC,CCWGGCGCC,GGCGCCWGG,CCWGGNNCC,GGNNCCWGG,GATCGCGATC,AACNAACATGTGCGTGC,GCACGCACATGTTNGTT,GCACNAACATGTTNGTGC,AACGCACATGTGCGTT,TGGCAAACAGCTATTATGGGTATTATGGGT,ACCCATAATACCCATAATAGCTGTTTGCCA,ATCTATGTCGGGTGCGGAGAAAGAGGTAATGAAATGG,CCATTTCATTACCTCTTTCTCCGCACCCGACATAGAT,AACNNGCACGTGCNNGTT,GAACNNNNNCTC,GAGNNNNNGTTC,CCAGGWCCY,RGGWCCTGG,CCWGGGWCCTGG,CCAGGWCCCWGG,CCAGGWCCTGG,TTATAACNNNNNNGTGC,GCACNNNNNNGTTATAA,GCACNNNNNNGTTATAACNNNNNNGTGC,GAACNNNNNNTAC,GTANNNNNNGTTC,GGCCNNNNNGGCC,AACNNACTAGTGC,GCACTAGTNNGTT,AACTAGTNNGTGC,GCACNNACTAGTT,AACNAACTAGTGCGTGC,GCACGCACTAGTTNGTT,GCACNAACTAGTTNGTGC,AACGCACTAGTGCGTT,AACNNNAACGTGCNNGTGC,GCACNNGCACGTTNNNGTT,GCACCCANNNGTT,AACNNNTGGGTGC,TTAACNNNNNNGTGC,GCACNNNNNNGTTAA,CACNNNNNNTCC,GGANNNNNNGTG,CACNNNNGATCC,GGATCNNNNGTG,GATCTAGATC,CCANNNNNNNNNTGG,CCAGGCCT,AGGCCTGG,CCTCGAGG,GATCCGGA,TCCGGATC,GGCGCGCC,GCGATCGC,CCWGGWCC,GGWCCWGG,GATCGATC,GATCATGA,TCATGATC,GCGGCCGC,CCTGGCCR,YGGCCAGG,CCWGGNCC,GGNCCWGG,GGCCGGCC,RTGCGCAY,GATCNNGA,TCNNGATC,CGCGCGCG,CCTGGCCA,TGGCCAGG,CGCCGGCG,GTTTAAAC,GATCGCGA,TCGCGATC,TTAATTAA,VCTCGAGB,CCTGCAGG,CRCCGGYG,CGTCGACG,ATTTAAAT,GCCCGGGC,GATCTAGA,TCTAGATC,CACCTGC,GCAGGTG,CCTNAGG,GATCGAT,ATCGATC,CCTCAGC,GCTGAGG,GCTNAGC,CCTNAGC,GCTNAGG,GCTCTTC,GAAGAGC,GGTNACC,CGGWCCG,ACCWGGT,RGGNCCY,CCTGGAG,CTCCAGG,GGTGATC,GATCACC,GATCNGA,TCNGATC,GGGWCCC,GAAGATC,GATCTTC,CCCWGGG,TCCNGGA,TCCWGGA,RGGWCCY,TTATAA,AGGCCT,GACGTC,GTMKAC,TCCGGA,TGCGCA,ACCTGC,GCAGGT,GGTACC,AGTACT,GGYRCC,CCGCTC,GAGCGG,AACGTT,YGGCCR,RAATTY,CTGAAG,CTTCAG,CACGTG,GRCGYC,AGCGCT,CTTAAG,ACRYGT,ACCGGT,ACTAGT,CACGTC,GACGTG,GWGCWC,GTGCAC,CYCGRG,GGGCCC,ATTAAT,CCTAGG,TTCGAA,GCTAGC,GKGCMC,TGGCCA,GGATCC,GRGCYC,ATCGAT,CACGAG,CTCGTG,GGCGCC,GAAGAC,GTCTTC,GCATGC,GTATCC,GGATAC,TGATCA,ACTGGG,CCCAGT,CTRYAG,RGCGCY,AGATCT,GGNNCC,CTGGAG,CTCCAG,CTTGAG,CTCAAG,CGATCG,GGTCTC,GAGACC,YACGTR,CCNNGG,GAATGC,GCATTC,WCCGGW,GCAATG,CATTGC,RCCGGY,GCGCGC,GAGGAG,CTCCTC,CGGCCG,CCCAGC,GCTGGG,GTGCAG,CTGCAC,CGRYCG,CGTACG,CGTCTC,GAGACG,CCATGG,TCGCGA,GDGCHC,TGTACA,TCATGA,ACATGT,GTATAC,CCWWGG,CTCTTC,GAAGAG,GCNNGC,CCRYGG,GTTAAC,RCATGY,TACGTA,RGATCY,GCGATG,CATCGC,GCAGTG,CACTGC,CCCGGG,CCGCGG,TTTAAA,GGCGGA,TCCGCC,GAGCTC,GATATC,CTGRAG,CTYCAG,CAGCAG,CTGCTG,GAATTC,ATGCAT,CATATG,GTYRAC,AAGCTT,GTNNAC,TCNNGA,CAATTG,ACGCGT,TCCRAC,GTYGGA,GCCGGC,CMGCKG,GCCGAG,CTCGGC,CTCGAG,CTGCAG,CAGCTG,GTCGAC,CTYRAG,AATATT,GATCGA,TCGATC,GACCGA,CACCCA,TCGGTC,TGGGTG,WGTACW,TARCCA,TGGYTA,TCTAGA,GGATC,GATCC,CCWGG,GTCTC,GAGAC,GCWGC,GGNCC,CCSGG,GGTGA,TCACC,GGWCC,GCAGC,GCTGC,CCATC,GATGG,ACGGC,GCCGT,GCNGC,CCNGG,GCATC,GATGC,ACTGG,CCAGT,GGATG,CATCC,CTCAG,CTGAG,GGGAC,GTCCC,ACNGT,CTNAG,CAGTG,CACTG,GACGC,GCGTC,CCCGC,GCGGG,GANTC,CGWCG,TCNGA,CCTTC,GAAGG,GTNAC,GAAGA,TCTTC,GAGTC,GACTC,GTSAC,GAWTC,GCSGC,CASTG,ATGAA,TTCAT,ACGGA,TCCGT,CGCG,CCGC,GCGG,GTAC,AGCT,GCGC,CTAG,GATC,GGCC,CCGG,CATG,RGCY,YATR,ACGT,TGCA,AATT,CCTC,GAGG,TTAA,ASST,TCGA                                                                                                                                                                                                                                                                                                                                                          -                                                                                                                                                    	                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                                                                                                                                )                                                                                                                                                  
                 	                           
         
            5   "         
   
               
                                                               	                        1   #      !   !         "         ƒ   Z                     \                                                                                                                                                                     -                                                                    	                                                                                                                                                                                                                                                   
                                                              )                                                  
       	         
   
    5 "   
 
     
                     	        1 #  ! !   "   ƒ Z       \   v<  wt  w’  wÒ  |>  �>  ‡Œ°|…k eÖ×îþtÑg¬		e	ê	
?
@
_
¦
ì3Nn‰ÀÒx�(hrb†Î¶n
KÚI€í¤1½” UÃŸ¿] ÃÖÖ¶m
�Ø ” .U²ÊÃHÃã]a½	%	 	m
†
°
²
Ü
÷
�ØZ`X¬ÃNTÉí)ªÖ*mßŸªÄ‘¤‡q(r˜1((˜Ä©½hñr%Ä+v¾Ëç	c·®ÂäáËáO
É²»ÍãÙ‚¤Å1{c5Ä–jW¬\‚o
ŒÄœI	ÁÆš‚:“ÔÄê	Q
ã*pã‚Â’¹ î Aû§ÚÃ3:Æèƒ
Ë	»j.1ÿ’½’^f‰°ùõ
Êzå ktƒ	·>Y±µ,>ãG&ä”¿ ×¹ î Aû§Úf&uEÃ‰* š°? ¤Wt˜êÔ’êsÈêêÈ‘ð¥ªF KÊØ•|áù`êƒ-ŠêÈ·žt˜vU
�
Ð7·]Åf0	•Ýø™
7d�xÈ*f!ZLj¨
˜¹xè
ð
f2¤~
Ô’ž$‰ì‚ƒ—	ç	
I^yÁf‰°ÎõùW€S¡œ÷‡‚ î5™œ	
p’…•¨Íïðñ,˜ÄÅI‘±	ê	ë	Q
R
u½8[•ª
«P~�	†~PIcD
	¦[x}ôÄ‚Ÿ	~Æ‰
_à$–[	Yœ1 ¨±8 t˜ù`êvƒU
�
-ŠÔ’ÐêsÈ9Ò€p°3¨˜±8•d'	6BÄ–” U|¿èá]f¹		ð	
W
m
å
ó
‚•ÊÝûµ�ÒØôø!%[xßüi¿ä›@¨I‘±	8•Ýø°’žK	~
Ã’1<’žž¯Ô �V‘…Ýöl¶ØhýÛÒðª	ƒ¥¸lMh:'2øŠÆt˜&ä”œ¿÷ ‡‚×€ÈH½Ok	¼µ—ß). ž:ÆèŒ. Y8ž‹Zê‚¹Ê3:êÒÈÆè �!vËx´½HtÎï6ì™�ã6€ƒpÏÙui* š³n&H	³*	[x#Õjhý	‡
Ïþù¦Z.¨y¥Lj˜#Õj‡
Ïþ:Æè‰¥î 5™O°|2cÏ+Ëßå	óX“ö aöiŠ½9½ÒŠòzÈ
#‚ÈÆž‹K	ÃÛ’1’žÌŸaƒç=Ÿo°Ý™ ZXÎ,Åä°Êe	ë	R
v­¾é«ËDQíºmÝ” 'ˆ		
Ïp KN&Ôjj¶	[
†
Ñ
?¤Î÷T×½ QcGJ`Î “ TbËßì]ƒá	Îò	W	ç	
O
p
�kW¦·•Ýðñ^+ª«j
q+ãB¬I
{øUŽ!˜{ébìƒá	ç	k·•N&Ô[
†
Ñ
¤Î×½GJÎ Kjj¶	?÷T Qc`Ò�’�;3QÍì9ˆ~óŸK¦	\–M KN&3ÔjZj¶		"	Y	[
j
†
­
»
Ñ
`?J¤©Î÷NQT@ É×K½ QcfÜwGJ`³Î-™ ZXÎÝðñ,^Åä°+Êe	ë	R
v­¾ª«j
éq«ËDQ+ãB£Q=™á‰ÉÜÜ$Ü¯ÃGFö=Û*óCPgª"èÅ[Ñü³žÕž·ŽBK>Îí?	Ã\ïmmþ5á x ‚‹-ØðsBóêè	rºúŠ K]“¥=îŸáUÁ7ŠÑ§àãm?	mþÃ\ï5|«÷mw^ó\·Øh’í†âýÛHBOÒEú&uX.	F• ¯ Vg	a	›	 
ô
üà!ÖÞ	¾
éŽÚü�ÎF	·ÍLÒBgL—#(ëu³c
½Ùÿ%9/6ÅÈœÚ4T@	I	LlÁÆDœýd nÏUÜš¥þÄ,ßí		7		âìO–Ì�„	”	L
í¢£~ Õ 2TÊ
Ö
àÊTÈã.h½Ä–:re(	1	(
ú£7•ˆÖCF	·#Ú�ÍL(ëTÖ
à.üÎLÒBg—u3Z	"	Y	j
­
»
`J©NQ@ ÉKfÜw³-«Ø÷hm’wí†âýÛHBO^ó\·Ò “U	±pd —Õ	NF¬ê�	,Ê�ï + { ›Õ	-	�	Ý	"
¢
º
Î
F¨Õõ�Þ#mZ¦?z – ¢ ° W;4[h	,	Z	b	œ	!
Ú
õ
ý	(3aKAn°ÊILzá;Ýùx‹ùlÇ´Y¦¥²ÓPç!lyNÖÿ	"	Þ	j
­
»
¾
©éNQi Ž#fm‚r†-v 3j‹¾[“óž:¾Ó‹?ª·Õ˜óu�™$Ù(Ökä"£ˆ
/0p¦°Ðš¿DJ`¿ÿuWßàéMŒN Ôž	„
£
°
¹
Ï
é
ñ
_g§ÌÖôöÚŒÖ3Tb¥	·$­
[§>@ }¥â’
î
–BFŸœëŸŒL	
ÄÉÜa²»	ƒ“ç2=E“Ÿ]o�Ÿ°ÔÍÕÝ  “ TÂËÑà]	Îò	$	X	
O
p
ŽY_“
¸?Z¾ÉÛ�W§²Ýñ^+	‘	«Uk‡
d§\qy–,ê~ ãQCm©À)ƒãôb²–Þ9æ?ù2˜,W±�lvÄèqo  i “ œ Tu{�™û&<ÂËÑà$*WÙ(]ÂÖê9krä	“Î"w|£µò		$	X	t	ï	
O
V
]
p
ˆ
Ž
!/Ž0yÁ<Y_p‡“™¦°
#>W«´¸ÐöBSf¥ÑÛì?Z^ƒšª`{¿DJ`”©¿ÿbu¾ÉÛõWßäýL�˜ÃàKW€šž§éCMŒ²N^' f m o q ‚ É Ñ )+bmu©jlÀ)iƒãÖôb¯ÀÏÞí L_�©Á²¢	×	x
�–ÕÞö9Q¶æ&?Xù2zT˜Ã,4W]Ž�±ñ:k�ÉËÍ@lvÄÊ×è*a>q}äoº Æ ï B“üAXµÞ¨Ûèb
†±½Û–o„ÄMk}ç%—Âë�˜×àSŸú™HV¼ ëb¼}ÕÉmS ¶°v-�?JN èDäq‚Í©ÛÚHjöezÓîi±¡>õ&	>	]	bdj¶†?A\Ê˜d[è{–Är	W]‚…‘Ù¡ #g÷H.G „ŠGpµ
Ä&7BLËr¦«¹îÙ mKº Æ ï Bq“üeu�™õW»$3Ù(ÖAXk—µ¹×äÞ"£¨ÉÛè	b
ˆ
/a†±½0¯p¦°�ÐÛ#j–š.Z¿>DJ`¿óÿu$W…½ÐßhËàošüéMŒ„¿Ä/N¦ü	dØtŒ°R@;¸Çé  0   
    è        è)ª3Ž³œFg2‡hi¡ä¦–ImiÀ-¤­“öf¯2�—§	X?>?\óö‡-e‡&+öIsÖ@z½¡ËXjp•ã÷ ÒvÔ‰¶cÔœÿæ‡-aÂVÏƒi�Òv¦êùè4�¹É¤¶Îiöc
 ÒvÖ dÂ¡íÀ½K½ÿhrÖ**ƒ}V×êõX²]{Ïö‡5`0�Èœ ¹™M¸92¥zS Ÿ°oy/H‚¬÷Ø3û°0ÈC#Ã;žü ŠÛNŽ8çœùÏoN#d‹Øv‚Rˆ�¶›nz¨Ö*.g�WÚ©Ú?ao­TZöîé�QhàDDõE?m+„14õGëöç}Ø¼3[Æh‡F=ze_GÎ-¶ŠòâXš¡FÛhý€…Öˆ jµyÕ®¾º®ƒ§»Ž'�ªÚ8çÆ§Iªm u`¸øgµ=JöiŠ©®£�9Š®-:/»Š‚›hàä´ÕY[ž¤CkEoI©Áte´è
´•]„u" †EgƒŠ}&«RÔ!ƒŠú½z>Š_A¾_®{ãåk]!U¾}ô«ãTû„D¿Döï¥»GàtDÓ5€P5O	„×øÚ^`EÄ{±'öqÉøi�zo¦Ÿ†˜äæúa‹ôyÍ’?»m~àiÕj!Q¡àšéyŠ;êœæ g8êXú‰¶9£¯Éƒ«j»ï¢eo‚Ž.êa¢Ê-r‚#xŠŽ×ÿx(h÷ß‹Nú¼«:¿ûù£Ü0^Û<øú?8àt°â€ÞkÈ"‹ S‡/«Ø8ìøŠ=øã0¾¸ç/ëíoL¯¯Ì>8ðî0û¯2ë>³ûGÁ»ú€óïóàW åá]ÁAgÁA3˜pÖUGE•sp"€²¢¶W0
Âýƒ{‹ÿ|Gý YÏÌ«¯ªÿßÿR°!CôÍ=rÀ0Ðþ=“Fã4àä ›ýÌþ$Ã6”Ì0")ÌÓ!ó�èôÏäÏÎú³«¯ëêì÷+<:¿ËS¹[ Ûú�+Æ¤Ž§ûõUèi+rHlþ*¬þ¡Ê½ÊêY {¢½^×{_æì.kª™@j€°ù ¥U„á©uV¥ÌZZâˆ‹J@ˆ/ô;ý44RcTØÛµ¤´×Ðˆ/ô;ý44RcTØÛµ¤´×Ù/Ïù{ÏÛóþ^óô¯?k¼ÿ`áåªªjcD<CÏ¸û„æ½’Cª Cä:£UNüè™½ªÁ¸mDtA²¬Øh]F�Í
ï:CšÃ˜x×G[;†<ò+Ã‹LÐü+ª‹Qñø¼#øX^4CLÃ› à÷¯£4â;¢ÞÀP9 1Hðï‹nß£¾<EI½¶Ö0Ã�œèo~?k}LWlÛr{<.‹A†àqDÛ@;3ÓÅâ³ÐíC3cñÃnË!ýƒøèñfØ UƒÎ«�­±â Áó›AÙ2ƒŸÈfŽNƒX:û#©Âló¿Í3lúæÏ®‡ºá0à
ÌVSý~=·«÷Ï>¹…B€ë²«ÀsÃ�†ûÓ0íŽ®³÷ýz*hÓ¦X)Õ•5“mÕ«ueMª«xÚä¢
‹Õíµ‰ºm‹‰Ÿ,~ääNƒ%¶dâ¯ˆ…h¦ó·Z÷uÙÄðSeH•> �–—·ihÊ3·�Î¯K_‹#Ó�¥…°õÌÀ*2hî¼ëìíáìã;+0ÄÂm;{T0–p¦÷E´—4bUMT=òUCÌ£ƒ*¯d;Ïÿ‡mÕ[íKD Å™QŸC*ÿàS¿²3»â¼�:|ø¼ú»úÀS Î®Ö;s‰	»JÂ$,¬ïS€â#qü­?8Ï¦ð—›.„½	Gqé³Þ4÷‚]“DÄ&$0ŽtJèR>^pçy& ›Œî8SÒŸ¬Q($î†ðÕÕ÷Î	0‚ª¢£SMs4UTµo¨n«œáÎÒÅ^Ü¥ªamUë~Fú¥iU…*•µ¹Rfa%z‡J}c¥´„7æí1¸¹«+od£áïòÈ‘—œg§Ûƒý#�aŸ1ÜíðïF¦ÓY_OOÄÍ‚ø×©¼ûÛÒæ–Š<9RJÏJY*3\¢�hçCl‚-ÎË*	ƒ­­;Â¿\mC�†ÿØ¢5U0¤ï¬/¼l¢ÑIJ4Šmí‚˜4Þ6Zîž-�o%ê¸‡‚{_RÚáH˜ÃŽèü2ÖpgÌ÷dÑz•Hí¶�W+¬{µéóŠ½+—÷²7õáºÓn©êßL«€„Õ]V<ÕT”wb…žÙî¾ªÖi¡M©´
h»a0gf¡bjEVWV@+ÌÝ«üU#ß‡,plnüoù‚Ç»IÖã¸cÍ’”ô›Žþ:"(³„’3U©NuÔ5‡ÇZ6[Ž�  »  
  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  $/<?xml version="1.0"?><Features nextValidID="20"><Feature recentID="19" name="AmpR" directionality="2" translationMW="31558.16" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="6754" readingFrame="-1" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment range="5963-6754" color="#ccffcc" type="standard" translated="1"/><Segment name="signal sequence" range="6755-6823" color="#ccffcc" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="18" name="NeoR/KanR" directionality="1" translationMW="29048.78" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3662-4456" color="#ccffcc" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="17" name="WPRE" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1920-2508" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;woodchuck hepatitis virus&amp;nbsp;posttranscriptional regulatory element&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="16" name="ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5204-5792" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="direction"><V text="LEFT"/></Q></Feature><Feature recentID="15" name="f1 ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2824-3252" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="direction"><V text="RIGHT"/></Q></Feature><Feature recentID="14" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="50-429" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3266-3595" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="430-633" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3446-3581" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4632-4753" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="AmpR promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6824-6928" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2574-2622" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="lac promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment name="-10" range="4850-4856" color="#ffffff" type="standard"/><Segment range="4857-4874" color="#ffffff" type="standard"/><Segment name="-35" range="4875-4880" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for the &lt;i&gt;E. coli lac&lt;/i&gt; operon&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="CAP binding site" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4895-4916" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;E. coli&lt;/i&gt; catabolite activator protein&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;CAP binding activates transcription in the presence of cAMP.&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="M13 rev" directionality="2" type="primer_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4802-4818" color="#a020f0" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;common sequencing primer, one of multiple similar variants&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="lac operator" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4826-4842" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;lac&lt;/i&gt; repressor encoded by &lt;i&gt;lacI&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;The &lt;i&gt;lac&lt;/i&gt; repressor binds to the &lt;i&gt;lac&lt;/i&gt; operator to inhibit transcription in &lt;i&gt;E. coli&lt;/i&gt;. This inhibition can be relieved by adding lactose or isopropyl-Î²-D-thiogalactopyranoside (IPTG).&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1899" maxFusedRunOn="1899" detectionMode="exactProteinMatch"><Segment range="1810-1836" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="2" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1899" maxFusedRunOn="1899" detectionMode="exactProteinMatch"><Segment range="1840-1866" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="1" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1899" maxFusedRunOn="1899" detectionMode="exactProteinMatch"><Segment range="1870-1896" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="0" name="Zdhhc2" directionality="1" translationMW="41982.66" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1899" maxFusedRunOn="1899"><Segment range="706-1803" color="#ffcc00" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  ><Notes>
<UUID>133751de-e061-46cb-a9a0-62e6e87ef9e0</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<Created UTC="5:0:4">2019.1.23</Created>
<LastModified UTC="3:52:9">2023.7.11</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
</Notes>
  ½<StrandColors><TopStrand><ColorRange range="699..704" colors="green"/><ColorRange range="1220..1220" colors="red"/><ColorRange range="1703..1703" colors="red"/><ColorRange range="1793..1808" colors="green"/></TopStrand><BottomStrand><ColorRange range="699..704" colors="green"/><ColorRange range="1220..1220" colors="red"/><ColorRange range="1703..1703" colors="red"/><ColorRange range="1793..1808" colors="green"/></BottomStrand></StrandColors>  õr   	    é        é)ª3Ž³œFg2‡hi¡ä¦–ImiÀ-¤­“öf¯2�—§	X?>?\óö‡-e‡&+öIsÖ@z½¡ËXjp•ã÷ ÒvÔ‰¶cÔœÿæ‡-aÂVÏƒi�Òv¦êùè4�¹É¤¶Îiöc
 ÒvÖ dÂ¡íÀ½K½ÿhrÖ**ƒ}V×êõX²]{Ïö‡5`0�Èœ ¹™M¸92¥zS Ÿ°oy/H‚¬÷Ø3û°0ÈC#Ã;žü ŠÛNŽ8çœùÏoN#d‹Øv‚Rˆ�¶›nz¨Ö*.g�WÚ©Ú?ao­TZöîé�QhàDDõE?m+„14õGëöç}Ø¼3[Æh‡F=ze_GÎ-¶ŠòâXš¡FÛhý€…Öˆ jµyÕ®¾º®ƒ§»Ž'�ªÚ8çÆ§Iªm u`¸øgµ=JöiŠ©®£�9Š®-:/»Š‚›hàä´ÕY[ž¤CkEoI©Áte´è
´•]„u" †EgƒŠ}&«RÔ!ƒŠú½z>Š_A¾_®{ãåk]!U¾}ô«ãTû„D¿Döï¥»GàtDÓ5€P5O	„×øÚ^`EÄzìIýœr~c^›é†'á¦99¾˜býsd„ÆnÇ[_¸uZˆThx&º^bŽú§9ˆÎ:–>¢mŽhëò`êÚ®ûè™[à£‹º˜A(ƒò‹C\ƒ ˆÞ"£‡5ÿÞ
 Ú=÷âÓ¾¯êÎ¯þþh÷¶Ï>>�Î8 ì8 7‡Zò¢ÀáËêö;>"�~¸Ì/®9ËúÃû[ÓëëóŽ<;Œ>ëÌºÏ¬þÑÄ°nþ <ûüøÀ9xWpPGYðP_Ìæ5•QÑe\Ü ,¨­•Ì°¿@àÞâÆßÿhÖsó*ëê¿ß÷ÿÔ¬Pý³O\°4?�dÑ¸Í8¹ &ÿs?‰0Í¥3‚
s4È|çz=3ù3ó¾¬êëúú»=ÊÏ¯òÔîVÀ6þ¤
ñ©#©Ã~ÇýUz@†
Ü’Û?†G
«?¨r�/rº–Hè¯W�uÞ×ù»šê†¦P ¬>h)Ua8j]U©s–¸�b"Ò�"KýÿM˜Õ66íi-5ô"KýÿM˜Õ66íi-5öKóþ^óöüÿ—¼ý+ÏÚï?Ø8yjªš˜Ñóî>á9¯E$„ê¨ù¨ÕS¿:&oj°nQl«6Q�£sB»ÃÎ€�æ°æuÑÖÃŽá�<ŠðâÓ4?
ê¢Ô|~/þ�Ó0æÈ8=Ç+èÍ8ŽÇ(·…0ƒŽhR<A»âÛ·èï�Romƒ†5Œ0ãg:ÃŸ�ÚÇßSÛ6ÄÄÜžÁ�O¢ÆÐa¸Q6ÐÌôñx¬ô;PÌØüpÄ²È`Æ>:<Y¶`óªàklxƒÃ€ˆ0|æÐvL çò£… Ã‡Î¾Èêp›<ïÆ³LÛ>¹³ë¡Ä®¸L¸³‡ÇÔÇ?_�mÄjÆ½óÏ®aP :Álªððàa¾ôÌ»c�+¬ýÿ^Šš4é–
ueMdÛujÝYSjªÞ6¹(‚¢õ{mbn›bâgË¹9 Ém‚Ù8«â!Z)¼íÖ½Ývq<ÙR%O€#å„„åíÚZ2Œíãó«ÒÀWâÈôãial=s0C
Œš;¯:û;x{8ÎÂÊÃŒ10›NÞÕ%œ)½Ñm eÍEØ„ÕCÓUA|•Pó(àÊ«ÙóÿáÄÛuVÇ;RÑ1_ÇAæTgÐÊ¿øïìŒîø¯ãÎŸ~/>®þ°È3«µŽÜâBnÒ°‰+;Ôà8ˆÜ_ÿ+OÇÎ3é¼%æË¡/_ÂQÜzl÷ƒM=à—A¤Ñ1	‰#�º‚—œ9ÞEI¨&ã;Žô§ëTJ	;¡¼5u}ó‚L ª¨¨ÔÓFœÍUíEêªç ¸s´�qW·)@j‚ØF›UAºß‘¾©ZUaJ¥mnT™˜I^‚áÒŸXém!ù»Ln.jÊÛÙ(ø{ü²$eçÀ@éöàÿHãXgÌG÷;|;Ñ©´ÖWÓÓÁ@ñ3E ¾5êo>öô¹¥¢�ND”’³Ò–JŒ×(£Ú9ÐÛ ‹s²Ê‚`ëkNð¯×PÄ§a¿ö(�UL);ëï(´RRƒÍ"›{`¦7�–»§‹cÛÉF:®!à„ž×Ô¶¸E’&0ÇÄ£º?µœYó=Ù4^¥R;m UÊë Å^íAº|â„oJÆ%ýì�ýxn´Ûªz·Ó*à!5WACU�5UeÁX¡g¶{¯ªµšhSjmš.ØLÙ¨Xš‘U•Õ�
ó7jÿH÷áË¿þ`±îÒu¸îód¥=&ã¿ŽˆŠ,á$ŒÄÕjS�uC¡ñÖ�…ã¤   »    É      À®ZTR

BASE      ª¢  xÁA AÁ³¶á10@x` ýçª¾³}¶}§'½÷žõžîîÉ¶ôÞ{>ëüžÞ“¥“¤gßÓé½ç»Ó�ß�Îç§;ßÝ»³üüüÞéÝ;Y¾“ßél¿÷d¿w²ïü¤{'ëîYZ›6l][º­t[·ŽeëÖ�µ[·±RR¶ÐvccÐÐ¬°²²­l´¤¤kI×†6+c£[’4°±¤É`Œµ4l…ÐPR Ö„£l4¤lIÒ€4°¶a	-4I–@J)„5Ë’,�•-Ë²¬M–-KÖ64[2(ËÖeÍÚ$KmCIÓfKF»uMhciÖ&…�$m–ve440hGIX²°…†Ö6lcIƒ- MRÒ$Ph¡ …­�RÊÊHYÐÀÊJÚH3š`K“°QÖ²�Òdm2hC €@�•5+a e4+Œ–RlXÙJF³&IHBI�,[Í’ÐfÈÒtKš…dI·@³Â6 I’†ei2l,,K–„”­Òf Éh²±°•A´Ia-’6[hYÒ¤…’Ò²nKIMš±$	-K’6m´¬IÖR–em³¬¥…d”fiÙÒ,ËšuMÒ–mÉ¶&Y»–5iËHJØ²¤ËRdÝ»{òÓ{ïžô|Ow¾g?¿÷îYÏ÷ô¬{òÓ{wÏ÷tÏ÷ôÞù�ïÝ�¤{~–uOïYïI–ïžýôÞ{¶Ï÷Þ»gß“ïülÙïÉÏgŸ,ÙöÓÉÏç»ç§“O¶ßóI¶ÏÏz>ùÙ'[ÒùùN¶õl[–,Ùçç÷ž%ßÙ'ŸeÙ~¾w÷Î>ßI:û¬w§÷t¾ÓùÎçÓ“Ïgûä{:½'Izò�}w§gŸô¤'ù¬w²d[º»'Û:Ù–$Y’Ÿ}ÒÓ�îÞ“õ¬“NòIöI:ùôùÍih  9ä     9Û®ZTR

SMP4      5¸rU  xÁ[È÷kzôï÷ºw¿Ýó<ïn­É$NÖšI553ÓJÓ¤I[QK	‚ARQ‘6A°r‘KOn<ðØ3<Ò
¢žkÓ™ÌZëÝ<Ïóßþ6÷}_—Ÿÿ­ÿÈ¿³ƒbôÝ®ëºC7½é÷ÃþÝððú§Þ|þù·¿øÎg?ý�ŸþùïþùwßþÁw~áÛÀÏ}?�¿€?\öøCàÌþßÊïð‡ù–ÿYüN~Ä»<áÿûßð›ø¿ü£?ÁÿõÕÿûÇÿçý“?ýþøO>üøG?þ§òtzùôüüãûóóõår_–uYZ5Uü:þB9œ½ÐLjÌ¨¤Q¥Fš’
ÀH%˜ŒTRI3‚€0 FªÑ,{ Ò  A3£3˜Á`& F 5±©�Aœ…0Uk±&m„JíÔDq hfjf4£ÁL©	Jg®:%A˜ªµX“™R FRÄÁ5ÂT›¶f-Á;xP}[}‰-	áŒ&� •T‚ H•¢ i •4©`ëÔ@S FR•0ƒ6Z¢S� �5q­zI�0ŠÌ¦¦Z%©¯mÓ‰"	­€DÐÌ�0XõURˆÎqsk w1ˆ53x:aþ5¬ºVcp=Ì¶Ú &A æG-V×œóc
Û¶nZ,zñBaþ+0X«„Hìú¦í\Ñ:"¾Rò¿ ƒµê|ð¶PàÅy£åƒµ*Þ|ìLÚ‚Ê€`–ùa`hìœ×z¾oâƒ÷d6äÏa VmÚ?ì¹œ?=9ô“:Ò,*Šbw�;Üž¾ùt»I¸’šÿ+ÁŠjÃaàm™nèžš©m¦}òå6_k#	Ó|�lÜLŸE?¿ÿt÷i®[’œ` uÁÒ=¾:â«çg“7c€º˜¿`óZÒñµ_ôÍ×ØMƒçXþjm�t�m».f©óFj~#Ð*pèS›çSå�Rk¤æß€T×¤;ôÒníŽ~ò¡€mÚÜøÙNî§ç�ì…Å`ùW` ¶Ùü´·å~¾"…ä«Póç0 :×Ú†~¾�WÙ}¼ž.—¹†¡¶ÛúbÁ�SW~rýH¤Þ™« ª˜¦Ñ®óÖZ|¬BÍ#KÙÊþí[”_�4…·»#æõéÚº4H… ¨4ìûaÓËz‹ˆÝ¾Ÿ—ë|�cJÞHÍÿ jAñé¡×óõzú^=¨ùW`€QËº¼z÷.ÿøëçÛãa®
Ë=Œ€ÎÀ´ŸÛývgLÎ±1¿ƒe�Õj|óö°Ü>~šw¯Æ¨æÔ˜F°²¹½—2_¤³aüyY¯»ÁÆüa VTŸ¦Äz)Õ£8`X±áÕÃþ|yúˆØ�^©fù{0Ö¶ZÿpT¾ÿô„~ˆcïoëýöèöi7Úírrúñ8øùùü‘®@…åFja‹i×ùv™‘:'¤æÂ VnêŽ‡Nž//Lñ Gf«¹0$+÷Ö…àó_…46ív»ÁÝ–—hÝh 5O0s5ÌâÃÎãÏ>~�úilÞn·u>Ä 5ÿ
Œ :õ}×‹Þë¼øG¯õvŠ…ã4íu[Ÿïnãa29ŸN·eßh„��ó’ö?³ÇûOß\.ý4¾êF]Ï—Y¦ÔUW™¿€‘ªk‹Ã8´ºl&~ÇP…šÿMÀ&K±Ã›Çº|ø
þ³Ýnm
X~#¨„¥½³y½iÆ`0 :¯%><ŒåÃÇS}è§ØÐ*ºmEÇ·o¶õé'W{¯†7¸ŸÏ÷g¸0u‰Ûürs¾�„Ñ¨õ¶õŸ=âvýÑö¸?v#ÊõÓm~œ"ÌSóoÀ jmwß½}ÅÓùùë6ì�¾:…�¥]\ÿù—ÀW?ù'À»wÖ5Z�oŸ½9¶¯¾ù3àÝënm°®¡µÛ²{üÜ×}ý¼a?�3AÍoa¤šëBß–Ûz7q}ê¹Ý–óâ»!€�:—»ÞMòÍûß¯ãtlÍ`š˜	u¾]íág�¯¾úã÷x|µó¶ÐÈV–%ìßŽ§�O?ZžwÃã›]Ø^.î©;z€ÔüŒ`ñ…ÓÃºl·—üÔA…šG©-úÔ–õ|Rrž�yEiëÖ?¾ÂõÇïrë»7Çé0/§—÷!“újþe –v[ã«Ÿ	¸üÙ{`:˜6…å/`Ù£¬ºMŸ¿»¼¼ÿúc˜†×R™GÙjÙpÜw~»œ_àöˆ›§æw0²Jsat+×ûºÝn±]ï·ÕùéØíZ¹Üg‹¾«®Â@-õ*ÃO½í?Ý~üÝñ�šFª-(iÚmõ~¹¹vŒ^Ø˜ßÂ¢èÂýë>Ýž?uá¸¯J¡¢:Ã4_¶eGO�æFj­†cte9ÙS6æ`këÝ½~wÀû�ìSãæ¨¹ƒ‘j[E©óõºÔ]ìŠ5ÿ>Œ`CÑ´ÛË§û§ÛÕ¹ÝÔK­×kC7Il¤æ/a mm³ôêmº==exuN€m­Ú~]»œ®û0jþÔZ7×Þàþüñšüað0q5V§¡ïÇ‚m-Æ]¨u»oã›oíï_õðö5¥°1#µ ¥iÜ|½V‡)îýÂõ:o2úTÙ˜ßÁKíö¯»ß?½Oé0²Yö¨(Ò=FàT_ >öG`]oëµ†ñ¶­.3jÓñ0Èíz«Ñïºæó#uc‹ièëVÊÕlbhŒ¬X6<¾9Ö—§ožñ0uÔüÛ0²U®‹ÉÚí®*œ¶hšw0+h±›âZo÷Æ0©ù¿†‘­Ýftoß`ýx{±º‹Éµf´‚5º}§u»>_ÊãaŒa-—2/pÓü§ù²Þ´©ÁåÏ`deƒëFæy¸žÊüC©º˜¹‡c¿Þ¯/-uÓ«1èõô¢%ÆdÎŒlu™—ãÛÏ»öáëjÛë7cwsù3©í^×~÷x˜¿9½lCï\ad¥Ò÷#Ë¶œ×.ù@1Í;*Tø Ôu]—>ï•ù¯ÃÚ"Óè/×ù‡à¨ÌFØ¶Ý1<¾“ûöþÃÕOãã0¬Ëùþ’dèúÇ–�±ïµÖz	@÷ˆ®è½^t]¿hþ=©6×kÜ½y£/Ïï¿nâƒ
ó/ÀÈ
"uÉd¾]�Ø÷ccY×ù.œ~+åö\"Á‹2O06)Õíö»ðt»Ý*RŒêl¡i¯©™×u-Ò06lwÜœ÷içûµÜ.|ŸÄkn0)q•æÆ×-n·ÛSÙqT—ÿ ª³ O}œÛro‚>
½äÿÖ*]—¢S�µp¤wÊü;0«¨ˆ»Ý�æeFuÝà….£ùY+¦×:éóËÓ²ë�"´ü´Â˜¦$¶•¶P|‚ƒƒÚ†€^¼•²4Æ>0ä	F:›uÝ«èpZ®NÃ.6¯ù{0kJ	Ã°mg»#ÄX]ËŒ(�É%µuC18Q�uá8½9àvút½÷é8DQcþ¨ÎuõûGO/Ÿ–n×wTQXk%ÊˆXumÕi×%©m)Wpè‡×ºn¥9œ3æ?€iµ>=êh—ùCóÇ®s%5³¶‚}—\Ýêµ©óQ˜?‡¶Í•!Dá\ê­±SðrÃ
H—„”ü-4¿¹&1Á×­,ì\˜Blu­M­glÎò_€¶"Òw^dÙÖ‚À‹Y³\×\æ§ë­º!ˆÉÜÁ`Õ/aì‚­—y¾‚½FÏük0¨5Ý”Áz¿bs) å¿mº$éÕ­¶Š:‡hÌï`ÐV�2Å®É<ßÑ|Q¨ùïÁ¬¹-2tY[³éá]~†)¡ÕÈ~HÞßë2×Ø{qp£ä %L+£uèÈ¥nA#½—ü{0…U1©ÃSÛ¶yq±óÎÁ	ó[˜Y	%Êà£ÊâÐ|`0ñ’G˜šVñâ¢¿[óìBXQ4bìXµÂ‚÷Éyp	›ºèá
¶L.˜€æ7?XWt^šI7„dÊR›©KIã
08gNIÍ0£º‰vÒù®`.WQtÑ‹S#ŒùÛ0ÖZ� KÝ†­ÌE­·¤NhZM¦mY–ëê]ê!ð$ó[Xk›3£«¶•K>ÀWJ~ÕjJ18),
o"TÓÍ”S�«÷‹n%u�h±mÓê½%­lŠ"Áœ£‰ä70²µ�ƒó´‚ÅYô"Æ<ÁL«˜ ‹]á¦e½1qF0a´ -ÔwA¬,­z‰�"¦RœhLièï«ÞÑÅ(B¨jcr©XEs�Àó[`Rb¥è¥ÛxmóŸ†è|Û´­Îi@PÐÔªD©t®›2Eó
³Ô»}¨í\Ïkëelp¤™¶f.„®ÕRš!õ®+¨usæ¼Š˜étpÓèÏí|9Íôû�4ÜlÆ¶S	p ó˜™¢%„1&]–unâEàŒùÕV#\/V}éá ’ÿ>Í·bdÝ¸©9�ÍQò3+asˆ©sÚæµ:v1H�ÝQ$HL‚VÛJï¢ó�­–fQ;—ÐJ-�)G`Õ× )Q½+,2Ð˜w°V).¥18”kÛTèûêK„V)�^t«W5é¢ÐÌhÖ\c
A¡÷Ú¥	¾›Ñ<½2ÿ‡PÀŒP[£‹]êk¹uœ	ÍÌÕN¦¤3„a¤Óe¾l­O�sT¨m€ÄØ[—óµµý4õmÞ®h]ÍP�µ”†}Ôr›O­�Ó u½_¹ú8%áÖn‹Àïà¬éæÀêVþô¿Áÿý‡Àÿ
%H³ìa€‘JhF3€ÊaÌ3*i0,{4TÍ´Ñ³‡Ðh³‡e# • (E	R	 {ƒÒEéEjÍi¥� #HT‚`ö0‚TŠ
k€AÄÑ‘TÕêµF	‚*¨¤�JS˜‚¤ƒˆÀ4‡¦f&t,˜P[ñÅ[ë”BÒLr 3fjéèE¤ùÖ´©	Í50Bš
SC‹ ‚9§htââ Ì	FómsÊ¡Yj[éF82ÿ<Ì¬øê$Eá\êV$2ÂÁò/Â`UD‚�œÝôêC7FÇm«Kô1"ÂY~£Åêœ²ë¥¡–ª–œ§	µ¢±ë´­õnÑÅà`ùgaPÛd1^õºÎEú©3½—›ƒ÷Q;¬Î•àz	ZÛ�«‹c×]çíÒ,;qZ�¤Ô9_lÛV“±„uÁÍ$:æŸƒÑ\‘ £øU/¢èÅ›`(„õ}çu¾lZ†tÜ=z{ÿò5ü«Ç‡]°Ëå2Óï¤[�Ö¶ZÂøf4ýt:c½3§°ü9¬aI.LI·r¯œ�ÌUQµb«‹�±ÇõSk>úA�Áòg0Å-iˆ{ØvÞ6’y•¼ƒ(®øÐyX[]K=�Iþk0ÂªÐ‡¾[Û}3uÖYlÌ;a•~
­Þ—ŠŽ�ÅÆü=`›©¸½`[Êùî÷ýöérN²ëYá©y‚Z�Ô�i«Û­ÆÎ‹˜ä¿µVÅtèÝýeÛB˜”0óºô�o§OÞ¿¿·ý¡o4ËT]—câóíÜÆÃžJšåÂ@më’Ò~×•óå#œ‡ÃÑÍ/§–†ñxÜðñò	uì}£šåßƒlØ6ÿøVÖÛÓû-¤.6#5w0ÐÚ¶"Þìy;}³váXæª.Ôa<ºr¾Þt7$Ôü9Ôb�xœxš¯§qŒ±Jež` Z)¥›Ž®ÎOç+»É0FP]³i?r¹ÝjÄ�ªoÌß…�Š²i{|½¯×ó‡÷–üîÕÁêËóÓÕMƒpjîa ‹m[·Ÿt»¾¼lnß³ÌŒ IY†ý±ßêËKéÇØ7×6•Ò¦®=?=ÍPô�»x½zçxŒ ¨y€¨ºp÷foõùåŽ£¨&ÀVKöÊËóú¢“ìÆCXÊóÓ%¾N=ÌSsÛZ»ý«©ÜÏf@ü¸C[_ÎOêûÁ ja VÙïR[ïç[M1W™¿Uç‡q¯ëzÝè‡®ÂQó¯Ã è¢É§Vo§§5b}°Ëékcþm¨UÉñ8q»Ÿ–5L¡¹Êü·` V[ÃpŒr½�fø}ðM¨ùïÀ VVM‡ÉËùz+©?ì¾>¿†Á©Ò’S[6IÇG^Ÿ>|Ý¹qg¨¤æ/a ¶­Æ8õX—»…˜‚z§ùXö(eé¦·;ÜÏ'Å.õÆf–{ÀæÎÕïß¾-íãÓã´mAÍr#ˆ­UIo—†nl*Ôü«0PÛlq<­ÞÎËÖ…T¥2ÿ;0(µênG”ë7üÑ©kfùKAl6‡éqÀíþé…ã®«¾1¿��j+5úØN÷Ä¾7Ì¿#hîŠ8ìÊVN×SêÒaÁ�×¦4¸
gšPK+|xÝëíüü	Ã®HÍ_Âªkˆû>ÝÚù¢.¦ñ0ì®ËËi«>uûQÛ§ë§?±±1ÿ
Ôv¯ëtÜµz>=Wú´;^N×c¿Gccž` ¶Yu8ìâ<_>‰hÔü»0Pkmmëzº\J	Ýî�Òõ¶¼ô~Ô50‚fkí^=Êéö~á ê‚ÙßìñþôÍæÇc  êbÃ+�íåé+¯†XÙ˜ µ˜ønpRO÷uHÑC ù¿„‘ÚoÓ�Â½]ï†  5ÿg0Ruk2ô£®ÛrÝ
‡iz¬Ûéü)¦CrÅ;ÍFP]iý´Ûêm9_ÊÁuÃ¨e~~©@†¾/·Ëõf]ßHÍÔ6W�]·^Ï/W}•R…ÓüÛ0‚†²úÇ‡�ÝžçÍõ{áæ©ù‡0R+Šø½³Ûý¾I71*©ùŒ`CE7œ]nK³!ŒšG©…ÅÇÃy½oêÑ=Œãv»}¼×Ã4Â�š¿#[»ÒO¯‚«÷Ó:»ƒu·ÛË³bè¥B¨y€ÄZ·øøvçïOO¶~Øï Ù®§SÝ¦‡Ã‘Ûüü~77ŸG©:oðo§~½Ÿ¾wÑ”`îa±•‚ñuJëÓ§Û%í{©&4[œöÇÃ¸ÕÛÇâz¿Ž�ÿ8ŸÏC‚ÀiþFÐÐªw‡V_.Wí‡ýN÷ÛryiH)Á5#­±5ß½]Ïëó&Ã4�É�ïÏw'¨y‚‘ÚV·+K)uâ 1Àˆv7?Ž½Üoë¥ßPó©º˜âÍ´_Îç§—±ï†ä¶åÔœï::ÍF*l8N{Ü®÷ËŠ©3ÑüCiUÔvý¼•—ËÚR×ï»¶Ü—{úê%0Rm«–†`§ååfÉ%SGÍFZ£±§N/·ùÅ²¦ ×ÓéÜ‡ÇÉß‚‘­¶Êé�t[Oæº}ßÇO÷��p©Ssj€¶»º}t�o'bJÞ@Íï`¤¶¥;<törz±C'«H`¤nªax|^./””†ê¡ùWad‘ZüpL¸Ÿ.g8<ŒŠÓ|¹Ýý�àŒy‚‘m+ÅŽo‡To/—Íu½psÔlÈ¿£I3?»AëÓMú)za>@ÛböS‡ëå|Žè;5ÿ9X…!í:µe¾Ýb]k9-7íR?íüyYÎ7ršÔóïÁÈÊfCw­]î›¡ë’óÿ CU­ñ¸ëäeyBÙO“9e~#‹hKÃ�J½�ç&ah¡2O0¢9Œ©óéfÚMÞ	%ÿ FT¬žûcÚ].×÷†èFˆº–GMjA:vƒÝ_nKÜq¢Ý¯·S™Bè•^`[	Óëòürúäqèb²y»U¸ÎwJ/ù{°¶Öêã«ÉŸ.÷ÓlÉ%ˆ2ÿ´Þ÷�¶­Þ´�ÁÃY~#µ-¡uã �·šÚä"œ¶¡–aÜa“óËóÚÇAÐ †Ã>Õåtº§aˆ±šGY¥Ñ§±Ó{¹­K½1¦[³.»n¹?WxŽ�
¨yk˜º	²ló‚âû}Úq^Î¼zI!¨HþÌŠ’ý´§¿_çÙ»>zÀåïAuU¤¡SÙÚ›KÑcÞÃlÓ–vÃ”¶º®kp.gy­hÁvIZ½ÞoÁ�~ánz×1‰‡ËZÄ:ìcóËý¶mÑÅ˜ÿ.´ÒBG»¯à:ïéDòß…iQ	aï÷í²‰x'4æß„¶Åy—®Ûnëy¤÷ÁÃ)%�ÐVÁû ­Þ—Åù®ßl¹]Rr4æïÃÌZ±Â4 Ôk½£ïCp¶°Â.‚÷ëuY&ß©8³ü¬’ìc—6­‹.I¦)öE·U«$G/M%ÿ¬U�2uC•u¾—Íº±�e^
�œˆ:ÍÿÌ¬mVƒ›ÆÅÏ÷çâ‘btêhùK(›ÀYl-‹1¥DPòµqÑO¦6—•!E/`¡­ˆntnÓ:«:	ùoÂPµÍ(}<¸ÁîÏëÒBË¯a U— ÆÞé|Ÿï|4O#ŒÙÃEŒi¼këŠ†(½	hfùÛ0Â„ÚVƒ]‡¢óVe´Ý$a©s«Œ#“F´j°¾]¼.çevnBZ���¦`óv^êˆ®‡3óƒZº»¤†ûÜšO^Ì_Âš‰’B[ÝRíÄSŒù§ ­Šw.±¶b0Iâ©”üª•ôì¦ÈV/\ŠBó ÕÍ—ÞÇjJ…‡‡sš9ØF:î:Wëz_ïœ À`P :úSˆ¥.›W†(Î„ùw`Z]LÁ\©J�Q��ùLkmsuì"8/
 xtJ12ÿe(-�“Øyg¥¬³j—¢ó­Þ[-¡yD¥€’ÿ˜±%£Cd+mcˆX�+]œ/VëV½0š¯`þfV]	â:inÓ¦6Ñ]˜ÿmÔhZÅ›Oˆ­p‹âÍ	� Ì?�ìfEýbå\JóÉ…J£d3 ù-˜‘M·m3D¯ÁŒÌ†–m•ARò*Ûê«F‰æ›�`þ×akº9“	½•µnÁIFšÌf°¦[4\¨mq¤3G(Ì†ü¦0 ¿ûð'
€
PI%ÍòF*©$ Â0˜ÑŒf4(ÅLh4€
ƒ0#Ô„FŒ ÒŒPSXTÒ`´ÒDà”B˜±EkjÖ  $HÔ@ÕÌTR	`‚„U¨B	PAƒ‘R@S³ÕÌ Šƒo¢EM-* i¹ƒ¤Ñ45jƒ6%ˆˆ¨/¤oŠ`¡ÁJ¨Ô ×¤Á˜48g„µ ªP³¦%{ák5TuŽAè˜fªÚà‚¢ð¤ÐY~³&€¤aèÝª—V;!öÁØÖF09æŸ�iÓÍ[’Ü¸’@Òš¯Ñ""�Å·N!`~£ù*N}IÛ¬Ô;?¹Tu�µHôôÍÕü¬
%ú.µe­ŽÑ9�³ü×aÐ¶B¼zÆÛ<_°…Ø�)@·µÎ-ù¤`V¡è·ùvÞ0:Í$ÿFs¤: \×Õ€(ÓÞßÖûõ2'ß}˜ëýö2£ŸB:Íï`´Pš}
e½ßn½wÑÓàÚõº¨úx@×êu�:H5�U¬.î	×óK¼O)8Ì·—ÅÜiBB‹ÚŽþ²]®Ë:ôQœ†ÆÒ0¾Þ»ùÓ7ï[êžÕ4–býã+ÜÏïß¯H’†×ÇWçÛ‡Óêúƒ÷h®›UÃ!ò|¹ÏeŸF·‹àz?9&ïc�iUÊp²^o§ê]š)÷§ëÕÇÞÁU#šrö»·oÊéÃ‡ÄqHÍ`ÌŒ@£Vßzw)'¡ø¸Û�Ëíþé4†«°Vjëú1q)—å*¶o¿ðï[ìeŒû¶Þ®÷u¿ë«7Øäzãô3ßþôÿx÷vðEËÿ2 Öí^â»oO_ÿH¹{%ºëí|ÙÆ�óæ¨ùû0Ðª­­ŸÞ6>½¼·æÄâÃŽ÷—§O¥?ŒJa·eë^}ÇµÿèGßàáØÅ8F¼œ_š±FÀ€ekýî[xúúãÇ¾5Ð,ÿŒè4vlËm^5Ä”ùs¨XÊ†ÇWo/õÃ7×°ß¥¦Jj`PKÓñ!àòòé›Þv»VáLó #h(¦ûõùé.IÒ°úzz¾¶]—úhçû|m±ƒHež` V5LCØNç§º8z9ŸžO¥OM¨ùwaÍÆq¿`y)×´K æÀbSú~šìù2_á»TèLó¯ÃHm3l<ø°Üæ¢OÅ™ia ¢l5ì^½šëóû'ì^T#j]­û©ëWO7ÿj˜`…Ôü³0°¹‹×Ãq\o×O÷Ž›§aKYííñøtÿ³—{=<&lAÍò?s[Óð·Óù¥¥Ðuißuëe¾Ô°ëÌHÍ¿PÛæº×;žÎgö9¤®¬óµÕ}ô#ÐÚR÷oâ°œŸnì_�AEÍò/ÀÈ¦wú¸·2Ï×‚®‹hÌŒ J[lxóX×——4ûj…Ö5ØÒ–ôæÍ>¾?¿»W©U lëZŽï¾­å«Ÿ\ú·ã*j–jÑ»ß¼ñ//ßwS
CC[ï/7Äª˜iþG°ìQ¶¦»ã!Ô§�kŸGkjÌß�Š¢èìýO¾ÇW?~º¤ýžØ°üf"µ-«ÿöÛøòòÕŸúwŸíR5�å·°ìQë¥õ?õ:]Þýá6Ž}7í§Ûòü²ŽþÁA…šÿÀfóÒ½ý|Z>}õõ¹Žc"&Wt]æ:J¤‘šÿ'À­™M�#—ó§S;îGÀü©K?<ÜN§«î÷ƒÔü_ÀHm›qŒ\Öû†ä’ŠÓü?Ã nvgÿfgõýóŽÃCE%5�0Â6é“ÕuÙLï•TnV?KÔËùlÝ°»¤¦ù3©ºiìÇÞÝÛË�~ð¤æ/` ¶uñÝÃ8øäº]ŠÀ4�0‚&­J?ÆVN7l¨!~vôó§÷ï-Lc€ùìaÅtç_‡pZž^R}µíŠSZs³KSæí¢šB ³‡é¦aè7¯k±Ðû fÓUmèÇV–e|¤æ/aduK�Éù¶–YÅ9£šPZŸvhËºlMÕOÇrùxáaÜm*€â^¢‡€û‡“³¡ÓØ4O0RmuÞï{®ósYÐ‡®6æß„Õ§q*eYæ¶ÕÃñmoÏŸ.’58Ó<ÂÈVšºÃ>`>_–µ}s•ù»0PK-Ø�ƒŸ/Ï×†}2 CÕæÝ1Ú}=a¥J·aýÑÇããcÐ¸e«V}WîwÝz]eö°jêã..¼Þ7u§y‚‘•êü8 ÝÊ34…dÞiþ!Œ&h]·÷m]î0áà4ÿ°ŠÆ~â²ÝÚ†¡‹)F+÷²¤ÀÁ4Fª-muûÃƒo§Ó{¦qˆÍUæÏ`¤êÂ*Óc�óùùe0îÇc°çË“îû�p% k‹éUD»Ý¯ºÞƒNó¯Âˆ6ÃÆ]ßì|¿I‘Î¨ùû0Rk­[·ßyúô\�zg^³GS,ãðôüò±9?M@Íï`4šøxpa™×så>©3j`•Üñ0®÷ËSµtì¤B¨ù¿‡éÙ¥ãæçÛm	Þó·`4Ó5†W¯Ë¹Ô˜z©4j` ¶¹®ãôþt¾Ý¿ïFÍ¿#ª6öûý°m§§KpÝ¤§ùç`º6úÑt½®×ê‡è„ù3©m©ŠÇWåéöõjÝ~HE”jº°¥Ý!µëér÷cb¡ÓüK0RÛ¼Öîñußžž¾9ÕaØÇ–ÿEJS§½Óëér+¡ïL4`m5KC�Eï·Y¡æ=¬pM~¿ëp;ßo=„C7^Úe¹Îì}×àòß‚a«Uã«ý€Óùi†ŒQ
�æÀÐw7½yð—O/ß€ýn#¬Þ.ó]œLÉw©·ê}¤Ð XÑÕÂ«ã+½>¬’£4Bó¿
£¢V;L‡¾œ·‹·>Žê€ÕZ×~Ø¹ù4×Mb–0ÛjC¿ï»r?¿4c×�Á›Ö‹qÞ{e6ä?€�JvÝƒà|½ÜVõ½ï*7­«"y/ùïÀŒ…µÊþØ÷åöé¼ú‡±—
Ÿ'�.=&_îOç}¡æ/af›m5M‡±.§Ût8È–¦:›ºc€Ýnç{‰!y*ó¦…i?MXo·?ÅäƒŠäB­Âdèz§ër[7ß¥`tù×¡dõ‹ëù Ë|»›K1ÒDòß†A©¡‹BÓ¹0y³üCª´æÃ¡c8]ægïûnB´RkiÞ‹'„ù—`PÓµ¨�»Þnçåì]êcDÑv­®sN”ÔüFXu±ßGî·ó}±‹Nƒ*ó˜YÛšÈnY®›£N�åß‚ªoÍùÞD×­"\þ.ªÕÕbjÓ
/Œpù?…A­šó~œü‚Ëõ²4?D Ìÿ9Li^g±}<
ê}Û*F½X 4¿BBçÑµ^- ÷ÎÀœ ´®¤Í©¤(jÛ¶$KAœ1…i•&±‡Ôî§ù"]êiÌÙ[¾‹ãu›OóEºÎÀ™¡´D­¾9&ïj5Q_stù”›©´.Å†ë¶ØRïÌ©1ÿ˜Ôš©¥qpi«×›ôCÅQæGdoZAÛûƒØz›oÜ0¤(¾`Es):¡0ÿ0ƒ¢RØÇ©Åµ,ÛÒc’@/´ÜC	­Sw¨Ý}+çÍ8M¾khÛ6Ã�ˆ &ù5¦j5j�¾Š®¡ ¨‡ÉoaP 9U„èb©V(ŽÑ(’ÿ%`Ú`ÞÑ©®æ·®¹fÕ9ÈhA+×êJ7ú¡i�×Õè½�"æ_‚™š6ºd¬f®™8
ó¯ÃÌ`ÚJ€ëÈ•K‘Ô# Ì¿³ìÑ‚2Hb%œBæ
%ˆêjð~€×²U ù!×£€ù»0CsZ;çSh¶P}Hïò?…*�‡‡•PD˜?‡ÂZ«�à»WÚr/Š¡�¦ÍàÊ@xeþ˜ÁŒ5¨JˆÞ¤ªvâM„ù5jf•®É'msYWŽ)H5+N»e€ï¤U¸FÌ5Jþó0(5•hÎGºº5Þœ@$ÿ.-Á¬:ŸDÑ6(¼ƒ‡@hV�1ú`ÖLÍdþL	Àª£¦Å<¼9
C£O=¹¬ek.¸@ç…ù
54·t-¦Nt¹Ý/âcï½+²˜ÐÑ9z1h¥¸˜Fx[6Ûàzt A0'˜YkM}_\½£…‰¬¡%	NL­/�÷Žù€k tð†
Â‹º&-ÿE|üáÿþÆH•4ÀH£’f¤¤’#‚ 4(© ,?À €‚-�0ŒBŠPH*¬Z‚foP i& 0”–¤ujBM,B	PIÀ(fBƒ5¨™e/¾JS4¯Ú@`0À²Í%T F**©RT0XŽ0ƒ©©Aœ›VúÖj„º–½À7¨¶âµF¨«b4Ð  Ì •05…’>šSÔP|‰¦§ #H˜s‚A-R¼'�«¨¾g,kídr\+ÍÜ`Œp`~ƒ•°1úMî‹cŸÆ +–ô	QÌ×üÓ0šoƒ„ÉsÓ¥,AüØU·Õ°Qé™'˜V¿F„©nØ6†–ó¿£…*}è#k)kqœ�T\Ëß�Áª[’ô]Ø¶eÛØ{Gß¤åß�Áª[é\½­÷u½wbÂü¯ÁÛPÙïýøtÿ´ÜÌÅP¥1ÿ]|uÇa‡ùürYR×@æFèæ¶ÔwŽm.5‰§3Éÿ1ŒÐâ$¦Nš.+à½ ´üïÁøÿçº²mW€ÿ1f¿šjö>×Ç$dìÛB"Àr„!	 ?
<Ù
x=déÞÓÔ®ªU«›Í|�×Ù¸¶u5~t†dê¡ ZÖšÞMkß¿Ñå-p5nÔ„ôt>ù�ûëÛ_ˆdJP¡´*ý§à¿>¿~ÐÛ›Õé3 Æ[u×OoÇÇO?­NÎ4tú”HdÆLÇQ%{o$Ó%h…„èÝQË\SŒ(A6õéìž²,s«É�Ã§íÛë¦äÇ tŠP�V”bÏ©Ãóû£h7²©N¿‚‚í|~çõöuaïM|ï»Ûóë;œƒU!’©‡”åÀxJÝ¾<ž¾ë#"™z(H[-{Ÿ.Áÿyþ¸)ÄÆMuú5 ‚Ã†ëÕëüøBcŒ¶�Q™(AQLžj)Y-;#<P�`W˜áÂËý¸U“qš:(Hp ÐûyXŸÏ™K�*“L¿…”å0Ý59ýøxQ<Ô’Lÿ ‰æ|øñéñ½~ø!‘R�~ ë!öýl^�ï[;un$(5H2'Ô|l›º@Vhú¨!«¯�×7'—ŽEˆdê¡DÒ²Ò�BËÇ~ 8kA™DÃ	’m¦³l*M?ƒ€R‹ñ¹ü”5�ÊÐé_¡ ‘ûx½z~Ì·ÖY‡óp®Û÷¯»¤“ˆ[ài€´ aˆµ•½=”H¦‚‚D6Hƒ_·5‹I>]¢=n·ï–Þ‰Š* „ÚÈ¤H²Íõ@rÖ6‚‰îÐÔõÈÇ¼¤Ô…¦L2}†‚¹4s=%<¯Ö\¸ÑÔAAÚJ=Ü§®Ãíöq7}g*‰êôs‹Ö–ýÛoß—B®7ýµÇíûßõÍ6 Z¤ñézæç¼=SÎ5&™”@Ê‡Åå:âøx&%C…°#›áìê²Ý‰;ç*H¦
 JÍcz?n÷oJÝõ‚å~›ëùìÓå-ìù6W:Y7|â¶[T—Îç!ÏË�êÓ…¹(tú%$µª?]ûe]^/tÉ5a JÂbâ�¸ìë¶ãÂÉnû#ï•8˜k°eÿö`:Ðä Ô¸ñ0:^ê¼©3Ü %ÈNOä¾<¬K2�P¨l’?û·Œoå–ÆXÆ…¦
@W©±ÿ�î¯ÇŠpŽT:õP�TA»¼ŸÌú|��RS�þ
ÐaÞ€}¹¯E"ç‹ÇŸ¿ýHÝ›ñé“­ûëKkûóYÊóöSÚ®q<ÁÇãNÃ˜Œ‘LïP�¶RWsù4Ôõ67MÒÏÞìúåûk¿ö#£:ýJ äZÌåÒ—ï·Õød �>CAÒŽƒNçÁäÇÜ8¦ÉÔC	¤\sÏÝçÇ¬Á¦ô~iåãë®]#€¦�‚¤¶†î-Ú6ß‹Ò¹ûa”cþr³8;ª Õé(Hd«ûx}k¸}ýZcŸœ(JÀ.¹OïÝþxÝ–!D†0  Êî­|¬K�¨P¢VKÆûð¶>××½‰OC¢ï_�› z4õÝ9Ò:ß!o!ˆ2ÉôßP"‘\áÆq;^û¼7u©¾?rç¡ÉÔC	¤T«KçP¶çcã±SæF“bú=$mW>ù°ÎÏÆ®œ­‘é�P"i¹Q7x^ö¶Psi<y+Ï×ÍÐÕ4YhEÁØ‡°óžm„ÉôP5áê¯ç*��eEµÃûç®.·WÓ]Ç¦š~	%�¢l>½�íõœ_èÆR@	²5
×ŽË¼ì™û #ÓA‰´qÙ‡ð©£ýö}Ö;*Ä“…´”"ç²?‹ë@�éOP¢Ö–ÊãeÔãö\†¨P’éWP"Ñ]-�É•}~-5Ë$ÄÍ{0çèÚýññq—¾‹f~<?è:ô
�,´eqƒïkËûVýÙ©’é÷P"-T¬»¤\öû±PŒ¾²�L¿‡pðf†·skÏÛXßçAêó~;¼;Ã—ÉBj>÷Ž^ëãh& $Óÿ@AÒ¶þÒËãq›C“’J”!~8Y·ÛlØ÷æ©ƒ¨i®ö£¾^Ïr¸1  ™$ºKã÷S4¯çñ�«Æ÷óÅ·��ï¾¿†³!QV®dÃÉ×c_Ëf¸Ã@¯}¾{ƒ#™~%ªDêúà÷¶-•£uP0)„Cê]-ËpÉ[�¤�šÐÇã8êÊlœ•©‡µ"À¹g}­¯ÃÚ”O¿€jÑŒþøØîó.ƒN@Íf ¦ Èºm�±jDµí$a=—�µYï§h¾.[Ùj8]btÛk]=ûáâó­,£éÅ*Éô;¨ÖFè/éµë‘}®0dú%ªT3õŸ$móë»”Äò4@Q¥I®¯õ›¶‹`¡i„"7ÒñL[ïÇÍ7\Y°¿nùxs‹U™~%jG#œ†áþš×vIÊ™~%ÒÊ�ÎŸmëvÀt–yúG¨aëë×²,">Œ£}=?îR§L@Û¡£sš×­:k­Q0¡Ù,>öQå8ÊZÙö';à8«1Éš~•Ü´Ór¬¯gâõ”üöœ¿îŠþ-Ç²ïw[}öÛ’s&ïc£é7P"mZ_N�¿-scÓ%ßhú;hE;¦!Ëò\öí/Cäeùª¹¿h;²ºaÜd}­óÜÌx9ñ±ì÷WR2œ�N”MmwŽüqÜ�E½‰b¨M””T9�C�yþ¾ÃøÓ9É¾Ý>°î³?)æÇ½hgÏoCwÌÏýÕ�7R…5Ñ�œîû>o­Ã†}ýú±šè{Éô”¨jSw.öx>ê‡Á©‚Ôãx-â½1byJTj¹�é’y~ÝÁ]•‹jÛYû±·Ïc}­…ƒg_X�”|c¨kymÆWl¥©ƒY³výÕÚ×ã¹ÀuPÐÌ¡>v!Ë‘[ðÆ¥©‡µ,Œ¾íc›³».ˆ/ ™>CI¡édŒ]çç¼!¦¢Ïy-ƒ/—Ž×y.‡ãu²/k–£ª€¦m‡Vºq‘}~=suçSd~¾îKƒžÎÐ–›86qŸ÷‡°·Ž­Ðt‚T4ŽC.¯m³·`¥éwP-*lzïóº¼*ŸÂ¹7Õçö(Ñ÷�ÍG�·-kÇŽ‰iú5TØùÁÇnçÃ2¤•flô©ê¾-T$ô©§¼½^óŠÐuv§¼?
x§Þ¸W~Ø=ö6&¨n$C£ßÙ²�Ö3A§¿�Šd%ë† i¯mm°©gƒòZ×­áÔû¾æV‚?›Î-û«ºäùÆ<ýZìÂ­Áì[[EçAÓ"Åö¤»B)‘Wf(
 !ŒhõØ¶g­óô"„Á;ÊÇ¾ŽÃè4Bå X78Wë«
EÃÌÓ mE½5ƒÇ.Ë.Š`Ãèô'hËP×ÙxÔ}]µx¨æí¨ÖQÓô"G³.EÆ~,Õ9ç± ’¡Ô¥¤-Ëâ›=ûHµäEY}$ÃHV1f48¶ÇÞ˜zçxr�Âäƒó‚�ö¬Ö¦HÔŽ­ìÞ¤Îx“e;*øªÛªL]ò�Å¾-¹8�!U-�HÝÉ´\²6f;zp^�µçÁ’B3`m
¦å²K1}7»Û6R¢¡íµf±±óÙ‹(M
Tu2Œ¨½æ%Ò=�©žþÍfq.v]ÃRž­™Œ2�iì•mUak¬@µ9JÌTò¡Y¹ï‚ÛÛ‘×jÙŸƒiz´W;(…SÐ¶çùÈÔ9Ã¬ª(PkRWízÌGã@�ZËÚ4Ã£#«ºiòj é¯¡©¬d}ˆf¯ëò¬-…"åCjfôlÉ2«/lÕ&øk,“‘Oª¨ é“í$ïõ)Í…`¤Š
â.x—¥´\“·†XdRê“óØöZj
Æ+Œ*¤ªQ	ª-3%œU‘£X>‘“R×ÜhðÖRt ÒŠ‡wA9hÎÅ ¼ï-³¯=´�:¹€5o+’sÎ°  ”@P©Jœ{­eÏ+Ñ)tŒzÈ«5ö�|3š”Ägp°)*ê^Z³Î’bš>CU*˜CS)4kƒIÄä1M=š«¶Yã´
Z+ é? B�J®I¨•l+”hºB! šÝŒåÇQK–“8@HÉ°ç“±È;6p´žˆ�*k¬�Tµ�1Ö†³nÇÑì�’S)åÙŠ�½7~·¹æj›!…r#žþ „šÝœú3-íÕ�ÝÉ™¶n[Î7"(ñô÷¢ÖªtˆÉ)e‘â(0,)	tú+(´i±J>8Öª¬Á±µ–”ªÍF8kö¼E½ï¬W‘–k:Ïh¥ä
G†Y@ é!„¦Õ6vù­½´Nðbñôï‚BZ1ÞDbÔc-ÕñD,m×ã,‘e€@Ó_BªÔ˜ÙR—¬bÃSÈŸ„R�£:XcˆH‰”xzƒB›VW½3AllŒÑ‡†v´\ƒ	�3Tv.gÔ5(‘2Oï•â@‘=·¢ÌÕ�hú¢ •
66Z¯ÇÑ•ÀÁ(1ˆ§†B É¬s¥¨v`Ð\qàÎÄ{«-šˆ€V[Ý�³Ñ³ê¦*päŒ*ƒxòP¨juc­U-n0b*Ñ!hµ•£¬Z…YgÑôoP¨†"'²…Ze5†T ÿ#bÆÕBASE      ƒ  xÁA  ƒ°YãúÀ þµ,¹ÖpÂ!®¥ËYÁ
\ilâšÒæÆF:·5uM�ÎD§ÓÜtj®ÅRÚ¦iÖh¸r¹Ô¥m±˜[Ì�6\æ³�`”&,3·Fº¢ÑbU9ÈÊ–6b)ÀFUŒr	m5 ¡6ZkEÊ¥ˆˆˆ"¸�†‚µD'7@¶ÚF‹±¡ld›ÎA›D™ÉV°!›ËF£¬Í–I@F• )�F¹�Ô„A™¥TX¨ÕÖVµÒk-—±ÜªF¹\lR1Œ*R¥H[nI¬�XQdUÔ*—ÃEV-®lk-+-åÒ…@@‹UˆŽm2¦0$¦Ôp¥VÃ ‰ÌJ“Dˆ$ÅþGBPOS      ‰  xÁ±a@ E±Ðû¾ÞÙ¡IÏ(4¬ÅèHÿýùñññqÞß¿¿î¯×W=ž<¯ŸÝÏûùöº�»�ûäì™ž·ó°{n[÷ix§õ^–ÕµUËîî‰ìv¢V-k£;£VÓ+­ !3FšÕ¡£Ð6‰Cw¶QiÛ"CÙŒFÈ‚È1tÇL±MbvAŽÑ&'	Ã´;k�Z¬evç®Á2®5´hF‹f´MãÎÑ†Z³,#c°Z´ŒiA¬5ƒ	`a@¬©e EÍÀÄšÖ@0hÂL`™€l(„ †XF4-€6–5™@Ab2I–VK ¨$ IL¬ÿ#Ù+XCNF4       ß2  xÁÁJÃ`…Ñ/�üIIcm¡ qáB_BÜß×rë›¹sãZBQ¡%VÆÉxNµZƒ*šÌ
Ë™ª®ëˆ2~ÚS.æ»}Ï‘©Ûúr¿;�Ý»ÅÒ‡qCûy²íÜ~A?Ó|Ã š0Â´bdPÃ8è‰0]âE�xÑ^´Æ‹Ý¦5aêÓ5aÚ*˜zÂ´$0S�¿Ý(ªq(ªq÷®€ã­©à”¸Pƒ{ûÛZ˜zœ¢Ž×{¼8Ó9àÞ1uþr^ÜøxÅ‹%J”(Q¢D‰%zæn¤gxTEXT       Éñ   xÁInƒ@Ð”:€ÝúU-º‹f�c1±”’³ŽÉ"æüycZ OcÃr»ŽHeðzªË<†ÓµÊÓZæy†eJ54¸HA“ÖËû%šÉ¸BdÁ F£üí²¼_¢™Œû!ÔÂ.…11ŽŒFUÍI2ÈYŒFUÍÕ.Ð|µºjóÑs›îSÜªf=¼ûÙŸRý�TÝÎ}ÈÌ0Ü›>z¢ªS�®rÏï_<ÚYáñhgCW‰:þ½¸4WCLIP       	           :x     :o®ZTR

SMP4      6pXV  xÁÉ¯®kzäßï~š·ýšµÖnNã:ÕœrÙÈ©ÆFØÆ1‰�â.aã€%dL#Ñ[À„I@P"ˆa†Ï ˆ)H þƒ0C
$ƒ°‘•J5>çì½öZëëÞ÷}šûæºøþ' ý.Ìœ‹¡�CØ…¡›§Ãôêî~÷æÓÝÇÇ×vÿö³Ï>ûì›Ÿ¿ù¥OÿÚ·ÿæ¯üüîë¿ ü÷ønŠøe¸äñÃô·ðÿ&�¦¿šøóñÃñÃÔá%�ÿÿ€üÿýÅÿéÿï÷?þó?ÿË}ùãw?ýâ/¿ü«ÇŸnïßùîÃ9_žOçåù¶ækÕ’kSü6þ!Üñ/A~øC 	“WÂ@¥@SÀ`€€‚
5S3kP ¨Ò@˜ÑP‚TÀHÀL@À#ŒD,y@£@ �06Çæ¡„0ÒDŒ�¨ šÐ `¤A€JQPSMI…ÁÌ‚p´mP£ŠRˆQ‚ 
•&  P553•Fˆ„JZ@%H%€ iò0BšJj
0À f
¥£3q0kÞ$ÖLM	RP¥QÀ 3$¯pˆ€gQQgâÅ´ªhpCè\­Ûµº�Î<Ó/Áh¾øb¡»ÌºlU¼�¥_ƒÍ¶ !ú	Ð%[è…4AU
Ã0B¶åŠƒ÷Ä|ˆÄVŒ”®‰O
ƒU¶†¼cÎ¢D£k©‡Á*W�.îØÊšoˆ2¶ Á,ýŒæª+}ô!4]¡‚È@géû0²µŒì­UzÒ\KFX‘âýÔs½.—ˆ¡MÒ·a š‰ÇãÏÅúþËí:NSh*ªé›0B«™ï£ù¼lf�ï`’v0 U‹“ýn´óÓû§øºŸ„ê©é{0 UµMûÃ}~9=qr U\¿ïýe»jžºi¸nO†½�LŒÐªˆ]œJ[·«�ÎdúÁæ¯Î�3òvU?K44¦ÿF ¥é0=D»>?©ø]—ÙÌÒïÂ’G©W7~òµù«ÓO/xý0xTƒ™Ëz2ùú·€¯þògÀñ0‡RK?„4^Í÷³æó.ŽŒØjuû�w·Óû¯V¸ƒi¨ŽéŒ rin¿óËz:£M»é(çÓþèŠYú6T7ô{�[¾ŒR™þ]A³Šn¼›k~9£F1Â„­®w»~½<¿¿Äq4A3KÿT+¥ÓÝår•~��šÔ¶ªôû!^®×ÜÇ¥–~f”ª·<ýÜ=>{üñ#Þ¾¾HSƒX»”ñ£oâO?ý1òÝÝÝ±Çu{ÚÐM14Kß…Ð¥¶þÕÎ_¯—k;ø88WÛE·1†ˆ šf˜	uÙÖñÕ§óóÓÓûŒy TÇô÷`PWp½Éþç^ÿ3Ë—_þÝaÇjj–þTÝš„ûÁm×¥ŽŠÀ ÌùÜÆ¯}¼ÿÉÓtüèNUM�é÷aU‰~�xÙnÙÉàš«L3€Õ[iÓGßÀåé‹gÄÃ~×¡ÜN'ó~8qùàúãäcóÔô_Ã6©ng¶õÚä:ºÊ4ÃŒÔm=»ý·>Å?ýâÇ?Ãë‡{USXú5AS¢ÛOÀu;£›(¬LÿTÔjYm¾¿ë¶§çÇÆÝ~B¾^žÛ8Œ QÓk”ZÝþMÄöáÛ�Í`éw` 3×±»»Ëå|Þw‘R„š&˜	õV®þ“�^�—?Ý°{èÈfL nm‡û×§¯Z‡è«À”Vôø0æðtz4ô»»O†¼|xt:O46³ô¯ÂÈÊÕæþèô|É®ëz²2í`&ÔåªÃÃ×Žžß}…r8(¢fé` «­®;C¾}x>wrÜ¾­Ï—<÷“�• ´vãh/g–.ö¯¢l/kvý_…š>‚�Z[ëâÜëõv©½öÃ!J^.›÷;5ý °ášåþí�®_}8c÷0ìb8ç—Kñãa¿sËå”Ã¼wžK#0ê²äÝ«OQŸÞ}ÑÂp8ì´>ú8Å.³Ðš‡×ÀõåÒýÐ!4¦·0‚ÈÆpØy[NÛÒ�CPPÓ#¨È2÷w»õ¶ž\˜£TOM?€Ô­l¸5
ß½¼ ÛuJeúªmæünî�_®m›ÆÝ�o×ëÓ©»y?k½¬On›çÃ>–ÓùIº)F5)rƒŒ¯öœžWÙ“ÀÀôÀ¬ŠùÐ[»^¶ë.Äýêörj¡ï``UÙ÷{Wó5sb 4¦�`jiqÚõr=ÕåÀI€Ê4Á¢”\woz†ËûÇ||èc£3Mÿ&ŒÔ¶ÒÍ“w·Ëmq¾æ
Ó#µVø8Y×ËÚ»è*Ó#Õ6±¸�ã²>ç«„¹ïKY®f#æ®ëÃm»\á†aõª€YVçç!´óõqèá7PÓÂHÍ¨qÜ…±]NÅd2@M¿#5[Å|÷*¼\N§ì÷½:Ó[hUvsO}¾.@ÜMýõº]›qƒÇéœ¥� ŒšÞÀäFÙí£l§u«ý0L³ ÜVø5lL?K·œ÷ûoîp}|ÿâ§ÇC÷°l/u~è²9jú©¶5‰¯îëíôþI¦)v­�šþŒ¬Èæ†CßÖó-£ÍÃkëvº*æa'`ÙÊÚÎÃ X­jÝñ€²žžB£x8júF€Ù®˜ëÓóãsˆ‡Î•Æô×a umfóÇ½«_>_ë°{Ø÷{”¼nÍ…ž®¤ßƒ‘šQØ´—ËµÕn?L3¯ëzËÞ»èm½å­ÇìÔ©¦Ì6)Øíz„Ós†ÎS +Û–ç‡W®µ^ê8]u%½…‘Eúé8Ù-?Ÿ;¿‹�Àiú·a¤U[Š>ŒŸp;¸¢Nc§.3Í0]Q9&ñ/n'í¦NÓ[Ù2Zìæè^ò‰Q&/ÍQÓ†íÜ»¶ÞnÝ8M®µe]fšwšF©(Mã´ûñz=e'ûØCf+4Çk~ÖæB7Í;ÞÖíÖü‰*i‚‘ª«Ó)ìÁºžÐü0ìÖò­´âÂ0‰•å–Å�€ÍÕ\ßw¹åµÔ!ºPH™ëRÜñî§Çç›bžœù–<J«ºß½9¶ËéÝZ†8ÁÐHM=Ì„m-Ùï^ÝÏyýò‹Úî;´æaº‰Žýj[Öm£ëwÎÕ%ßd„oŽš>‡�ªyƒoÍÞ_ž´ã$`ƒµ‡1V\xs±c,šÕZ‹›îvº}8_çy×õ¾æíE#Çq7ú’—R‡~šÃa¸-·Å}O€Mjq®ï»Úò–Uúè´Tsýô`®=]ow]çÓ¯ÀÈ‚êýäB.Ë¶Iè‹Hšadö¦0Ë-7CègÒê­¬ªó8ûP¯K).vÎ7!©K1îßìÂùü.ß¤Ÿ‡ê®ù|¥�¡ˆ@K÷óàóíå"~ÆÎ³Ôª›ÙÐBX.«`î÷®•[ÎÙ…n™Ë²ï{çŠ°‚<†¹…µ,Z‚R	ƒ•
ïgŒËúr«Ñ¹¾�a-y»¹N<¥Ð­6öû»u}Z€8ŽDjz#3J»‡ÁåëéºôažïB©ëe±.Ž¦LÿŒÔÚrvã¤y{VÝõ½¨˜¥FfY4N‡Wäé´®1Á™Hš¡%p'�(97†(¾2}
­
�¹wÄ¦
†(Øj«ïŽÇËûÇÛeßïbp&Â4¡¡:ég¥ä«h” ¤¿mE#‡ØAKc]d­u…ï§¦¼)´ý�Þ–sqœ…®¤ïÀ47Á8}Ùž¶[ëcŒ®™ m47L]ËvÎÚÉÔwª%/ÛÆnœ<°mk…×£Ý–[užƒÁhºÂÂ8‘óË%l»®ë|cú¬eÑ;ÇR.ŠµC´7ÔU$öýC[¶%#†Þ¼2ý
´ w6ëº¶Ö%ÓÕU0cß¶Ûº¨ó�¢"iµÍ#†ÁK-yÙ,ø)(êVW³Î"i„‘…7ñÝ4‰lÛº­CßÏ}‰ÛÚXD‚ê´eTt¾Û‹¯KÉÕEïášPÓ+©…Kà8øŠ[^uÁKc` RZßcÌùåº¡ŸDüFZE“Þ�âÐòM¢R i„‘ÚŠŠ„¾g]/\Í‹xÀˆ¶mÙÏw÷3–¯N”{?)M‰ÒVóóþÁç—ÓÙ÷ã8‚æÂäa¡›57†^4¯—k³0Ì½hYóÕ‰‹¤‘š^ÁHÕb|7ÀåëZúyôÒJ.ŠQ:QÓZLC?ï\ÎÏ/ÖÅ©›š"[Uxôf®–Fö;ïÊ¶lMé\Px’©‡Z›Õ!ºûürû€m‘0iÒ()ÀŒÚVÓ1¼™¬��Û¢Ónßï[;ß¬vˆpMØ¶²b¼;Ævzÿt^M‡‡ºÙm»:ë½8uM4ý5šdÂûa¦.K^bpêÓ÷aÖPÂ<±ëzÆÑ‹åm[Mº®•º¬Mcìc°ºÖE}tÎ5_)éFXeAô¾SÔ[UG7‡›æVEBlÁÄPaD×I´­uA:aÚŠ3ñ+Šô]%Úju£ŽB—~fZ54:/m+€Ø©oéM
sß‡AŠÞZ)ŽÁ¹JI¿Õ¢Î….Lµ­97ë‡	d^´kNSƒªa˜&ÈåeÝ†8I œQÀ˜5Ô¹ÛwËÓ²íÚˆAA!Ó=Ì´UÚù’—­¢SŠ#˜¾C£VŠô.šnYzÎÞ�ÊÜÔéû®r]is˜áôjÙ;¡U8ï(5oK%d!T‹(	àbÚœ—(JjºƒA¥‘EU°;Çr¾eC¥�F*`0Ò´B£‹·ªÑuˆM„Ö¬R��‘µ®Ò#:‚lmk"Ýc­·óµ9ï%¨˜ÐJIÌ@tƒù®›£oÛmÙ0Œ!„¦kÉÁz@¥¹
']ç`YsîB�¹¥bóâ‚uh¤` j�YèüÐÓ­×eS×[Tï	§
¨USJ?Œ“»l·UèÑƒMšY•½w!Ûjd° ˆ¤¿…)QÐ"'éU—¼Â‚M@3*»Aœ®X ]ì¢ku-€ §é×aL[+ï»âÖ²5‹Mœ:5aúUZ 5ª²ëD´™‘Þ|%ÐŒ¥c?‚9·­„fnuË‘Á‡æTË4Fw�Í¶­"v G…0}JsÔZéb·ó£<�ŸBÞP½�â,ýÉ[m*qØu‚õt-Æ=aV©�Qœ+&ÍQÓƒŒ0Û|s}šæµU=km�ãa\Î×b˜Å‡æh ‘éc˜ÁŒ¦›™øáŽqYÎ·Ã<N¡µm3è®¡ÅFaúÔqqTÒ’‡¤’hQ•T‚ `f0 hÒH©…¦3P(À0˜Á0Ààš@B5Õ†æ`0# Í-À 8uê•.y­Òªo ÒR€¤�
*`(Ô@ˆwâ�µø�ŽBmª­€4PA5M LF`¤¥ #H%¡PAS¦FT€š<¨LF¤TPAfPmf §s0Í&¤sÞ€âšPÍ™80ý·0X«Í•>vS¢5@Ò¿ƒ¶ÚüØ‰_·mE� g´ô	ŒæµÐƒ—¶ÈJíúýëvYWãa×ï6½ÜL‡= PÍæÙ=k»Ô:êäé›ê&â{öµ.eƒ‘^ii€Á4ûì]ß¹V·¶mÞœ�¥oÃÕbæCœYò5ƒžQh®¥  ;¿‡ö¸<	æ)Œ�žš&ØÌÖ	‡°G>½lÁÐiêa VmæÆ]D~þ°a÷�þz­!C„yjú­¥Äén×Çíý:÷!ÀÁÒ÷`tS†ù8Öõrk1ö3]3¦ïÁhi5ŽC_Ëåjˆýà’gú€Öªáð¶söá±¶~ìB(„µÜ$ö»¼>Ÿ4†Þ{t/Ë‡m‰ýÐ9óÔ´ƒ,ÈaÚÝÅËú¾ÝûÐ	¨é0€ºeÈÃÝÏéééñi_E�FjúC˜¹Ê[)ñÕÛ~{~ÿœ­›ûéWŸ®eÍm„	°æM_}tN�_Õ~Ø;#i–~*rÙl÷f²óã»«îöMiÁiY]~ýjÜ–¯^®ëÃ~ô¬¤¦·0€M7�o÷;~øðRwÓÑ5aK[‡Ãq*§ÇçœÝ¸{=îú²ä‡]Pg`ú�` ¶2LÑ•Ë%‡Þw&0M¿P3Ü¼›wÛåTÐ=ÔØ²™Û;žß_®ÃtØ:jz¹•þþ¸·Óõ	ÛØqzul·/ÙÂ4Í˜ö0Pk…ïÁÊË²‡4jú6T”ýî!¶Óåý9N~7¾íÂãùñYâ¼{õY\ž¾z×ºÃž±–&¨(²-˜^é?|¨Yúá¸ëËöôá½bºÛÅå|~iÝq€fL3WQ*Çý¾-ç[C7xš*°¥Ðßœ}x|®»a¨fi‚Ð-‡ápÄöôtÉ»£ó4ƒ¶lÅ¿z=£~•O‡ÝA+`°5wøùôÕ;ö÷ûRLÍÒ[¨¨µÕËþ~ïnÏ·5ÐÅý¾Ï§Gè~ŽR…š¾	Ku•°ñòôÕ©{˜GGƒ¥ß‚%�Ò*Ž¯&çž¿ú Çñ®?Ôóåìw‡>Ð`é¿���Ã°óy=_ˆÙS
` 6]åÕë=Î_=ŸÚqU–~ Pkë†‡Wîúr*Ú�ÞYØêÊ»W£¼ûðÓÜºñFÀ€Rïï(ç—SwÜO°Ñi­Ó«�å¶¼/ñaçûÓ÷` «*‡Ý4m×õj~¨PÓç0 ­NÃ~Õ—Œ sDjúça ÚûÞm—ÂØÁ³ôg0 z³|¼Ÿ_wÏ–2ÏQXHM`kÝÂaçôúþ‰»8‡Z@µZÔí]]Î—»Ñ±�šþ>€.«v¯úõåg^BœÆiÖ§N2ÏÇè¯—ç³‹×CF¶Rmœz�íiÅ8… �éÂ ¶ªµßO±<¿_4‡nccú>Ô¶*†ûNÊù’A‡ùð
m}ÎÝxORÓoÃ@µÒd˜†!œ®ç:wƒ“Æôó0Âj“0MÞÖ–]CÐôßÁ@m«¶i·ïÎ·Ëív÷Daša ¶­H¼óqÝÎÐNºþÕ½ëŸþJ[<ìÔ+©i€�ŠµHÿp?ãôüîªÇ0ª&«Eí°ë�Ï§­sŒÓt�Ûõ}Îán Â™¦Ïa ¶­è´OçÂ‚z§é�adk7�üÃ(ùt~éºn(0júë0Ð
ö{©§ë‡ëý4„ÜHM#Œ ©ŠR·íE£y?Ý9¾\¯R÷Ñyª¦ß†ÄVsØ½=ÈõÃóW8îƒ«�Ô4À¢äR÷oï†öôn9…ýÔI# Ûj‡û]w¾|õTºiò,’F¨v«%ìçO.ËÓóyÚïGL—æÂ¡Gù°�Ìïwû½Ïï_Nì¢�…Ôôj[Í‡~¯×õ<ø¹jFj[«Žûp»>-¶¿�ÃÆÆômAlÚúãÝ=·óu‰óìƒQŒÔ­Ö8¾êâËíCk¯§06:M#UÕn¾½žßßú>FR©é{0RÛŠ¶î×—ç†¸»÷îšŸ^�ûa<¼f,O9Ç9Jué#©º ý±‹[¹^s;*œ¦ïÃ6dS??¿¼¼´0íº!–u=mS×Ç¨ ¦·0ÐJÛŠßÝMe}~ÇcohÔôMi«»ûÊËùê{ §és©mm~:»¼¼\jew8z¬íùº ïaš>‡‘ª[Žþxj{º,fïL©é×a¤ÖVÚÜ¿—Û‚±ó¥¦ß…‘Zk‹ãýAðürZ8ô]€—ô›0²¢hè÷s_Öë¶‰Ÿæ8—öt½Hˆ1x( ­Ùtw˜Å�oOß9…¤¿€‘VÕ8Ì;Ïu¹ ù®ójz#+Švqßum¹Æ~S¦�aDUÑ¹“PKYò8Žû€ëùüÒÅ1ˆd¦FVúÙ±ÔÍpÊôw`dUã8ÎkÙ6Ñàwc7×u]�q„¯"é#Õ¹1D¹–KSóÎ¹&’þ¦«ƒ½Ër®·Îu�obé˜e3æ.è¥^àÆà.}
³B�~‡ ·ÒŠ‹ÞƒéoÂZVç‡ƒ“%ßŠ1ôb”ô˜n&8„hºÔ+B„pé «–�Ã—u;«8ï•¢iÓÒú©7^K)ÂNE,ý=2,ô}Í·SWvPÇôwa¶ùÃ$¼–Ó
GE$ýÌjsuÀVr£ó Kÿ¬ÕBú™›�Ëý(¡Ñ¥O`ZL».@e«[ÓÑÀô	´ªXØÁAëvaŽýØï/­U7x	ÅYúh\…}7Iár[…®Ÿ6»ÕÌÐûAÍiú.ÌlÐ†Î—e»Fé¼ŒéOa-Kíc?ùbWÇÑÑW¦ßƒi­BÃhÛ¶ä“ø ¦_†i&cçv­êm[à£8Q‘4ÃZ1“Îï²Õ¬ðž�ÅFI«,‰
+YÙ3 "és˜ÏqÔpÎùÚÅ‹…FIL‹™¸Ø{æ­�ì}ºôC+LlôÁ·–³Yt» ¨¹\=:‰Î˜é?‡™j†yßí½mëu[ûÐO#´]3Ñ9Ä*¦34nb£ºM—º‰ë9ß …ÙÅn�°–k5g1�0ý”lUÍ»n‡q]/¥CôŽ•¢­jtCìj¹å†!Œ}€å­¸.v@Ë7J$x%A¦ïÁ¬š9ƒIÉÚÐA ˜þ˜ª+â\è}€.š›FÊ¦[.y B€Ì·ï&.·›Ó~p”B€) «Ö‚ŒÝ�¹•Ú9Al ÈôÏA‰¦›SÎql¥Àv€˜~¦lqó‚a™Û­lèM j+&ìû€›^XÌ1Š:˜^ÁZaÎ…��Õ-;Fx/`ú”h4ßõ!lK­â½‡W£¦f€i…¡ÁAuxzõž00(aTÍ2:Ý¨Æà¼	I¥¤{(aÚ²Cì‡@lymµçB%ý/0ƒ¶Js!D´bJíÅÃÁH# …°Ím!]W.Ëº‚sƒ%¦”€jUeæhåÖJóp^)l­1ºÑiËêÐ!˜s56JúE˜)Ð¤š¸;Ó5sƒgßB!¦_…Jj+¾wXµÁ	<|ò¨,ÂÞj+E‚Ç'Ík½¡yo�9¦;˜Á´°z‚Š­µ©‹ì´@I¿ %Z�µ÷1Ro¥5Äaˆ®Õ-Ót² 
¨¢é‡™Â´Zc¦ží\–cp�˜fü#à¾ˆ6£Í3Pi YÚÁ`i‚%K”  ) ´ ˜¥ š‰Å–"Œ4#H3‚)‚*ÕÓ   )“‡�
*©¤¦F*©©¨¤¥ *h#•éF*iéŒ4˜TOe
0‚TÒ¨ `‹ª ’F%•«3S¥E8a_\ÕjÌÞÌ„p
&šQ	TÐlQ•4#¡  c:ÂÐh5øÎÃ�™#<œ(Ù´å(]NkÙŠúaÂ°n—RU¢Í+˜:Mª5‰~VÇ¼Ýš �âÌIz€ZMá}†¶´¥@‚ô„ÀÒ«àVöj�õV?tyvÓÓg'¨jEðE5+4Š9z¦_‚Ñ¤JqÁKP·j	ï}ç¸µknè\”É…µn«Áuè«Óô_Âh¾Z3ïæ>dœkË§³ô]aUéú±÷z[³¹Þy¨¤¿#Ð´ìöX¿z¾ÚF�*ªi‚ÑduS<åË?ˆ¯’v0Âšµ.ö}¸ÖÕ(¾+Ži‚Ð’!ûùá~¹<>/:wÞ5QMß„¦+$ì†å%_�÷�Í©¦ÿh­Õº×}¿Ôÿ?úþWo;kj–>‡°¼•v¼ûúøÅË‡¯âÔEÌûnÏ§å9ìÆÐ”ÔôË0˜”Z_v‡¯ï^ž¾x\î^½Ù K#Œ`eÁ<„áz»­a}aúe¨šÕuÓ¨ºÞ2vÁ��0¡êêéfçóš¯Á{‡À€Z¶Ð½:¯§§Í†Í`és¨Vªöûq´ëraNIMÕV”~7âõvqóØE%5}°µíÖ½>ìpùâCÃÛÉ¯j°4Âš-w†§Ç—<™�wc|üêG8ì_M‡�d]>\zN1J!5M0 ¶Ýj¸ÿxÀãO×6Ü+7,ý,y,m‘WoÅ?¾ÿ²Æ×=üpÚËó»ŒpˆÑ–¾3a»•e|sgÏ_ýûý¨€¥?†TÛê0ß‡|yy„†Þ÷¯"ÊËùe‹¼¿ûäˆ§/ÿêQîCÉ°ô#ò­ØÝÏ½Î×/ßý8Ìwc¼Ì„­f†iq½]´‚¨i‚@i:¯ëúN1ö½ ™¥¿3‘V–ß~<>>}ù“GÞ`hjLß€hYd<Æx»œrè¢ap›ž—º�ÕSÓG0 ­ä6<Üáv{´A]%`TŽãØÕu½Iè½Jeú·` Ö¢˜÷c¼\/¹÷Ôû¯ÂïþéOúŸ»¿6TV´¸›{;(Õ1îÞ¾úòÃW?Õy:ÆE+”’—<|ö~üã­¸?öý®ëÊËóµ„ýÂFjú€Õå†éíƒ<ñÅv�<|ý¾|ÿ�Œ»7¯»˜·—ëû‘jú©-[ôã ëº°×#´äaµÒO;'çK­`ö}ãxþ'lŸ¾®µ‚$}°áÚôþ“ý¥|ùau‡Ñµªc` jÎ~xsçÏç§/°ëâ|7µåýKÝ½ckj–¾3Wy]õðÑ+¬§ÇwmðƒÇq\o/[7ìÄ“ÐÖì‡·¹Çw?ù'Ûñnî'éŽÛör-aôDfúÀÂ­Å»û¸¾¼{9•ÞMoÞŸÞÿÕ�hhAÒ¿`·mÃgŸ<`ùÙÏÞ_$¼Hñ–F@]±Æñ0òvz>�ãÐ³5ýŒ@mèúÁÙ²-µï{*©ésÀÖšöÇqZÊùâvS­1Í0Å÷wÂçk¹V§óþãÉ^¾º<uo&õTÅ…ý¬¸­Ùûæ*Óµ”ÖuÇ£Û®—2íz‘Lja lÝÔß}<áåýËâÇ°óÆéÓ?¹}}wˆJ5K= Ömµøö�øòéÇØ¨Yú&Œ aÉýýý öôá±ŒèŽŸáò“wv½çFjú.,y”ÒpøÚ+·<¾×áÁwc?W;-çqêûÍg¦ß‚4äˆÃÌrÚ^‹;|ò­–¿|÷Ó“ûxË°ôFP‘]Ü�±•ËŠ¡)™i†¬ºÕn¿ëêöî±N»ÙÇnìü²\ £øjzµÖ6ûQ—Ó)[úùÕ±¿|ñø÷“˜9ÓôAÓÚü¸sõz¾¸}Ü7¢2ý)Œ 6T?{YÎ7ë]�éÛ0°a«q?ÞázºäyŒas…é÷aÉ£le=~ô:_^~tý°†¾›|È×Û‚aôl ¦ïÂHÓÜLæ·¢íü(Û1Ä OMoa¤–Ödš£]Ö“Ô¾ë¼:j2¤Oa kÛ69|4ãéé]c<ö"Ôôë0PQê•þÕ7vñýûw[ö±úFÓôû0€ÙÖ÷o[[ß=6Ó £PÓÀHÍ~é»É[Ë7¸(pšf©º(ºÃ¾ãõzª~èœÐ¨éû0Pë¦n|¸ãz}ÙúÝ®*5ý	´–×•o>ÝqyübiÜÃjFMß‚‘ª‹q8¸hëùqhcð0Oƒ®ùŠ×_»/_¼÷è0b+jú`n&o�G[žöýØïC®k^ÍOŽ`ú0²eU™Ã×í4à0:6¦·0RKY�Áëã‡KàÜ…FÓô‡0²*ÚÐíEëÒ–8ô‘^5�ÝÙÙ~_Üúr¶6ŒmVI#­a%¦»û®=¿<_5îcefšadÁ»a?åír]eèFq…éP›µþW½=µm7äý�éS˜fs]?ÅÚÖ¼¨ïHúoà8†¶ž_®ŒÇU,ý]˜e6™b„m/KÓ.ˆ4&�æ²ƒìš‡êæ,Ð“¢¦èÆ	@ÙJéå0ÄËz9Ø�Õ¥ïÀZUéÜWò–}Ç^Cºƒ­Œó<b»–këüL™>�U%ûqvrÛ¶Œ¾Ÿ„”ô¯C«™ÈävËÔ(ÁèÒF¶¬†]|09Ÿ®ÛØÑƒé ÕlQºQµl%{âÕKú*¯Æy€žoÛº±�MÒÿ
#Õ64ß÷]ÞN/KÀvÎGX©7.Z¨Lßƒ%ÍµI·ßMùt{Ùâ»nŠâ´®@p]Jz#•�j1Ž{èúœ¯&“sfÖjŒq’¼m×�h°ô¨Uƒw}œne+†ûýòú|=AÎCÌÒªÅÈ1DÑšC™Í¼¤ß�‘Zµø.îwÌ�—‹Ô¡ï;q5ýT·&ìFÛN[vŒÞ=Ó#«jé»Ãà)ç§²îbè*©é7Ñdº¾£åÚ`-z?º`ù¶-Íil^™v0+N{?÷ÎµE%öÒV¡ì†ÁqÍÅŠïD™¾	KµYñqÜ{½¾¬+dÞ$ý´¢yVÛZÚæâa7ëi[#Ã@ƒ‘iB“�èâ u-ÍzôÍ»ô9Ì´£ýÈµ]P%²ƒÐ¥fV!M:ñ¬Y«9“Gƒ¶Í•Nf¯M—²°èšVaÔÐ»aáM¤£@„é#T.¾ý\ûu9u×�“u%}¦NÑVÒyú¨"ésšh•æ¼Ùr½ZqcÜ™=./±\¡¨Uiâ¢(s³ì{?£¯¶Ô5èèTœ¥	V]ðÑ9+Úà½gúÚJõ:Ç]lzY/^zôêØDSƒÒ¤BÐIÕlÕE@$½�šYídôÔ|ÛšêàT„`úa€šfhèÇ9ÊV_ÔKç¢ú&BK3¨Yi@ßƒ”|¾å9Sô&¹6§»n€¯¥Tu�1qJI_ƒ¡y4®S¸};o·ê¼§˜"P­ê\ìlºÖ%o….@ &Cúga
5mÕ3†.äVj‡ t� ¤3¥JÇ®sæÖV‘~'Øºm›Q¼†ê*˜~f
kµ:ïæ>T½\tÑE£¤ƒ¢A½º¾�R¶øè)Ò¤�é3S‚õèÃV/Ð,ˆ‚fV�µ�3Û²¢0Ž6VmFxéšk€�éS´€VÔ¹>Ïö²¬½�CMk)�æÍ;#Áô/Ã „5§ð¾éÆÆ g h)ÂÔ m¥yô}WÊvËÛäÆnDÔâªY@L¿Sƒi+êÂ4ŽN®Y[ˆpJ/Lÿ>Íi8ÉÒ–è½ïØY­šƒ’`ºƒ)Zlš\"ë²-%OpA�€¢UÔ|3lMZ„xO¦54É�¹.zW—ºû¡så&JH€FIo`)@Ñ¼¶rìFÊr+ÙÏaˆÂ\·
ßÁ“žÒÒ'0@kPmÕ >Î]iù–ú	¢­¶êCc4k™`ß‘/åìà&ßI%)Î…Á`ŠêUØ‘¨°•Ž"–z˜Í`¾‹±ßêm«ˆ~ŒMoVÍ#ö"­TgÞ‹s€”a3mUûØGm§µÄn˜´œ¶‹]DÄÄXú~ˆÿþ+ügø±Ó`FaF%�0Š‘Ff¥h¤ÑŒª´ À` ,EPPR�5BƒB�-X ”4Å03À !=ÅhUkE `ÒÄ(âa¨¾	 	pfTW¢6ÀÁ‰‰SÓ*­™A¸F•¢)À@%‚ 4£Âfj€Ñyuôæ›†BµSA+ó@¬±ºÿ¿ xÙÕlÉÊúÍ·±Öú/;wæÉSB6ªê D�°,w\²[…eÑ‰�,w,÷
T/~?PyNî½ÿëºÄeNÆh$Åp'ë™	* 7Ç )„@ÌÖ#*ÚL³* ‘)D!P†a‚ôê"dÀÊÿJÊRŒåh=°‹“BŠ»ÝÖµwtcz ¢ÕVË“÷\·¶(†0LÖÈ³nÝ[v 2*½7¦H¬�Ú­af2 ügPR’Ý
mß¤XçŒ¯„Êâx ”Mz�0F�jþŸPB×cí8¸Úî‹ˆwÁˆ5š?A¡½ªjRh¨e±Á;S¹ç
íMÈóL±Ôý¡ÛhÓ8¦fžë®ž]âæU•¤7R
l	µ	[±Â–r„BšZöÃ—·Gw8+D”g(A++{Ÿ¤/­!8µJ””ÐÛ®œCÄó)ûäÇb:“ä%@ŠjpGÚãÙ¼•�ÓWƒëÛêLLÆuU@Ihgë£—}_‹1–Î”€jwcý\÷½vc¬3œ€ ›­ÎÉ=êZœM¤
(ªÕ9@÷ÛÞ\ÝuhŽPPçãq¼Þndƒ0šG(€Þ›ÌñóXøý£{ðŽÁª¬v'õÓiÔu{ïkw6¾œ§zÿùŽÁ9?¤Ëûrw.D¯,ÐÖ…âtŠØoCœ³ÝˆäJ€´ÁOQ×ç³ÊÙ)³æ¿„HD­Ÿ´g}:^¹Q¡ Ñ²u>}™õy½Ü0¥ˆÎÐ<C	$(Î£Ñe)ÄÉSg@	(­Ùã�ÃéqùCƒ1çS¢ýò¯o8sL§_Ìtûù'�“W1Õ±’ješF >ªÚ)�+”'(H¤(Íi"ÜJéÞZ4&É# ÖŸŽ¯Ø–�»9X�¨æß@AÒz§yŒ|Þãì�é(¡t²ñ%õëíº"Ž:“ä	
YÕé€þ|6§–ãç1~¿üôN‡×`Z�p'‘jìiŽ÷ûÇ²Î‰y'’ü
¨R‘ø2ùõúvçù0ˆiD’G(HdcÓ ²®Ú,B:Ð—gô³µÝ’ä%�jíqL',×ëêS4PþoP´Â1Ú²>Ê–º·/§Ï~yû^Ã‹‹m'’<B´Zzúœ^—Ç÷Þ†Ù3‘äUÓPÄžŽ_ÃrûéÑF!Üåß@³E©‹=üðGfýø¹ª5ötšÇíÛû*}¦¦ôqû·çñd¤1Iþ%€.ºÌ§¯Xo} ÿéÇƒý—oßîz|Õ†hþ-$}%:¥ØÊöØK@<¿l·ÛRðñ|r}»<­Ÿ$ªùWP ZöjŽ?¦º»/üzh¦Ê	
@‘ôé3­oßî>NÔ[÷Í™Þë6_ù¹üô0îœŒ+P%êºînü4èÇÛ»ð8B"P 7Ð<i/·æR *Jù/  ifœC(ËUâ!+ Ôwˆ‡þ¸]ä�b°BªùÏ¡ Z­)æº]ÞÌ4·sWÍ	
�Ô"áðz<_>>Ä9£Ã§ä×ËõaÜ§¤® šÿ

’^„ÃÑš²>vµ¶(å¯P€ºì�ÏŸB¯ïß0ŸgÓ+ThEeþtªíþ¸ÛCò,
ÍÍ¥nnü2ÑåýñSUº
©{•óçÉÞ�vŒÞ�
ÈÚz<¾Vùø¸õñì¬
4ÿš-j%ù4~©íòýÍO£;œf<ÞÚàGûr¸ýü±·4Všÿª¦¡V7�¿¼\ï??h:®Ê”@�ºspy.èÑÁTÊ3$²1†O^ÚsÙàù|ø
Ü¾½UžBŠŸB»Ý¾?ìiˆ¯“”ËÇõ9¦™
D5ÿ
 ðùå€ýþ†Â_±¾ßÿõ�³=�^gô÷k©³>¿Œ¸¼Ý>ÙñåêÇO×•“Õü
¨ÓƒúñËhïoK‹óÀÂÕ±úJ<Ž¶í±ø0C»­�g:Ö¢Qþ% µwŽŸ-áãò‚�/_Ïß~þÎá0ÎC¿<uJ£øB$9A	$¨:¦è·ò±¹=¨Rþ?P©6ã¦!Ö­¼W®”% .¦P¶çs‡uñåø©\o:½š�”JŠªi|±h÷w6átlz}{7˜CêdTò¯¡ uºoæðeÚïK#±@ó‰¬ãËÙ=n—á“·PPž¡jÜ‚a×µnÍÚ8�my»ßvœ,	(ÿJ@« yJ²¬ëbŒó‡äõq¹Tc€X’üÿ¡ õ¾—qzý±/—7æÏ£:e’üK(H°µªŸO~_ß®5zæ×WZ¿ÿáê^¦±»N$ù ‚RãyzÙ¾=ŸRœ_�~ûøé£œŽÑ
uÊ¿†‚¤Øñåt}ìÕÍ†Q(�P"iMä0��û³97:€ò% ù�Xô‰FC Óò?@‰¤	hŒÞÔ}¥v° "•ºVùü’o�º¦Ã4‰½\®}ˆñ4Ofy~¼•sQ†l¢á˜îëýÏ?N¡½}»u|�Ü®@uS„éñ\®Cœc0�Hò i/­¤ù5œ®Ïï“Ÿ­W"ÉÿJ íµšt°Ôž—GŠ§Óèoo¼¦™«�Z¯ÖMS�kß¼³žŒ Jè›Ò4[×Û²�ar°Fr„»T7½žê~]
æƒ$€öÒ]˜É­ÛºÃ»0Ï¯ÜŸÏ}­nŒ/Á,�çVÝ�ó¤z½mdÇóéìe¹¾Õæ§IxI Ré’SÔåã
ch**ùŸ  m­Û0}õËeaJ$J’¿@‰DVÕ4-_¯OM&Óˆ$ÿ %ÝYÃtä¾UÓ)œF¿×ïbbX“BjQ>Î©/ÏËøùtjùþÓ^�Ç¸Q ¥+O¯Çq»ßšÇÐUI mMtc—ízÛc˜À@IºÊ8Î¤Ë².V†�"d\Ÿ³MÖ4C’€Iíjü0h©[gX²…6QS€<ëÆ6z…2©jíÖÆ9P©wn‰“¿B‰µÃN‡YäþlÎã ¬$9A‰šˆ¸ðÂÃR®­ú¬‘üJ$»š,×Ûc]ù0£¶ýr{Ûâa>'¿]?VÒÁYH¶è¢pÃKLí~ÖÁ–„$ÿ %j]ÄÅ×D÷íŠ}JÞ)É?@‰¤öâ< ì×µ|ˆ…%[tTqî4˜eyT)ÁÊ¿‚IkÌ)$Ôeï-l4ÿ%’5‡˜Öþ¶l†çé5ø½\—k#{ð6ÛýþL3O�@å½¥ù0•çº^UÂxžý.Ïû²#¯)i}<.dÏéó¼ìWév8ÍóØq»>Çä–$'(‘ô½V;ž”ÛÇMðâƒ$ÿ %êEº='1ûrõ>&ÃÍä„Ê.äã4Z½o7r>[)OP¢ÞªÚp²�¶Ë¦jCL¾C	µ
üáØÝs¹T7ÌÖ¡ü{Hß1œN¼Þ—çÝàó€jí„áxpú\ÞÕÌ“3®Iþg¨ÀÅaÔ^öÍÈÈ^;åÿÕ*‚á¦­>ÖÅÅ!¨Éˆ¬�t8„^¶Gq<9�Q-Li
ºÜÂ!yF£üŸ hÒ”¦ãTe{ßúæCzq¾?×Ë¦É6j4ÿ"‘ãlÌ²¾£’KsÊ³ìfÖ*wÊ?BdWv)	×ºíÅç;15íÝúapõ¾<¸…dlgåßA¡M»¸8|_Ÿû­7ÍîÓ.ËuÙ«Îvî|Û¯7@´�$3–¶œÛÎ”ÿ+:mŒ8FÓû£=\‚ÚÒ&€üöÜöâ¬5Ä- Z¨z3AÚ²46ƒ#RÊ¿‚jåê�Æô²¶êœµ¤–óUm•tGçq_x›£·  ›BÌ>°i;5ÆX€òW¨TQçÃµ/u/ƒ·L¬ å!RÅQr.´Z:(&kòßB{«F‡4`Ù–�œ÷B&ÿ_h£Ý`°Éhß‹!¦@Âœ•&†œ	Ìu“]œqq^!¤¾šjkàˆ®u“Ni˜Èïæ±ï[‡Ù†]·µÁ'›ºW(WxFA[[……Ò¡é½çª¶V
œSp›.OêÎŽ!tÚÚZ¬Cèå?…¢ÛÞa%ÆÁ?÷­J·ì@d üwPU‘¾»>X'ƒ´ÒTìœæ¹ÕíþlŒuê*T«+ƒ÷¾£/uaõ“ŠÙžûÞÙÙ �(ÿg(Î¤4h]ÛÚ5p&£Ðü_ Õ¦J:xf*{Y²C7Ð¡mT¬a.f-µ6^J9@RÑ¬~dyïa b€òªíhÎ†0ø½î ƒ7,L�ÞÖù‘üÚV*v³ëem…¼ê„IÙ€òŸ@¢…aìhCïËÖ[€e‚”gd§@§�ÈÙ¤uíÏf1†u“²í+f?MIÛS°#ð @›0!¦X÷²¯…=3›F¢üÿ ¢ ÎÅµÁzOµ&²ðâ PP…j§Ýª÷	\—ÚžÕŠç¿�¢soÌ<X[d#21Yp)Lê[”¥žÄe([¨’*:5CÖ1¤ïÅ¼±­¬kAHá¨E÷¥7µ.EîËÞÑ²mlD€h¼çV+`<9uJ h>C¡¢R¹Yg\0EÊª}2,¥±7êºmd4ÿG¨ŠJ!'.Ú$e­ˆ-ƒ•�ªÁàÑdåUaÉÃA¡Ò¨ZãM0²Ä‰m¬J “ÿŠÎU‰ü0XôµÔnœõÜ‰M\C€ v*‘‚0+(ÿ1²UéÄ&9¥²I#âZKÛÄd¬ ü¿ ª‘Âð~°v¯ë¢2Ã«�å	ª�;Ù¤¦ëf!QÙ J”=²U@+UkÔ”UØ!˜Nœ'ˆ6nÞ1C{c8!kY	ª†Ýà*M‰É‹É_!­†Ä>IÝÛÚeDèœÿ*½Qs>x×i¬%cÁ¤*U9a[J—)¹àêVžïÿlÁºÞBASE      „  xÁA  ƒ°YãúÀ þµ,9­ÙhÕUmˆ–”M$šº­±XÙh6ÚÊ°I6’V46i«Ûšˆ­Yk#,È¡–kÄ¦«ÜVÛP+çr­eÚ¡­@Ñt-•µÖ]åP`iZ5”ªÆ²„
ÛæPAËJ[Z0Ð�¥€Âp£±•¬ˆ¥ÁpÃ¨Vk46`¬l�¬Š%°\B›µ¢emfˆ¥TKÈ­RQ•Kn8H‚"ÊÀ%C€.‡„ A¤°Ò•²QÙÐ’ bÐ4@‡1"n €¢ T†• m0e�m¤’¤�VˆQÑ2…A’§-­"°t´l¢)åÜ”‘¶¥’
Úêìpý¼BPOS       ûŠ  xÁÁqTA D±…ÆÓzó]P›Ò"t¤¿ÿþ|{½^ß÷õëý~ýøýÜçé¹÷Þ{ŸöQ>ö|fú²>Ïg=1ÎŒÔ9¥³¨L:é¬{.m³{è¶é¶hwœI³¬ˆl¨h‚ !8È„	Jq´¦6+œtÀF´±€Ñš0‰Í–Â2£aiaÍf‰™L&à06�–6ÂŒ#& C��L­Éd-£ÑjÑ™Œ‘4°Ì`€˜�aÂ¬AX‚i ,´ `ÐhcÄÈZ ZfÈ�´ š¤eÐZÓ µ ‘] ÕbùqÝ+gCNF4       Ê  xÁÁJa…áwüûøAB³BˆÀ6vÞÀ¹¸º.·Aëf¡-Fí8~=O3�€ÖW9Ê†’w™Çó—çÏ×�÷‹ƒOÛÉï‚Ýña»Gç¶‹yÑœ=×E3:hUéhõÆ@QÍpèž�¢%½0­éƒ ª|¬ôŒ	ša×S-Ð¡z�at1Œ‡CQ¥�ÀÀÜöSLØ¾Ìcð·c{ÜVN•bSÙ(Q¢D‰%J”(Q¢wþ	�^ÉTEXT       Éô   xÁËnƒ0Ðû)ó‰ug,ì‰…(�x�ÔRºnè¢áû{Æ4´@ŸÆÑc¹]G¤*F=Õ•Òót­B§µR5b™RÎ
A“ÖËû%ZÈ¸B–dÉ F£üí²¼_¢…Œû!ÔÒ.¥11ŽŒFU-I2ÈYŒFU-Õ.Ð|µº¼ùè¹M÷)n¹Yï~ö'†T åÛY£…†{ÓÃGOä:õè²{~ÿâÑÎ
ïˆG;º,êø>4ÚCLIP       	           L›     L’®ZTR

SMP4      G"n  xÁI¬¯[~ä÷]ëë¿¿Û³Ï9÷Ü®Ê×e»lË8‰±e$*@"šd�‘a Hˆ	`æiÄ-	L2DbÀ„H(Ll—«ê¶§Ýg÷ÿþkÖú½<ÿËÿ’|YÕ®(ÚY3mjßžWg§ËE{5�\½xùÉËÕç_üÚ‹O^|õÙ³ßýâ÷¿úôê×¿ø­/~÷÷ëÇüÛ¿ýÙOþÎïù?þÉàÏ~öÓ?Æïÿö'!Ãï„9þþ4,ðgá3Àÿúgø³Pá—ø+ _ý‹ÿÀÿñÏþÙ¿ÄßüÏÿôÿùó¿üúŸÿõ¯þòÏÿïùÍŸÿ_þí¿ø¿ûåÃ_ÿóëŸûîý÷ßýÕ»¯·÷ß÷w·¯¿Ù­ïžw�Çývû4û±ëÇÍHü›ø?¡?ÃÙãþâÂùa¤H
@È ƒFQ„¼'$*Q¢J4J’3:s„IA”€D™$TÈ ˆr áBBB’’I‚@dbç&‹Ë$“ƒ<ÀÁ @0†N%H ��D �‚0Â(J5DƒÁÌ`ÎyŸ"ÍFÄÑ›>‘Ž HDQ„Qá9d)Å¡Ì|åcg3OO3Àˆ13ÈKJq]UÖ›ù¼Î1Ž|	Ÿ9þf£¨Â7Ž}3“óY.0¬ FçXæuÓ8mìP¢È3:y…%2P0gr
We1õ¹òI^Ùpè€ÜrÀg
¿Ñd±oX–…‹±sc“2dÎ+”Ó�[žUL±•û&Gn^áB 9£¨ðw Eþ	DÁâ>±]Ìg8Ü>Ð¦eeÎ ðïA!þ’�È %Eï†ÿ‚¨C?ð|q¹}ûxÌë¶IQ&†/ €)n©“‹j\¿~Ú·YÓÄ$@á„@K½\9+9î6_7Þ'Zê'³ª�Û]—×>‹v�ôÃ¾]½¼¶ï¹g³˜æ…
‚€¡?6/&îøöíÝ°¼¬|o‚ÂO!€©G\¼š�Þ^ý˜?;m|Aá34ô«ætº=>>¡­ªŒr’Â FËÓâöæP.ç²Q
�:`²˜¹øô3¹aNý8úóÓSÙõõÑ�­êbÌ`á×2!œ%K	ŒI±ZµyÚí�Ó¢ö0(<ƒ ¦!¦z~1Íï×·}›-æËY�ãÝ°Ž('%¡ý±ë6'/F½½ÿf—M'U)`t‰³YËqÝÉ•™,”0ˆôDÈ`ø
ÇÍ8¹¼(öë7o’VÓ‹<aØÜYëÛÉ	Ð .«æ•ð°ßóÅé•ß=><Öh
31ü ‚‚LSˆ¢¥�sóió°Ý¯³¬ià¢ƒ…4’ÂK¢l{°òÕE‡onQ­Nj)ÒÈPB Rgy{Vún·�~VÀ…sæÇ´î²ì³Ï?þp�ÅçS¦ÑI¤…?�À�}>©tëãØM'ËUcÛÇ‡�M[§è`áˆ-|A% 
¿ˆc�ù²Ív»‡ÁµE	å`Ùâ|ºØ¬ï»¦˜5Y‚¨ð%@‡ÁW‹jÿðM¾š­Ú!nî¢¦ù¢]Úm¶O˜4ÍÙÅX=\?«Ö'B B€ˆdÛ".f'Çaûx,Wus´0ƒ P� pÐqßcqz÷×O©8ŸVÃ 
ûŒóiÕ‡ClÊ2‘
Lq§¶9ïÖ›õ�¬™x¤ÐB lÜn~åñáö»ÓjzÑb³»¿A;¯2Ž€ ”hTø)0†j¶ Ž›ûèŠålµŸÖ�›cµ\ždøp·ù˜M|»\œäùææà³éDI‚Ñ�ãpÌ_}‚Çë·ß­›gógy�7÷‡fVW£
ŸA ì�b;›�q·¿©Pç>~‚HA01œCrrL4gýq�W|xwhÏ/²Á�…S`Š;”³“ëíæ©©›	‚€8îQ�­úñáá‹“6‹$g}·›]|þìþøæ#¶Óbµzìo_÷M±˜Ìµ8<lÇ	Š†æ%C¿/Ï>­›ñãÛ'”õâ¤öw¯wõù\ýèLÿ$‡ÔÇ“å]}3øÙÂ¥–ˆ¸ÙÅöË/žãûï_opu:ÅFp°ãöìùÊ?üðýíCquÒdi…¸ÝŒg_¾âãÇ_Þ^O^]”c$ p
ˆCÂ|9Íëí~›É|vöÔÝ?ÐÚ:7:ˆ¸Û¦æ³Í›_~w?ž|~Bjºí~²ü´(žÞ¼ùˆ“‹‰ïFKpèOéìG¿†wß¼þˆüÓËOÚïîî&ç«©ë#M¯ 
Óèæóy?>Üß“i3Q¡† ¦ãq,&Ï.»»Û®XÌ§DXh LÛôpzþê•oÿæXÏN®ž¥îñ‡[­Îç1%@áG™<½�d2€ºqÔ³OêÝîõÍ&žž×~$(dp pQT¯]š=/K|óöõ“iR¨  ÖÈ‹Ùcÿx‹â¬É�ÁE†%�åtÖlºÝ]r¨ª““óáñá�å,O'óÌooo1_L
 GvùÙÌ¾÷‹ˆ‹E%Ž„‚ 'J‚Â¿Q´ñ˜él5sýÝú¾˜Íj¢Â)€]÷äê«Ù…m¿{?àåeQu -vž““ªí¶Ý†hó<zX¨!B·Yš®f§7»�Ûlœ´™©PA"@Ñ'ç“ãîÃÍ�;›´9%(ThÖÇ"�Îì×›‡|6¯üè�…O`"œs°” 0ü6$ÑÉ�0@†]VÌnÜl{E7½¨üa÷4«UIš§äŒæŒ A&†Ð†´‹“«çõÓöÃZÓzÙ Ò ;ö]S¯ÎŠa}=úé¼qnp 
¿TÇ�›=›[¶~3b:Í	4�E9-ü¡;îêbRÐœ@¥¡0}yZ¬oo~ØŸLæu]È@/!ŠC‹ætŽá¸Þ¬·˜-*v»ý�Šºà,œA•ö}ª——·»ÛÝC;­s°xˆ¾\LÒ°}Ÿ4�¶íQÃúhP5™Í ãvX�?]Ûþp¿ÙWÓÊ›((Tacty5-·Ýñèª&y"Ò¸—;9}VºûõÍ�Î'UÑÂ f=bS/¡qŸ6û‰«œœBQ}Â¬9ñØšWÌ;?ƒ@#eTø´´O±^´ÝýîéÑ	Ean ,G·¬—ŒûÍíqÌ“E•†ÝaãlR¶…�C·ëÊÊ—2Gçac”«Û¦°ý5m9s~¢¨¸s©>=ËÝÃñ6åE»\N«c¿‹õ¬væE�ýNÍó%ö›ë¶‰UBOZÈ!€%…"lLcÖ.ÚvOÛ¡ÉæÞSÈz�¶ž±ïÖkÔYg´Ð@„�Q®Z4Í¡¿ß;-kGÃA„Åh–uy8>mÇjZÎhá!P±�ÌV§ùñæþn3ÄÕl~zän{‹jšy�€ÅÈ§Þí†í6AÓE•÷Û'�¾ežà,ü”(D1Â²r2/‡ýÓØguc.: ?�ˆ8&ß4yÓ§þPYÑæUÂÐ«£kòEå]xX'd-@g„…
Rg(–óYõt¼ýÈþ4¯‘H@i|í]LýàÇbZ-|±é6ë4´å¤ñÕ~<;_×–G†3”@Yøß¡��� …FÈÑ	fÆ�C”»¡iOçÕÓþikÓªÎ\-ü·‘ÆqÌëYM;<nýqVæÉÉÂ)¦YSxÇ½U¾)”™þ}Š�YéÏ'Øï?Ž=Nò‘¢Â¤ÁLÚó¥6›ë5M;-ÌòÎ Bi½›œ,§»‡ÛÃ|6){d±¸`Žn×ù¶Í
��H™(�²Nû]sv5Ýç>§§ó‹”Ï ��2Hi<Î—W_]åîwEvQåŠ€*ˆPŒèëòla÷ûÍ©®3*�Ni³�éüóÏ/ñ‹oÞ ‹é‚NFþ6ÐâþpÌN_~æÒöûu‘üª¡3‹SÝN\±ßï6[+–ÓÓqÿx¼ë­ÖüäÔµûÇ»”f³I–�^TX"drÌ"•Ì ÀQ� …ãápì^\¶ëû›wëûút9ÉLŽ£6‡ùòùüùíëwß­«ÙiSÁŒ&†DXêÅb¶°ÍÓãíhm=¹<)m}ó.ÕËUÓônN Š‡ý±X-O›ýÓÛ1µõÕùrýáöý¦)Ó†n ¤ðÅÑ�*'«“åÐ]oc»œÖàè¥n¿óñåÕ|ñþñõp¹š´�Q¡„`$í°ÿXëÕÉg¸}ýÍ[L/®Zô1
 ÃC�A@ÚïêË«Ã÷¿z×¯æ‹Ê9$8‚B‚`døO!X,ºb5]ô‡§ãÖÍ&eá|b8…!	ÖG¯ÕjU€�O¨Ëf£¿ƒÌÑf„ “D†¿É¬'ã¤Y–ëþéán‡lî3(üSH D“ƒÑÈð’% ªC1].—‡þîþ�Íòyé Â‡–†$7oËÉnÜ>³jš¢9ˆ
HAÐ AL4†ßƒ`pÒ8¦———Ãìã›ûGW•“")Q¤È0ƒ šõN“Óº‰ëÃXÍfMæ rˆP ï›iaÚm“¶j3Ž´T”å¤Lûm/�f67Û¯wÝ€v9-4<Þ¶¨ËŒæ¡ÑëEYç‡ÝÍîqÒ´óÜï‡ÍÐ§ªÎÚ¼*pÀúÀÌYrN`X@È‘ý€fu^:Ý?móÉô$+$P€Â+H6h—«^žŽÓÍýuìµh
s‘HÃ�P¬ÎJ—?<n†nU6bž((, BQ½Š|Úä6;–¾Ã	$!º%&å$ÛõÝ±D–ùLtBïG5ùj1ÝïŸ®‡ÂVó–~7>‡ªœÖ‹"úÝ8 µ/éÌ1œB Rïbë–“:î·‡®÷eQXn´PÁ¤qè™×ËU�»§cÖ-¦ä@†9J‡uuyêÚ‡Ç»H,ê¦#Œ1EÙìä"ßßßßíR³œµ��Þ0x�¼ª`ýa¿F>Í¼¼³p�Õ£È'µì¸Û'ÙlÖæq<lûM,¼ÏDÂÒ�©(+¯a'9y–ò¤â©isfÃ~³9ÊJ_�‘ L	tµ§�ê­ž4µëÆa€[Wš÷BêxôUsÎåþñn´iÞÎª,)&Wù&wô>œBãa,ÊÙ|VÛú¸�¾t5<è@†d¢¤åŠÂ¹1,æÆ,s äþkˆ“ºäª¢…ï‡µuÌ\-/J
9Ì]J½ËUV•!î8ˆMé½<Fg‰03À9—ŠÖ#œ”-4n¢2¯<3ï…”RD‘Yúy�±4�9 ‘�•o&5ûþ‡Üû:å‘&u«ºœÖÖmÇySd AÅ	yå3õÇ}ôhëÐQG¢ ÏEÊÉA€9‘däÂ� †¿Q””F¾¨Ëš²í8Ò•¬`T‚(:D¥¬¨š:bŸlô™+éáÑ›·¦­1îOëXÍçBÜlÖ)µY•)¤””eé`Ç6›åy7ìûŒy3m=ŽýqìÊ¼ÊÍÁY�û"k†dÇ¦Œ•yÅ$Adø!“"Æ¢,‹Ì:ëé|	gŠ!H&zç3’ÈD¤ÎçI™|f4ÂÄD ”Ed‘ò)uê½ofÉF?ÒÌ‹dø2àÍ—£(sÓ¡Snm•çè¬Ë,ÏŠˆÀPÀ H#Ç¼ÈaÐ±òEáJ ’ó¬¬L²˜2†SH‰æ„èédQ{ë˜»’ŽÎR´$OG(%˜þ{È “àœË`Cn)Ë@�]Î&o½Çqœ¯s_±s¾ˆÞ;
2@r¨ð~þßá9a ¢‚9#AÉ$™FQ¤ä  ‘FJ„ ‰D�(…2À P>Ò‡F3)Q Š æŒ@ ƒI2':çéI˜)údf	s+¢w4‹1&‹ H”FQ„Q$Á`=¼ É’ `dr$Ò{çSt–@€‰F'ÐB	I,ÚHY.Ä>ùäsŸyO†¯ šÙPÈW…\?XB)Ÿ›‚bêY¸¦É½�iŸÏ¦åd{ì·‡>«rææéÎ!XJ#\Qy?¦�‹™yd™hqœ¦e™[·ÞÆ¢d™�p
Ÿ@”,v™ÏÛªriØ?xøéjÈl»Þ�Þ¡á�lðÈŠ²Ìºc¿/bSNæ£¶»!±Êó;šMÚ6O¶Þ´²ž7³ì°Û+C]1—£Â”ÒPYîJ'õ²A® ÷�08yÌË,õ��öÐbùòR?|øö±¯Ÿ/WŸáx¼~ÿÐ¶óŠAatl¾|Ž‡íÍ Óù´àà©ð¢ÅÁeYSÝ>Å¼,|ò”º8úå³Ó¦óÃ~9�•#$*œCl@VVÓÊ¥}zšæ®3'ŸHY@Ð‹c>älYtØ‡©rä‰
Ÿ@0‚N4˜ †’2JÉFó,Ê&Æ8pyIÐ)L JÖÉMZ¥.�`]xxÐÁhÎ!ÐcRtu±på®ß?nÇfuÑæ‹þõÓ:ó«†.yBÉ$Ñ;GD92å…ÏÇÑF´Ì¼y…%$Ž`BÀPC‰²A[NON]÷pû±r§e†‘‰æÆØ!ÿäw
üâW×C¹<Gì�A¡‚9aè»túÉ�âÓí÷7xq¶ÌÆ�…C¢@Pi‘·gÕðáþ¶ë§ÕüüùãÏß¿?ŸÏž]äýÃíõ^‹åÑ�PXÀ”è2GKq(CÆp€,Qa�£ÑAÊÌCŠ&‚!‡ è¸9fWçÆßÜ•ÕrÖ' ‰F9 ‚¬FÎŸºy¸}³™=;)}g‚BŒ: ŸÍÊ‡§ûÃr&?@&:z19“%`Dò'³‹›§{Ïi•H¢BQñØs²œc¿{Úqž»H(¼€(Ò(4õÎW³iƒÃöHf� @¢è3Qá a¹¸øÖ×c?ÓÅÕ''þWo¾Þ»ç‹¢Ø%@¡„ hÜn8ÿä71üÕ/÷ù‹3Ïèb&Atæ`&—Òn[]~5Møþú:?½œ—Š€9aŒÈç§“c·¾y*.?ýüs|÷î¯6åìÅÙú8ÂÀPArH‡5ê/¾<;n¾ýùöÙ«³–ãH#¡ØÁg‹ýþ¸yÚÎV¯>…6¯¿¾÷ÏgYb*€Æ}f—íÇÛ»Ç±*fÏ_áñáÛ�¾¹j‹ $d4'u£ky‰ÝqëŠ¶ðÉÃÂ—ÀÔGßL/j;ÜÝ¦vÚf$ ‚Y“L"é)“Y"ééeQ^@rL]LåüÜÊõÍÓ*›ç3ÿvýæÖÚ‹UaLHdø1d�‡4z˜9s‘@2L¡�á8Æü|¶ê7×ýò¬­ý˜™~ÉAN¢‰aAÔÐ�œ½Z=ÜÜ¾^wg‹)@ˆ9˜“Š1tá· 	t$RÈLÞe`²1ä5<\Jc,N¯^†‡‡¾ÈšúÙå«ýíõ5ðòlîw2y§>í}öüd{¼þÕÓ¶:_8Æ$�FFÈƒ2I`˜A �ãXÖÍdì÷�6¯`ásHdêºG¬^®�¾ûÃóy…è…
�C·Ïž‰áøõ/6íòy•QP¨!9¤ÃþÑ½ºšãñÃý¶¸Z>:ƒÂBrHûÁ/—ÇÛýí²ºÊ`€Âo@€œ9$@¡FÈä¼,É\˜C ì¸›“ç…¿{ÿÁÏfÓ(ŒPø’C<†ÉÙe»x½9žÍ½71”�`Þèd–D`ÍN/Në›‡»�Õy[¥dH
9•$Ã$Šef 9�`d¨! ²­ãbuâÇëëÚ|qqrž}øðáQÏ&¾s#þ.q›‹ç³ço^_÷Õê<CO@áˆc¾­êÉIûÍ¶;ŽVŸ¾È‹ôñýfWŸŸ>;Ÿû»}9;i€QH#%(ü6@]Jãüò”ûÛï§m5½8uv÷îýG=›O£E@¡� X7ô:»2|{,sCfbøˆ#L  dbh €e"Ô�ÈÏ—Ë¸¿»ŽVùùË/ªÃ÷ïo‡ç/Y QE¡;˜_ž>tÃé¢¢Q€î0–'W¯âæõ›G;=›dƒ�HŒiíÛO^´éÃõõ¶¾˜7ŒIPø-´1¦¦<m6éáÐ÷ËYó¢ É� …	$š#!™1üŒ‚aŠ…ð ÌL Ã•uy³˜ù§Ã]ž·EÍä`á_ƒ`t e&0œA€HÑ(1´��=ýlÚdÇãÎ†ÁÕ«Õ‡»›ïñüt¡¤Pd¸€Ñ A¢ƒh&J  dbø‚DR0C	²Aû²š­Ð==î
Wž|2=¼}÷ÃûóÉégÏ°ý›7ý„ù³c2 â¨]´««úãææÍÎÎÎKŒp²ð’@:"ÉäÂO ÐÒ¾KÕêù¼ÿþþû}^.Š˜ )ü¢hƒ©nD¿Ù�S6t&*œC l‡ùÉi»^Üq²¬r‹´q�_Mr×wëa›gîÅ'v?|ûxöâeá’¾„8'Ç#1;»Âðtÿv�i}vµ<ö÷oÇù«å	�B°ãæ°¸|6=oÞîà.®>Ïªû§o?~À|úÉ‹+ÛÿâÛÝ/—õÀ(*”ÀÔ;ß~:ÁÓ›ïßñt¾ÊR(!úÃæôê'c~÷í‡œ_ÖŠ ~ì�g/ZìoÞ=¨�Î§³âðæõãzÖÎrÑ …Ï €1&VÓ+tO÷ï÷“C�?;;ÃÃÛÛM?[Ì²1:QáST ¼ž6¶=÷HõùùêéøîÍ=g«I9*I¡…K½Ë³¶f»Á&9	iì#WËf3¬·‡ÂÏ
H´p
�²^MOO˜îž~ˆÓv1=}6½}úðnïÛ¶¬¤…ÿhÇýÈùåçùúöínð“yÝ™£…ß‚@‹‡äªå\xÚ­QY³:ýlò¸~óíÉ´*¢w*ˆ¢†Ôeíùìdýðxƒa¶³ÁÁB�(�–ö£«—Ëòaw7íÉÅÉi¾{ÿf?–Ï§ÞŒP8‡@‹‡>µ'Ùpxüx›j¹úñ&=Þ®Çs¿¨ÅäP:±™/2t›=ª:Ï(.!PÌ¦‹ù9öë‡‡bY”y¤B²!*Ÿ­VóÍÃzÇªm
B´ð¯B„¥~È|{rº·»ãz7¿|UáÃû»V“º8š£…"l�Ùt6Ûa÷x?v§¾�/!Š4
 ‚‚L#å $ÐH024�@�L‚1ü¨4á§§ó¸»YoÖÍÉÄå	
jà�ªöùå¦»¾ßr²j3ŒŽ>ƒY<ŒU¶œ»~{|zÈ\³XœÉ?Ý¬‡ãjñìôGóa¼¹àfuÈÂ¯A�Î%$ƒÈPAHt$2æañ0Z=9›–v»y8`>É²è¾‚‰Æp‰€7„LçŒNÎ(@ÀI€Âo@„©OÄ|¹Èw7k6'u‘E*œB„iPŸ-fg…¸½ew^–¢…Âˆ·ªfSlŸžÜèŠÆÉÅP@å`�	N„h H¤Á$P€KÜÍl’MâúþuÞú<C±O)/Oç®^o>ÄãI>?=kïÖ÷‡Ø³�”`½Tœ�-ñîþö£óùÅüÔï>FhÒæ3‰
ŸBDê­gsr~rX?ÞuËfY”I_@Ô�÷uQeY?$Ë²Ú
*œC„©;ª^.—ãÍÃýmYå–<`i°®˜­¦ídX?v©mêœ#Ó8t™_.óƒÖwÚ¬*"Ã",uÞ7“¶ÀxN
ÐÑÂ—°Ø›Êº™×èo{¤I‘%§0�ˆ4Ð•ÙÜ�ý 5“åreÕÝÍÇ'ËfufFZø",�VV'gÕíá~�ò´(ˆásˆ°tˆÃ¤=C×w£Ã¬Ê ÉÂ)urÙdVùýæðt´¼¢“£…¦Ô™Ãt±„ëîw¨&'ge…§ÛÞ§mYŽ$-ü>DsF)õã€êò=>ÞtC»\µæÜ †' œ1yá !d" 
‰2B ~
1º!jqr•ÊáázƒjUL"Ì‰pp4˜ †dN  Dˆ.äPh„Î 
4$ &� h‚)�zqöª½ÿønó´Z6S/©P@�”`(Â™œ|t’LT¸„Œp†ý8»úâù³ôÃ7oïwgËºOƒ’9@ëÐçõùy÷°Ý×~òI‰û¿~}�ê—gS sÎB	Adœ#ÌL&�tö´=Ö'Ÿ\Í÷_ýËîç?~¹ì38×®>}uŠ·¿ú‹·h^œÎÚ>º$Á\X@„¥>¥l2=�ãú®’»|ñk¯€×ó|õl~’�¢Î`21Gæläèá8rè�˜>¿jðøñ‡�§ýÅÅåËjŸ}ÿþfÏÎ'd’ÀPB€‚ $™hòæ 'Éä˜™!%�`øG�QÎ�f2€a	ÎÒvDyòòEÙ¿yûö€óÅª022|
¡çfÈÎ/¯âñÃí�þbYû!S¨!D‹`=¿òÝýî®ÛLª¢vD
SØen:k·Çý¦ßY]Ô1ÃŸ@�²Ã�Žó³«ùöîî~.J¤(*$8 ”ÑÁÆÃ0”³åKOïò“Õt½
ˆJ=cÖ¬ÚÆw›§½Ÿ5æž$(“I€ÈÐB`HP:ŒÆvqqåÜõ»ççÓ³Óv¿Ã›×w}^5-Üè0`Üâêå"ÿæ•íÅªò{É”ŽÍå¼~<Ü\¯Ÿ&nRçô	ŽŽ!‡yL„Â?„h R<tægÏŽo?Ùì¤.Ggž"!QP¸„¤4¨gÛ,Ë'>=ÜïYÔ9]rçEÅÞ³*šYòÝ6ÆTªð�cx	‰‚`=¶)[\.Ë<Ý³Í—Y]'É‹@PJ2_·nbé¸F6”yž% Ã?‚ÀèŽCœŸ<oW»›ë§ãéìtó€� S:dó‹b®ýí›õ¦ZUUˆTø(>6y[¹þ¸{iæryN Édƒõ¾]ÌŸ/ûÇ707k
0&0üLJÖ¨Û“ò˜mî}“ŸÏ®
d›íæ!÷u^f‰’†?€`!#Œ)‡.!(ÉÆdjšE5êx{·ÉYí�R:ÀOæu»žŽû}VYfp`˜B¢99À`4Âh !&Ä¦ž—ò»~[J_ƒ^`ø1N”…/!
s3X¸Y]5}Üqækç£cø
’" �Ñ—y3)b·M�¦¶ðyt0d™Ò(‡ªÌòØG²Š9ÃŸB&%‹]Vfm]å±_ßYžåðI0|™3ç$š#Ã’ÁâÀÜªr¡Ø=õ÷uÞ–.#0ü&J²É•µ«zlr0Ï`P!¬`’%¸°²¬Î[©ßÅ‘,
úl„)Á@8 d‚ˆYLiDÊQ%—zŽyFºd£UFf‰‚IrÃ‚@0“ÈL,¥º™¬6<<>F¢š×í‘Ýq¿�YV:f^�èŒ�äD†?€,¥ä\]¤Ï}™ç;‹.¹Ë@XŒc&s –P2ƒ÷¹"ºByž3ª³ÜÕ¹÷~´Á{£#þ1$KrYî Ñ23—Ë!š™W�Ìä�Cìé›².ÁíÐmR±œÔeŽýë¼mÊ‚c„Ñ;zM’Ñ9§8HcUf•7ŠÑy_fQÇ‘’/ádŠ(—U^YŠˆê<‡�I…ù,#¼"@†	dœlŒ…åUYbßoöu>›UmÜþòÁ?†ûO€ÿ¢šŒ‚ A‚`!ƒ "DH(9#DÉIFA4g„Q�œBF‘Dd’ š“œ @€H9‘p0		’@Ò9:8	&KB¢ÊAFQaTÈ ˆ`0™I¢÷Y™2P1^0‘¹2s.1yK�‘ à4Â(Á É98ï	HÑkÌe€"CÎ<9Ù(aÌDçÀð
‚ ' B"~
Ii$|^™âA>óÞ;8@¢b(! ¥Þ£)ê¦Âñ¸9®½r_z'Y—ËôÎ€Î (ÆQÎ—…÷ý0š«V–9*¥8fhèÜq°1ËªŒ.3…sfc,Çª*��CßÈXûÒÉì8Ræ¼÷d8‡H‹qðYÖ‘Ýq“ÜTY–ò$E…Ï!ÈH8BH0P ÜXºÅtÙ.7�O½*ßÖm^ÒÆ-˜®pðP:vc>[ÌºÛñ!/ª©GÊcø)¦Ø)Ö‹zfÝúžÝ|êœ«Ä±Ûo£oÊ²5?™9_Ð9…ˆ’:D,çÓ›Í©ÌŠ*o»±£¾ÊËrp[¥Æ¼óÂâq‡Éòœ÷O7oQû²(³®ï»”ç9èéÄèÆÓÓÅ~Ø®·ÇÒ·1‹ÎÈh#²Ùy–¿{|¿.0�Ö£åÖf«óË…Ý½y\ÃåY»¸`½¾¾F<m
¯ÁÑ»íòü²]ßmc»¨«ª-1ìwë„¼ö�Qqg,Î.«§õõMwVÌr¸*+£ºÜò¬ŒŽBb´Ó³Ë²»þ¸=V'm5X�‚BA°}¾œ/ëûí‡;§¦pMí<ŽÇîXN3:©ÔÛP/W§ñfûnÄ´Ìªº¨³§ã®kêº`írgåzy(˜ÃI²ñ˜“âíÍ}lÚ3:BaQ  £ÂO ˆiØ:÷ê“&áûïÕœÍ|æš<ÛÖOe“•&?…ä�ºþ˜_½\ß¾¿^[9óœœL»íMÓf’ ÁºãË¯–xûæWoÝ|•×~Òøuw�¶(óè�™úa‹úGŸ¸7¯_‹‹Å4“†iÇõ/ž?[÷ý[µ—¹OP¸€ ¦þgçÅöðz;¬ª©ºHCAÀS¿ºü”Ç››hggµ	C‰°ãÓ˜??/íñýÇÉbÁ¼n©þÎÆªTYÍ*ìTuá³Ñ)´�H÷�_¾ü7¯¿}�ì|>ssôÇ§£³ªò„³ðC"m\ov'_}1Å×ùËó³6õ>åá× Š 9·[­¾üÌxûÍû§êræ©D†ŸArŒãÓ6ñêKôßýü»üìù‚©§"¨PAr²-lru™u»·o¬š¶£"íúÃâ³çw¯ß\'ÿü¬tH&†O¡�áùâr±?~Øõór’û‘0ÊépØÔ«O±ýþÍkø‹çuÂ *¼„DšCÈEæ˜ö�}öãÏ3l¿ùái¹z1­«I>·»ÜÏ¼7'�‘p„	†ß…`N}·-.¿¸$®¿¿ëêétP3/Ün{D7Ï²äèrs:ìïËù�VäÍÛýÉ³™ï{H¿…ƒºlz~É‡»Ç�õÉªðc)Ô¤ýý¶ýâ“ÅøÝ×ïÞ/>;Ïúž2Ãø”?ûòå¬ÿå_½ÁôÕ‰ïÌ PÛ>âG¿>+¿ûæûmõò¼ÀÑ 1ümHp6ìP¼ü”O?ûþ)Ÿ.›I[åCûPÎŠŠÉ ðï@H‚Ë	ŒE42ü$ÀBÀp™¼¬:wõò7ÑÝ}w[Í^,$ K¢/àmÈÇÌÑ1Ô�@ÛÇxþãjúþëw¿j/^Ö>&Hg�wùóŸ\!}ÿóo~V]œîû�‰á¡ÃæÉ½úñ‹úý×ßl¿¶œ¦j2Ùm÷‡my–W�£…ŸAeëãñìÓß>o¾ùú‡oñü¬iÊ2Ý6CYd–‰
ŸA&Âe”E	"Ãß‡Xø#(d°Áìd5>Þ<íg8+r$@á· 9áÐõÙò‹Õ>|,¬™y˜
È`^4fÎ!9È	…s„LŽY’’Dæ´p
Qz˜ÎŠ1== ™Õ~#å À`dø'ãf8{ñw?|ó1ÏNN	P¨ ˆˆû]?½|u…ë·:_,Ë8@"ìpTuvR­ŸnÞ—ÓjRA�ÂJJ.÷rê‹‘èMãŽ×‡b^¹1ƒ…Ï!9ÙæÈ“ç''©ûáÃz19§ë)14�â~‹Ùg¯&ïß~ÿ«m3;›-âdëÄÒW0ˆHãxl'Ó
ëcÊ-g"ÓØwm{rÒö÷×óISš‹ ýñ¸:ÿôdýæ‡·ãd9§%�ä”C^_´8°˜ÔrQTø‚ˆÎz�½¼zz÷îãÏ—óA°ãåê
ãýÇí¡.Ûâÿ/Nvm[²³ ÿ#"f=W½vyŠ{ÏÍ’$mcHY€-p#7@‚HZ< ¢ÃÐ@¢â}�Bì´oqª½Ï®W=‹ˆ?ß·¸ÈÇ‡Û¸óYÅ`@¦.ØÉ´IãþptYål4P_�„‘p|y¼úk·ÆÍÿü\_/qDT¨�VDI…"þW ôÔ�Åâ:„÷vnÚ4óË)Æ/QL›2Pú¤Ð¤nÓµoÿÿý¿Þ¿ùÛ“UB|R€&Mñ¤!Æp
‹7¯/wŸxÂd9cˆ$Œî^nÌ›_ýmàÏþìx{ÖÎ³rÿtwsB95Œ (Q�Çêújjoßwõ|&™Œe 1�ÎÊá°=i‘)¤ø¤Uv=«ÕÙ+¶f>kóÎú�¤±F¢U�cŠy{ÆpÚ>¢.*+ Õ;�àÅÿ)9:J•¬ñ5HêƒfëËs|~¼�le>©²1ìú ¶°´Fýo€Þ!�övvýf±¾ÿ›³‹&O£5F%Y€"~B˜Â‘r±zS>==úv^W2hHÌ)™¡w†ñÃd^Mö‡íî8žÎD#ê(û ¨çµtÝn#Y[@’ÿ-4Q†!ž½z]íž>ŽÝ«å¤‚‚A†4;_"¼<~Òõâ,Ï‚5êW Ï0ê íì›ÃÓnYæPŠú
Dû;;+µ~|¾Mm6ÍŒQÿ/@(�X% ñ%Tc(ÐDŠÿ%T’¦nÛ<Û¶2¦I	Iâ(@…¾1tbÛË¹}îž»±m›Ì	�ú¤‘Ô]Ÿ¿sããæ Óe]è„’~
ÈÐëXÍ/&ùý—»c5™N’#
�†" ôkP 2iJôýËñÛÌXZñ9(  êK�N]5»x³Æãí‡Ä³U…(Bá˜iÎõøòe¯�©l6Zñ‚¤�‘Ç�^^·³û§›0]V3¤èÿ 
F$[Ogæð²‰EÛÔbD!¾1ž�•u^Œ‡ãi@™‰F|
”cDV\,gnû¸»¨æ¶Ê8Ž#B	—AÅÿÞÑ#’4�ÿP(RH³«³	ºç}ÛV$ù× Rh)Ð¤J!LcÛ7Wiwss“…ëyëÌ‰<%¤,Š&˜ñ8 EÎŒ0õ²¼ÊNãÓÓ'4Y[Ø` þ‚€Œ±<{#÷´Ù!Ík¢0)“óé‚ÝÓ0Öl3‹dÄ× P8h—¦«{:<6‡ù¬®]²‘Ãh�8#Vü
¢þ¤Â;Mš"¾ ©„ƒ5ŒÁ0â	ÿ(P=…`–k¹ß<q2Yæ™…@"'ê’1þC¨JŠø9(ÐtM±>GÜ½l_^æîÌ•ÁD_‚è€S–Ï§©6�Á…¦,íèÄO  ÄQÕD�x
EûãìòÍê°û|¿•üljl° ý¿1œ"Úõ«‰ëžžOmSe’Ä× @Ù�©›]®—…»ûršaÒNIüoƒAƒ©&‹5'»ý30k›Ü@üƒ
j“-–ksÚoo_
´M–$bD¥ñÿ¤QR©³"C<ír[‚>ÿEììüúíeêïïï·ÙÙb^—v4±EŒÍ5_‚ ï(þ�€‘0÷Õô§Wç¸û‹oïÍjvÕœ ì‘˜'‹"ñç ÐãaHë×óZ>}Âöª]—4��B¿ i€8‡ryÕ¾Åý—§¾Ï×ÓÚ)ô
R1"Ùb>�ïöÛGcêjQ#ê¿Ô�'Ës]âåéXµuS¹DQŠÿ	H¡„	Pÿ÷AhÝ8}Õ,åÓ§OŸ3œÍJöTG1â/@*Œ¸$š˜hý?AŠÄn|Iëo.ÛìöÛÿ{dÛ.ó„‘¤ø
SwY^œåF7]L³U^ªZ�â(Ø‹1«õô¤/�ýi,óŠ6ñ_ƒ`L‡ty•_Œ‡ÍûîpžÏ'bˆÿP(Žùúº\óåóÀ:ÏAc¬¿ ŒzcçídˆÛ§¸��fV³dŒˆŸB…0ÂqË×u�—û›]_Î�"€øŸ‚PŠC5©Ä¯@Ñtêc7;?›àùñnWËjÚX“D, ú*BD¡*Ä8Ž˜\|óÊ¾<ýðùe2}]ÍÂ8ª� cDüŸ€>Ó)D�Ì×—zxúøùX¯ªIa©b	Ðg £‰0³éyVØÇÇ}Ü¬()€C•$"_ƒŠ$4b…éHÖ6ë�{ä™É�Q…QU�¢F‘FT³¦?�ûm¿AÖ ` …¨ˆÿJKÕDkœŠÆHªñ+*C%Hˆÿ;P	¡0¦±D‘$=%ØÌˆSQ£Ê,ŸNœ=n�ÃPÏEÎ¾ß3:)m¦"pÉ R ñJ¡ÿ)R
)—ª´.¥¡ÏFg3
„0âÿT‰Y×Y³éÙþ°Ûë05u²P1–úßAbp*…ÍÉ dŽÌš¤1%¡ÀøkIÇ˜!¯Ö•	‡ãE[M*¥‹êLe¬u Dü;(G#™«&¦Öas´(M!0ñoA‰¡ )¬‡,ºB�P â 1áh¤\-êi÷|
Ùd²nÓ¨[XgE #âÿ:H„Ô¸©sû�…3&)	DÅÏ ’d0Î¹	lê±\3+
Uv�j‘[W‰‹v”!æâr*Æ,&ïŒøŸ‚*Ê4J–Š²ÈN±«‹:Ëè”
#Fü?IM£K,ŠÊ¥t4fFE5¸Ì0©‹*™Z8cAB	!…	MiÈÕey–4à�©g­5VxÔÞåõºÄñtTƒi^«�:0b@ã�ªJÆÞÙl2É7›uÕÌkÃñ�bŸ»ÖP˜R—P×EnÐ¿$ÖMfR
±HjÄXÒ¨!Ò�‡Ê•ù‰}/6¯rk©�l–ç™¤Ó ÎØÌš(±¤ñ$B�ÉDÒè¨V%¥¨„1Füï‚ï C2.«Ûzž�°«é$Ø§1ÈœSÔ(†FHQ!Æ¬ÏQTuæöiƒÁMë¶��:ÀÙ:7.

Dü7 €T$MÁš,sF8†2ZëLd€BŒ§ˆøAFŠšF,CŸ¬±6w&pg­5Ö B¿„’ �¢ªÍM–p¬MnódSoÅ&³†ˆ&éh$ÏŠª”á8Ä2Ï€ P
 “¬‘"3C„æY[kÆ�òÜ4¦¤JcD’t4Öº¼†î8ÒÚ&Oˆ�£Í
:§š¨P#ˆ* !A% þ_ƒ€¨$—(â`Òh2ÉjqC?Úh™Y«è†„ÜØÐ¤ÿÒýçÿ ˆ
½ÐgÐ;	!$  ñ¼£BI
Åˆ�¨JFŠR( ˆ
Q…€�¤¨€ �ú„(H¡€BR†€(|¦	¤1Ž™Ø,QuÈÇ,Fi¬•Îf
“ c5‰@Œ¡…BˆBH!*•ª¤Ø™SFª‹1ZcBA •`¨¨Q�´j-U‡’Ì¤€jìÆ¶Ê²ÁŽHÌa2K¿¡1¨É]“µì»ã³5y�·Öv§@—Ñ1–þ-H$´²-RØ/½M•›}ˆ�²´¹dÉÐ7 51IæÄ*cŠd¬XÿG @¦ma›²ax±…­rq4Bÿ(L:š\óºpcê£–®´È“¡ÿg (SˆY–OÄŽ}ß—¨QÒÀÐÿ!HC‚„ÆnˆÕä<«ºí‹ö®ÎlJê%i0yqœîŸ>élÒ”@Š¿Dýß)µeYãšeõ¿ ‘„ÆZ!£¥Š@ ¨ ÿ(dDdž[‰ƒŠÎõ¿‘(b­Ç‚ÉFÿt6oÁtl�5¢¾ÑA˜¿ùqü|ÿycg«Z$�4qÐéåº0�_î‘/Û’V	&¨   †.WW—›/››n?=/” 	*c…ˆ Ã¶Ÿ\Í«ãæÃ±˜.êˆÐÏ¡ÄATƒKFÄ7 P ¨£ÍòH]—Ù:³j@%”€Í!)ÆD	ùØ™‹c�#ÉP Ê[sìO”XÕçñÒ6�bšÖ)	*èñ÷Ó·³ËíÓÇíazÞ£•¢F…BB1$*€ $7Ú^½{5~ùîÏ§‹v’¯ÜÚìoŸ ÙŒ }z‡ØÅP¿^?ß~èÎÞÌ1Jñ
Æt<Îß´ùxûqƒÅ¤À˜ ú�Ñ~èøúÝj³¹ûžÕõl4ô(Pí3ãêÂCŒE™CŒ(@¨@”„ŽcÌW+š—Ï\9!£(èK�zˆ}þæªÎn?åti9Rü[RHúô±WTWK>î»žT.H(N@M
Šø„¨@…¡ƒN¯›f{ˆçM#FAú„Š¡U)ôçPCèvÔùÛo†÷÷~kçkôAH¡$5¦­+Ia:µ%„B?	¡"ýi²x7]½¿}¿???¯-F€¾…À C6™µÝ°Ý—RUj 4Izp:m�žö	Y•Sôg Ñ�N³«ëyúøùæáòbš%¥‚>¡"C&ÅÿÔPÐÇ¡_¾n'7w7›™kªÅ4«6Oï`&•ÐO@�¦EQ”!ž†`læ�„¾ 	�J‚!™¼ƒ!Iúk¢š9M<�cÖ‹Ë×ÓÙöæycÝ´2AP{1Å¬dèsÖÎÒB)¢ÑdÍ²ÆæùÐÍ‹Æ%ª?0¢›]x¼»‰\¯ÚÈÐ— (v»ÓÕª•‡»÷[9?oi‚‚þ¤A<íNù»wióøéÛSµh&«6—_�îõ¬�¡&Ž�i¾z‡ûOß=Øö«â(*è3¨ˆ„±s“¯Þ…›ÿó—�éÍº­R„B(©cõú<�¾|Ü6³e+&ôHûþ¹¼~;¹üôé6TËvr±ÆËÍç%L~Ñ¾{¼ýá;˜¦.ÎËzÿp÷=žÚi¹n²ÕwïËËu�)ú¯@ Œ;¤ÅzÕìž^îçÅ,O’H€i¤V� tý~æn=½ÌöÛªÁfg×³ÓÃÍÛ&_ec‚
„Ú)Ú©ûíÉiS@-)@:OõÕeq¸»?ôçó©@	ú2u`�!í¢)Mî¢ˆú
¤A:žN«óWîöã§ïšr>s)ô%2†®­ß6º{úþ4Y/fùIôŠ¨Ðÿj ¡Õìõ5ž?wU>iò‹Ë¶¼ýòÝ©+Ê²Z•Åðü¼A9+fËŸŸ‡ç/ÛqR”óözšžïîNùzî‚¥ø%H»çƒ^~ƒãÃ‡ïg�íúýñý¦ª§«,P©ÿK�"Ú,/ÝâÓÝwýp½²fg¡€¢ ŠT±§«/ÏÚüéñ8Y–mék�†Ò…ÁÎ_¿Ñ›‡o·Ã¬Êgeþô°9b±ªSJ ýŸ‚ÞaÀ1Î¯ûîåùkÛ^œ«Ãý—`ªIa“ôk�á„æÝ9û�Ÿžä'ëyÙÃ(`†~úõÏÚç�ßßc±šçˆ@‚pH!]ŸµÐÍ—¡™Ïk€…c‡æº*^¾Ü|DQ-ëóÕ4>ß|<UWsŒ�!õü«×ýÓ‡ÝñbÕä}"è’1B&¥ñH@Œ€dRŒµFñW €¢¾ ‰1H;_/Æããg-Qf®îû»G;m'E
"IÄWPCÑnsš½úq4ŸÞ?táÕ¼4š˜@ÿï P1â’&M„ˆÿc¨@ €*…¾†´*¤ªâ+¤�ˆB¡"þç E´åÕ»e?~ùþ¦o×“IU(âxGX T@ŒÀ�J@|ªD‘(*FŒP51&J;kˆ}ÿ‚¬˜-¯êSùñþ€åª%T(DÒ¸¾ø±>o>öi½j\Ÿ¨PßBE(*¤ø*U% þ�A0ª("P•D@¡
#Æ0i!þo� Hàónúöµ•Í‡¿¼+^c}ñæ?|þ‹�/ëo¦EP% þ
â¡Çbý“Uöùó¯?Í//
v0É …ý0,/þúËËÇ®;{3-@€5C*½ƒ@ xGñÿ
À¸ëµ¹zUÛo?xæÕÌ&&…(u dn¬ta‹¦CQÿJB¬uª1‚0âÏA	¡  jH
AÐ¨ö)ç¬n»Óñ ½kœSK¡
!…lº¬;Ýíú=™y
¦9_ˆî?�yÝ.V_óðx‡õ|VPE10+&e¾�§˜WÖªõ¿
4ö)«§Óþqórƒ¦®,’õT„bH0	@ ôW wˆÃñ”_¬fI?m*7�­\¶ë7_žëUQ’yDÞœcOO÷®º.s�¨ÿO wHÇã>»:kïŸî¶áì¬µ
£ RP'Mæb:D ve2â+Ð;Ä>¡=[éùîùi6m
—Q_‚†˜L½œL�ýËã õ|ÙÎ¸âþñhÛY›Ûd¼C
�©©œÆ†&›Ìò¼;�îr-j@DÔ_€�!–YYz™)è„¥š6ØÆûÛÇ¬¨*­x‡ˆ!3mÙH�0Tß€�ÝÀÉ´-â~¿9ó¢Œ™Šú5(PíÊf9ºM·ÏÛ¼£â"F3Éªã.:N�1J�†±C~¾Ôòx·é ‹v1[e§Ó~oÁj:)vì£ìÐ´Ë…†Ýæö¥XN¬Kõ¿
Ó	ÒÎm‹a7ì«º…U#êÏ@9Ê˜·ëå°Û=ß?µy‘ /Aˆš„S'Ùzm·ýC?Ôõ"FC_�Å¨§´Z®‡ôü°‡y±žÕÕñ¸y‹¬®Š "ê_�¤¡0AÅg @µ�É®Ï�·qZ59!
(’�£aJ€ hPÍÌÜEìã8º²°€Qÿs¨ CU�âh�êi]p<ŽÏÈÝtÞXp³{Ì«l*IÄ;¤8Ú¼Îx”±hLAï@PVp2†°È[j<Ž[Vc úP ±ëÑÌó¢»Óc›fR¸xè6''ÍôìTŒÃf»9Õr·§­5y“"þ— P4îáêÕE’—ûcH‹‰Í!ô¿	
4vC¬'U-»Ýöe¯U9oc¹ë_ÅÔM	�€iH¬–«vÔÝf—òl:]­ævóòü�çk›¥$¢¾0ž¢T“ym�Ç—1LËÆŠß€jìNU½hkö‡Í!µítâ°Ýîºg“jj8ö/ÀXÎ&³�û—Î•ËÂ˜ÁÑœ¢Ô‹*Kãþ0J¬ª5šúðò½¬3£J¡_ƒBaz™¯/²ÇÝîVí$[4µÛãa€«¦I`Ô7 Ži¬Ýºœé°;¤<.óLM  !j)‹ºÃ®‹im& �("‡”³Â›íã�ÕyNQ_ƒ�§ Y».íþp»¡™´ÎŽÆ;h@pEáco�‰³ÖúŠ†Î¸f=Ÿ¢8Ä|Zå–J¡?)ŒcV·%�/Û{–h§Ó«nØl;œªÉ¢�föe{ÜÚ¶n&ÓÕätzè„³¢T|Æa´\œ­.ôøÐõyY×çñêtÜ==Ù¼q¢FÔW P8¦}Y]ŸÏÒÍç—§îl1OY€¾!Ô>iŸ_�-ïåö‡mg—5R°úß A£`1i33>ož¸j>i.ºîñå¹àj¶äØoŸŽl%«]£þ+*ƒ˜Â5…¸}:îF—8r»ÓÕõÕr÷øáÙÎŠÅjUNK<}yÙczvý¦=íŸn÷ã|}yu¾>àåîƒÛ¯–‹,E’c{œ_\MO?|¸.òËÊ*	ˆø7 €)î¢iV¥Üßm¶@(V¯ÚÉóËíC×gËë·“ÅãóÓ¾³åâ|ñ®{øt³×Iq™A�¨ÿ (õD7[¹ìééË1Õ“|L„Â@@(H¡ Æ.æy#fÜ‡DK›D´¶ãüíô�½ùþ×ï™]­'¹jB2ô+’Òq+Ãò«WÀwy{+ß|=©“$ñ
B?ô³Ë³�·ßobQOÅŽ„w„P $CßmÐþtºàæ/>ÿp8›­f.ñß€ajR…uN$¸¤´"¾ U•Ö9&*ÄÊQÈI9·VOÛÃqöú,n~ø«çÃ|¹jbR¥ˆŸ�Hb$Ÿ¤øÙï�áý·~”öÝYz>©Âèa?¶Ë¯¾Âó¯ý9¹åÅòzêºÃÃwñx±šgAUœ9Nõùo¯ÿ=þÛÿøð¿^ÿø-öãQ)C’Ú.Qöã1>çYSMëŠýátBÝœ-7�Û‡ltgUc¡†¾C¨ßþ²ºÿr{3¸·‹N‘°úüÉåïþÆyqóþß€õúìØl>~Üb~Ñ”iHÆ`<Š¹~u5Å—?|?òõÕ›U^_>Ý†åõÙë¯_ÍŸ¿ÿöÛMZÎ'M`Ôd¼ƒÒÀº±Ãxñêñøþî!ŸŸM[HTREüOA¨�°ÛïÃââë×Õ÷ŸÿêÎÍ__d†‘z:†Ù«ëï?|Œ{5­´T¦�˜3„ñùyŒqÙ.G3ìŽ_RîfËE8m;ÚØ¬_-OÏ·ÏÙò|Ýº�,�cÆù›ÕÜ}÷þRS-�@‘U4³f?>C1Ÿæ (ôo@*ŒðÐmíòírrÚÿý¯ãòêõÕ"Ìv››c6ŸÌ�D…j#Ý´sÚ¦¬lEfI„ ¡
¦Ømw§öÕ�~üî>ß`¼žÔ…j¢¤1DSŸ�aÐ§»!4œ™P„aè–çït÷øùóÝPæëP¦0ÂuÛ$ž^¢AQ/§Çín¯uvyöùþñ±ÈÛ¦NFÅ·`IŠ¬nLž�29[žµÝóán”²46O]²ó«³æùæËûç‰k–Ui " HQ1&dëå9šûÛÛ±m«ËWeÿüé¾«ÝeÕF“¤x€h¯ã![]¼Î«ý§Ûe>%F ÅÏ¡ c:í›6ÛŒßß‘·‹*Ù`
ñ(Ð42ÖuíºØ•y�etÆÿ
$£Xë¬h�¤â¬£M*"F„JB	I†!%ÔÅbÞàååS*Ü¤qª€ñ-HB$��:?›¾sÃãó!”«ÒUPCŽ’2[.ØuÏ'Í¤l¬ÄÐ;PH0ÅSPiæ—�}|þØçÙt¾�EØ�ý~ÈæË9ÇÍ¾wi™×Î€Rü„Š(É	D& ¢P
 PAPhâ`ƒ-¦ù¼mO�ÇCQU‹•³iû¶£4yÀPýïB‘ÈÑ$VÓy›ßï'—ÍÚÂR³ñ?BÒÑŠ©JØSÜ»PÒ:'�”Fe•ÏfŽýáÍ¬n«Ò3Šä
çGôpbáÄˆ€À@Á$ øw 
`$“PÄ× „„¨Ðÿ…"•ú
$*L!Ù¦¬òütìNfbjg@ñÿ
Õ”Ò˜I™54§Ã0nórZNíÒ@“Á£F þ5(Tcì”UYWÛ‡¶mêÒöìzˆÉL‘D’ÏÄ_€)¥HÉ\Æ{ oËÒ�8v]®“vÚfaÜë ®Î¬…B ~M)Òä¹˜»„ÈCâŠ(è(‘�Ím!æyYIJGŒ&7Y–¬õÿ„B@ªÎÂ™ˆ€1"$A±³€HEò&Ëcãè¬TÌ)t�”ÖåjB J�)ÁäÐ�œD›l_@•¤¸ˆ1W™‘�Ž1‰3.7€Pê„þO@*a€ˆD—g¢±;WÐ¹d@%(TQXc$õ6“¦àOÇ1ºÜå©‰$`}•F$Ê`K;u™º.hÃÒ˜�ÊÄ˜e™3ý(¬›Ò!ô) Vg­
¢cÿ¼£À‚P° *cŠ�Xè Ö¶U“›ØíÈ¤mÆmØœL³ÙQOÝsê¦¬
u€
$ƒ�j„BŒ�� _€„™”bœetÉ ‚Iü;�LÆ¸d5d0B L„5ÞJÉZ‰4
4%¥ã�
*@B0Å¨R[‘¢DTÎYZ¦€¤ª´6—L£ �œiE
+Erš J¡I©‹Îºº(óÔ§cÙTÓ2;„Gk›¢,21H!Ñªd.‰DD&1b Q
4Raœã€PØ:+‡qL
Sä%¥©hT¢�–ˆx%�ØŒjþ?_ó…¹BASE      %³  xÁA  ƒ°YãúÀ þµ,9V8Äµtá¬`®46qMisc#�Ûšº¦Ng¢Óin:5×b)mÓ4k4\¹\êÒ¶XÌ-æF.s„ÙF
0J–™[#]Ñh±ªdeK±`£*F¹�„¶€P­µ"‡åRDÄDÜFCÁZ¢‡ [m£ÅØP6²Mç M¢L†ä+Ø�Íe£QÖfË$ £J�”F£ÜFjÂ ÌRª,Ôjk«ZéŠµ–ËXnU£\.6©F©R¤-·$ÖÀ¬�(²*j•Ëá"«–W¶µ–•�réÂ†  Å*DG�6Œ
SSj¸R«a #‘�Yi’±til(U¨’š¶U¬Üs1
BPOS      &¹  xÁÁ‘TD1³bþk�;v”óaCZ„ŽôïÿüñãÇ�÷ûï¿öëçŸggõs¾r_o¾÷eããî³ÏÂrûÐó™�»šÑ·Q½z…ÞõŠ¹Þ‰µÞÎÙ¨´f¯íÙ	1==qO,^¥™•fÛTâY"æ6RÏÖn+±Éªm¶*óHlSË¸™ÚL<°Ó2&X6­x1¯iÒšcÀhŒ6CÖhe�¦eËÃÐDf,šaf7“h‹1M@-[#Ql`  FjbB0­j1!È•AQKÍD#‹v ¤¹ífŽÅÍnZ¹Ñz ÖÝ£©gmZ$fì´†ÌŽ‘wËvkhiwCãWÍ‰� ‹¹¯O¡¥Õ°ÅÜë�ÇîsojûÞÑ³5í^ª-›CNF4      êw  xÁMrÛV…ÑO¼xh
‚M³üyäa–áôÊ½†T¦©ŠË’laóé9çîû[Èow4ÆÞî/w‡éúö|·¾­×wãóùõåôãøñ×ã_ŸçŠåžZ›L­ÀòiÂËP�0pÂ,Ï<\Î9P/Ÿ¨(–™ês6ž˜^NDå@oÈ€2X! á…Y¦B„‘)‚"Î†œ#•!œ�
�³!WïçŠ¨	L2Œ SQS–³Qh@FF–µFÈË@APƒÀP� ç@Ñç"¨(¢„àd¨É#Â€X‰Ê�PqÈÙPÎ�‘VX–s@y�©@°NP¸Y` € ¢&œEÈ9¢œ1²rd…@àl\¡<â`„µFÁ”�&ËP�œAMëä
* ˆŠlTÔä"*r@áä‚�+Xæe® 
¢¢¨¨ÈFËÏÏQÕAýýg6ŠÎ@fá„…«Ãüç…¹XžöÏ½ET@AýÇ—û×êómïëÚÛcðÔ†Ëïe~÷|ýãro¼¿êößë›mmñ`ý¾m‡íxØ.Ûý•/}ç×È�ã±«öÛ�7{÷a;ŒL+pÝ˜¶ëa[s'wr'wr'wr'wr'wr'¿ò?UübTEXT       à  xÁËnÂ0Ðû)óÄš;6qˆ”…ó(­ÀID ©«H°.týþžƒnÊ¶­µŒ»ˆ1åTn‹à×._‹Ó8 ,_û©	Þ¸éšà}¹Ù7¡¬¸97a[Ëœ:Ð\©‚>�,ï‡0Êt‰²¶ªfS£¼ž²¼Â(Óý%êk­jbjÄé2ö05R�Ò*F)ÄÔHetêµ²€þ{˜qhW½®ó4ÇµíÏÞý<oÈ©ûDN#¹+Ôˆ<õGøèm—Ž8´îvÿÅu8Þ)®ÃÉph…Î€Ev;ºCLIP       	           Ž<AlignableSequences><Sequence name="pEnCMV-ZDHHC2(mouse)-3Ã—FLAG(2å�Œä¹‰çª�å�˜)  (521 .. 2217)" ID="0" use="0" sortOrder="0"/><Sequence name="16_CMV-F_TSS20201114-027-5771_H02" ID="1" isTrace="1" sortOrder="1"/><Sequence name="16_WPRE-R_TSS20201114-027-5771_D09" ID="2" isTrace="1" sortOrder="2"/><Sequence name="1015-43_CMV-F_2021-10-17_C06" ID="3" isTrace="1" sortOrder="3"/></AlignableSequences>  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  $<?xml version="1.0"?><Features nextValidID="20"><Feature recentID="0" name="Zdhhc2" directionality="1" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1830" maxFusedRunOn="1830"><Segment range="706-1804" color="#ffcc00" type="standard" translated="1"/><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="19" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1900" maxFusedRunOn="1900" detectionMode="exactProteinMatch"><Segment range="1871-1897" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="18" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1900" maxFusedRunOn="1900" detectionMode="exactProteinMatch"><Segment range="1841-1867" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="17" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1900" maxFusedRunOn="1900" detectionMode="exactProteinMatch"><Segment range="1811-1837" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="16" name="lac operator" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4827-4843" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;lac&lt;/i&gt; repressor encoded by &lt;i&gt;lacI&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;The &lt;i&gt;lac&lt;/i&gt; repressor binds to the &lt;i&gt;lac&lt;/i&gt; operator to inhibit transcription in &lt;i&gt;E. coli&lt;/i&gt;. This inhibition can be relieved by adding lactose or isopropyl-Î²-D-thiogalactopyranoside (IPTG).&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="15" name="M13 rev" directionality="2" type="primer_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4803-4819" color="#a020f0" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;common sequencing primer, one of multiple similar variants&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="14" name="CAP binding site" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4896-4917" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;E. coli&lt;/i&gt; catabolite activator protein&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;CAP binding activates transcription in the presence of cAMP.&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="lac promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment name="-10" range="4851-4857" color="#ffffff" type="standard"/><Segment range="4858-4875" color="#ffffff" type="standard"/><Segment name="-35" range="4876-4881" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for the &lt;i&gt;E. coli lac&lt;/i&gt; operon&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2575-2623" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="AmpR promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6825-6929" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4633-4754" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3447-3582" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="430-633" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3267-3596" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="50-429" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="f1 ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2825-3253" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="direction"><V text="RIGHT"/></Q></Feature><Feature recentID="4" name="ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5205-5793" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="direction"><V text="LEFT"/></Q></Feature><Feature recentID="3" name="WPRE" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1921-2509" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;woodchuck hepatitis virus&amp;nbsp;posttranscriptional regulatory element&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="NeoR/KanR" directionality="1" translationMW="29048.78" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3663-4457" color="#ccffcc" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="1" name="AmpR" directionality="2" translationMW="31558.16" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="6755" readingFrame="-1" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment range="5964-6755" color="#ccffcc" type="standard" translated="1"/><Segment name="signal sequence" range="6756-6824" color="#ccffcc" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  ?<Notes>
<UUID>133751de-e061-46cb-a9a0-62e6e87ef9e0</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<Created UTC="5:0:4">2019.1.23</Created>
<LastModified UTC="3:47:25">2023.7.11</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
</Notes>
  Ç<StrandColors><TopStrand><ColorRange range="699..704" colors="green"/><ColorRange range="1220..1220" colors="red"/><ColorRange range="1703..1703" colors="red"/><ColorRange range="1803..1809" colors="light blue"/></TopStrand><BottomStrand><ColorRange range="699..704" colors="green"/><ColorRange range="1220..1220" colors="red"/><ColorRange range="1703..1703" colors="red"/><ColorRange range="1803..1809" colors="light blue"/></BottomStrand></StrandColors>  /Z               )ª3Ž³œFg2‡hi¡ä¦–ImiÀ-¤­“öf¯2�—§	X?>?\óö‡-e‡&+öIsÖ@z½¡ËXjp•ã÷ ÒvÔ‰¶cÔœÿæ‡-aÂVÏƒi�Òv¦êùè4�¹É¤¶Îiöc
 ÒvÖ dÂ¡íÀ½K½ÿhrÖ**ƒ}V×êõX²]{Ïö‡5`0�Èœ ¹™M¸92¥zS Ÿ°oy/H‚¬÷Ø3øîã�\È 8
ðŽëmúˆ,¸/žs' �8Œ„žjô]EAQòŠŸ¢¯n+¨¦*&¦�‡Y­Ë¾9?¯TJç¢ÕîA2˜E­=EGMGj„Q0ÔGãæç}ÛNµC›Æh…V-(i_‡Äý·ŽÓbŠéFÛx½€…—ˆ€jyiÕ®¶8ªŠ&»žf�ªˆ8×J¤IªeZ s¨óA[�hýQa}tªV¯ôÍR½Éâ¾ª¨‹�bºËHŽíæ¤çÚ88(VEÇYÚ²7æ*º`Y‚®î��%V�K¨!…QY ä¯Y®Ô¨`£J¯NÏ¢ `oEÔëŠ5}rÑI í[_ªùµ}é!mU|é t…»H9`NPK}[@ueö)ÒdU»gŸ†˜×¦úa‰øiŽNo¦¿GœÙ!ñ›±Ö×î�V¢	®—˜£¾©ÎbsŽ¥�¨›cš:ü˜:¶«¾ú&Vø(âî¦J ü¢Ð× È"7ˆ¨áÍ÷‚€6�}ø´ï«Àz³«ÿ¿š=Ãí³Ï�£óŽ@;(áÖ¼‚(°8rú½ƒŽÏˆ£ß�®3ËëŽrþ°þÖôÁúúüÃã�ãºó.³ë?´q,¿¨>ÿ>p^ÜÖ|ó9‡eTtYW7(*+es ¬/Ð87¸±Ÿ÷ÄÚ õœüÊºú¯÷ýÿõ+?@ìÓ×,ãÙ4n3N î@	¿ÜÏâL3iLÃ ‚œÍ29Þ�LþLüï«:ºþ¾®Ïr³Ã«üµ;•°¿©¼jHêpß±ÿU^†�!‚·$€öÏá‘ÂªÏê KÜ®¥’º+Õà]wµþnÂæº¡©”¨«š
UXN—Uj\Å¥® Xˆ´¤�RÿC¿ÓCE&5M�»ZKM}�RÿC¿ÓCE&5M�»ZKM}’üÿ—¼ý¿?åï?Jóö»ÏöZª¦¦4CÄ<û�¸NkÑI!:ª>Cª5TïÀN‰›Ú¬†ÔGA„*Í†…Ô`hÜÐ®ðó  D9¬9‡€Ýtu°ã¸cÏ"¼8´Í ÏÂº¨µ‹Â?……ãAÄ4Ì9²qÀÊú3N#±Ê-áLàãš� Ðnø¶íú;ãÄT›Û`á�c8ÙÎ†ðçãö±÷ÔÅvÍ±17'°`SÂè±´nM´³=<^+=Ô36?1ì²Ø1�Ž�m‚X<ê¸Û ðà"9´“(9ü†háDè0Å€áó¯²:œ&Ï;ñ¬Ó6Ï®lúèq+®î ¬Åañõ1Ï×ãÛq±¯|óë˜T(°[*¼<8o½3 nØàJë?×¢¦�:e‚�YSY6ÝZ·VTÚª·�®J ¨½^ÛX›¦Ø¸™òÇîNDè2[`¶N*øˆVŠo;u¯w]œO6T‰Sàùa!9{v–Œ£;xüêô°ø²=8ÚX[\ÌÂ£&€ÎëÎ¾ÎÞÎ3°²°ãL&Ó·µC	g
ot[@sAQv!5PôÕCÐ_%T<Ê82ªöC¼ÿøq6ÝU±ÎÔ´BWñÐy•ô2¯þ;û#;¾+Çøó§ÁŸ‹Ï«¿¬2êíc·8�›´¬"BÊÎõ8"7ÿÊÓñóŒúo	y²èK×ð”w›=àÓOx%Ði4LBbCçD®… ƒåçw‘AÒj	¸Îã…=)úÁU‚Nèo]_|à“*ª*54Ñ§3EUA»QFú†ê¹À.í \UíÊP ¶¦ÕPn·äoªV•XR©[[•&fW ¸t§Ö:[HC~nÓ‹š²¶öJ>ÿ,‰yÆp:}¸?Ò8ÖóýÎßôjm5•ôôðP<LÑH/�z›Ï½½.ih£ÀS‘%$¬ô¥’£5Ê(öŽt6È"Üì² ˜:ÚÓ¼+õÆÔ1)ØoýŠ#US
NúÂûÆÊ-” óH¦ÞØ)ƒMãe®éâØöòQŽ«ˆx!'µõ-®d‰Œ1ñ(î�Ã-g–|ÏvM©TŽÛhrºÀ1W»PnŸ8¡Ò±‰{#^­6êž­ôÊ¸MUÐPÕcÍU@Y@ÇpV(Yížëê­fšÚ›@¦‹¶vj&¤Ueud¼ÍÚ¿ÅR=ørÇÀFïÆÿ˜,{´�n;†<Ù)OI¸ïã¢"�8I#15Z”ç]CPè|u£aE¸é   »  4  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  $<?xml version="1.0"?><Features nextValidID="20"><Feature recentID="19" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1941" maxFusedRunOn="1941" detectionMode="exactProteinMatch"><Segment range="1912-1938" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="18" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1941" maxFusedRunOn="1941" detectionMode="exactProteinMatch"><Segment range="1882-1908" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="17" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1941" maxFusedRunOn="1941" detectionMode="exactProteinMatch"><Segment range="1852-1878" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="16" name="lac operator" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4868-4884" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;lac&lt;/i&gt; repressor encoded by &lt;i&gt;lacI&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;The &lt;i&gt;lac&lt;/i&gt; repressor binds to the &lt;i&gt;lac&lt;/i&gt; operator to inhibit transcription in &lt;i&gt;E. coli&lt;/i&gt;. This inhibition can be relieved by adding lactose or isopropyl-Î²-D-thiogalactopyranoside (IPTG).&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="15" name="M13 rev" directionality="2" type="primer_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4844-4860" color="#a020f0" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;common sequencing primer, one of multiple similar variants&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="14" name="CAP binding site" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4937-4958" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;E. coli&lt;/i&gt; catabolite activator protein&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;CAP binding activates transcription in the presence of cAMP.&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="lac promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment name="-10" range="4892-4898" color="#ffffff" type="standard"/><Segment range="4899-4916" color="#ffffff" type="standard"/><Segment name="-35" range="4917-4922" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for the &lt;i&gt;E. coli lac&lt;/i&gt; operon&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2616-2664" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="AmpR promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6866-6970" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4674-4795" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3488-3623" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="430-633" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3308-3637" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="50-429" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="f1 ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2866-3294" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="direction"><V text="RIGHT"/></Q></Feature><Feature recentID="4" name="ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5246-5834" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="direction"><V text="LEFT"/></Q></Feature><Feature recentID="3" name="WPRE" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1962-2550" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;woodchuck hepatitis virus&amp;nbsp;posttranscriptional regulatory element&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="NeoR/KanR" directionality="1" translationMW="29048.78" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3704-4498" color="#ccffcc" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="1" name="AmpR" directionality="2" translationMW="31558.16" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="6796" readingFrame="-1" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment range="6005-6796" color="#ccffcc" type="standard" translated="1"/><Segment name="signal sequence" range="6797-6865" color="#ccffcc" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="0" name="Zdhhc20-m" directionality="1" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1941" maxFusedRunOn="1941"><Segment range="706-1845" color="#ffcc00" type="standard" translated="1"/><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  ?<Notes>
<UUID>133751de-e061-46cb-a9a0-62e6e87ef9e0</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<Created UTC="5:0:4">2019.1.23</Created>
<LastModified UTC="3:45:36">2023.7.11</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
</Notes>
  	<StrandColors><TopStrand><ColorRange range="699..704" colors="green"/><ColorRange range="1845..1850" colors="green"/></TopStrand><BottomStrand><ColorRange range="699..704" colors="green"/><ColorRange range="1845..1850" colors="green"/></BottomStrand></StrandColors>  1?     Ç  ³        ³)ª3Ž³œFg2‡hi¡ä¦–ImiÀ-¤­“öf¯2�—§	X?>?\óö‡-e‡&+öIsÖ@z½¡ËXjp•ã÷ ÒvÔ‰¶cÔœÿæ‡-aÂVÏƒi�Òv¦êùè4�¹É¤¶Îiöc
 ÒvÖ dÂ¡íÀ½K½ÿhrÖ**ƒ}V×êõX²]{Ïö‡5`0�Èœ ¹™M¸92¥zS Ÿ°oy/H‚¬÷Øàú0ãµÈ$ÿÏž®£jþ~²xÓºû¯�Óc!ýÓßóºìøâ:Ü;¯Šû´õ�à5§/‚ÛÑ{ý~~= }‹ôGí#÷ÏÓzãÄˆ¯Ä·8CqöÞ*ë|5ãl4Ñ]Œ×­¾+�¹ß»ƒãê{Ø àH>ví8¾¯núÏßþ¯§;ã÷­m=+®ðN/°®ŠËo¶;Ÿ¸*8°ø>3Â®8÷×Ž(o¼ ÕüçÐ¬Tƒ‰Düƒ5§A¬ƒŽƒ£‚bµ‹ñS±M4^ÄŸÙÇ'á¦5é¾˜b~c“›é†/Ñç6H@üfìuµû�§U¨…F‡‚k¥æ(ïªs˜�œã©cê&ØæŽ¿&­ªï¾‰•¾
8»©„ˆ?(´5È2�â*8s_ýà £ß~-;êð¬êÿïæ�pÁ{lóãèüã�ÐÃŠxu¯ Š,N¾¯`ã³â(÷àkŒÀrúãœ¿¬?µ½0~¾¿0øãÃ¸Ãî¼Ë¬úÏíKïêÏ¿Ï�\ C—…wuŸüÎaÃYUUÍÀŠÊŠÙ\À+ôî,gýñö€=g?2®¾«ýÿýJÀ…Ð;4õË ÃCøöMŒÓ€;�o÷3ø“ÚS0Àˆ §3L‡Îw£Ó?“?;êÎ®¿¯«³Ü¬ðêÿ-Nåloê@¯’:œ7ìÕW¡¤`­É =³ødpª³ú‡(÷+©d�îŠõx]í›°¹®¨jeª jÃæ‚•V†¥ÕZ—1ikˆ"-) T¿ÐïôÐÑI�ScnÖ’Ó_B T¿ÐïôÐÑI�ScnÖ’Ó_d¿?åï?oÏù{ÏÒ¼ý®óýƒ‡–ª©©�ñ>ãîšôRHAª��ê�U;ð¢fö«áµÐaÊ³a¡u74+¼<èkaà7]l8îóÈ¯-3@3ð®ª-GÇâð�áaxÐq3lƒƒÜp2¾ŒÓˆìr‹xS@x8æ€Å#À4¾-»~Žøñ&öØ8cXÃ6s¡¼9øý¬}õ1]³lLMÉìðº,m�Åm ìÏOŠÏCµÍ�ÇA»,‡öcã£Å›`�V:®¶Çˆ<8ƒÎmdÊ!š8Q:1`8|ëìŽ§	³Îük4Í³ë›>ºJë„À{€+1X|}LsõøöÜF¬kß<úæ
¬Ê¯ÏïLÀ¶8ºÏßõè©£N™`§VTÖM·V­Õ•6ª­ãk’ˆ*/W¶Ö&é¶.&|±û“‘:–Ø-“Š¾"¢›ÎÝkÝ×gÁM•"Tø>XHN^Ý¥£(ÎÞ?:½,~,�N6–Ã×3 D0¨É 3ºó¯³·‡³Œì,¬8Ã	´ííPÂYÂ›ÝÐ\ÐT]ˆMT=5PôÉU2Žª½�ï?þM·Ulsµ-ƒüteF}«ÿ�NþÈÎïŠñþ<éðgâóêïëLƒ:»XíÎ$&í+�²³½Nˆ�Åÿò´ü|ã>›Â^lºõü%Ç¦Ïx4ÓÞ	tM˜�Â9Ñ+¡H ùyÃ�äPtš‚n3¸áOJ~°UD “ºÃWWß8$Â
ªŠ�M4iÌÑUPnÔQ¾¡º®p‡;H{r”¨-„iµT­ùê•¥VªVÖåI™„•è.)õŽ–Òß›´Æâæ¬­½’�‡¿Ë"F^qœŸnôŽ5†|Äs·Ã½›Me}=<4Rã^¦óïoKšZ(ðäII+=)d¨ÍrŠ=£�²·;,¨&¶´ï
ýqµJvÿbˆÕTÂ“¾°¾ñ²‹E%(<Ò)·¶
`ÓxÙkºx¶=¼”cªâIí}Kk„Y"c|J;£ðËYÀeŸ3Ý“EêU#¶Ú\®°UîÔ§Î(Fô¬b_ÞÈß×†ëMº§«}2®Ut5XóUPP1ÜŠ{gºú«Y¦…6¦Ð)¢í„Á�š…‰©Y]Y ¯3v¯ñT�~±Á°»ñ¿æí'[Žá�6JSÒn;øèˆ BÎHÌMV¥9×PÔ:hØQn:  »  Õ  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  &V<?xml version="1.0"?><Features nextValidID="21"><Feature recentID="20" name="AmpR" directionality="2" translationMW="31558.16" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="6445" readingFrame="-1" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment range="5654-6445" color="#ccffcc" type="standard" translated="1"/><Segment name="signal sequence" range="6446-6514" color="#ccffcc" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="19" name="NeoR/KanR" directionality="1" translationMW="29048.78" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3353-4147" color="#ccffcc" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="18" name="WPRE" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1611-2199" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;woodchuck hepatitis virus&amp;nbsp;posttranscriptional regulatory element&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="17" name="ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4895-5483" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="direction"><V text="LEFT"/></Q></Feature><Feature recentID="16" name="f1 ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2515-2943" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="direction"><V text="RIGHT"/></Q></Feature><Feature recentID="15" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="50-429" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="14" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2957-3286" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="430-633" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3137-3272" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4323-4444" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="AmpR promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6515-6619" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2265-2313" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="lac promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment name="-10" range="4541-4547" color="#ffffff" type="standard"/><Segment range="4548-4565" color="#ffffff" type="standard"/><Segment name="-35" range="4566-4571" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for the &lt;i&gt;E. coli lac&lt;/i&gt; operon&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="CAP binding site" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4586-4607" color="#31849b" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;CAP binding activates transcription in the presence of cAMP.&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;E. coli&lt;/i&gt; catabolite activator protein&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="M13 rev" directionality="2" type="primer_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4493-4509" color="#a020f0" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;common sequencing primer, one of multiple similar variants&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="lac operator" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4517-4533" color="#31849b" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;The &lt;i&gt;lac&lt;/i&gt; repressor binds to the &lt;i&gt;lac&lt;/i&gt; operator to inhibit transcription in &lt;i&gt;E. coli&lt;/i&gt;. This inhibition can be relieved by adding lactose or isopropyl-Î²-D-thiogalactopyranoside (IPTG).&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;lac&lt;/i&gt; repressor encoded by &lt;i&gt;lacI&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1590" maxFusedRunOn="1590" detectionMode="exactProteinMatch"><Segment range="1501-1527" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="3" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1590" maxFusedRunOn="1590" detectionMode="exactProteinMatch"><Segment range="1531-1557" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="2" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1590" maxFusedRunOn="1590" detectionMode="exactProteinMatch"><Segment range="1561-1587" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="1" name="Kozak sequence" type="regulatory" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1124-1133" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;vertebrate consensus sequence for strong initiation of translation (&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/3313277&quot; title=&quot;https://www.ncbi.nlm.nih.gov/pubmed/3313277&quot;&gt;Kozak, 1987&lt;/a&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="regulatory_class"><V predef="other"/></Q></Feature><Feature recentID="0" name="Zdhhc22" directionality="1" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1590" maxFusedRunOn="1590"><Segment range="706-1494" color="#ffcc00" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  ?<Notes>
<UUID>133751de-e061-46cb-a9a0-62e6e87ef9e0</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<Created UTC="5:0:4">2019.1.23</Created>
<LastModified UTC="3:43:10">2023.7.11</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
</Notes>
  	<StrandColors><TopStrand><ColorRange range="699..704" colors="green"/><ColorRange range="1494..1499" colors="green"/></TopStrand><BottomStrand><ColorRange range="699..704" colors="green"/><ColorRange range="1494..1499" colors="green"/></BottomStrand></StrandColors>  /|     A  ™        ™)ª3Ž³œFg2‡hi¡ä¦–ImiÀ-¤­“öf¯2�—§	X?>?\óö‡-e‡&+öIsÖ@z½¡ËXjp•ã÷ ÒvÔ‰¶cÔœÿæ‡-aÂVÏƒi�Òv¦êùè4�¹É¤¶Îiöc
 ÒvÖ dÂ¡íÀ½K½ÿhrÖ**ƒ}V×êõX²]{Ïö‡5`0�Èœ ¹™M¸92¥zS Ÿ°oy/H‚¬÷ØSÒÕUE__… OøŽ(Å�‘±XT_r>*"-GìaCˆt`éøµ·¬<èÅE·u«‡Ï¼ZúÑõT)f“l¿½èŽ¨ðªúÜƒ¯ƒzøà+‡ïëö87¸&ž~ÞÝG8ª¾ì+·€çbyˆ¯Œ ¿õ2 ýí8?¾_Œ
zážé>‰ñ=Eô9ûMaÕ¿Ô×OV…�ÂÕTQõ@¯ðÝû Oµ×ÍÞb�
ûÐ ‡OãÕ!AG‚#Ô�NIÇóð6£Á˜Ân"pE�öÚ"àedã,m_mM©ž�êöë£·¬*pY³‡è]ö¢@dSî·Oî¹âø§9iÓ´þ/­øˆ‚{ˆm·Oƒçn¾ÛÓ†Wm9Ö%Á�4?¬ôQÐ3Ã¾ã¶ÈÐô�t¯Œ×ƒ½+½þwwKÝÿÏvËìIýœr~c^›é†'á¦99¾˜býsd„ÆnÇ[_¸uZˆThx&º^bŽú§9ˆÎ:–>¢mŽhëò`êÚ®ûè™[à£‹º˜A(ƒò‹C\ƒ ˆÞ"£‡5ÿÞ
 Ú=÷âÓ¾¯êÎ¯þþh÷¶Ï>>�Î8 ì8 7‡Zò¢ÀáËêö;>"�~¸Ì/®9ËúÃû[ÓëëóŽ<;Œ>ëÌºÏ¬þÑÄ°nþ <ûüøÀ9xWpPGYðP_Ìæ5•QÑe\Ü ,¨­•Ì°¿@àÞâÆßÿhÖsó*ëê¿ß÷ÿÔ¬Pý³O\°4?�dÑ¸Í8¹ &ÿs?‰0Í¥3‚
s4È|çz=3ù3ó¾¬êëúú»=ÊÏ¯òÔîVÀ6þ¤
ñ©#©Ã~ÇýUz@†
Ü’Û?†G
«?¨r�/rº–Hè¯W�uÞ×ù»šê†¦P ¬>h)Ua8j]U©s–¸�b"Ò�"KýÿM˜Õ66íi-5ô"KýÿM˜Õ66íi-5öKóþ^óöüÿ—¼ý+ÏÚï?Ø8yjªš˜Ñóî>á9¯E$„ê¨ù¨ÕS¿:&oj°nQl«6Q�£sB»ÃÎ€�æ°æuÑÖÃŽá�<ŠðâÓ4?
ê¢Ô|~/þ�Ó0æÈ8=Ç+èÍ8ŽÇ(·…0ƒŽhR<A»âÛ·èï�Romƒ†5Œ0ãg:ÃŸ�ÚÇßSÛ6ÄÄÜžÁ�O¢ÆÐa¸Q6ÐÌôñx¬ô;PÌØüpÄ²È`Æ>:<Y¶`óªàklxƒÃ€ˆ0|æÐvL çò£… Ã‡Î¾Èêp›<ïÆ³LÛ>¹³ë¡Ä®¸L¸³‡ÇÔÇ?_�mÄjÆ½óÏ®aP :Álªððàa¾ôÌ»c�+¬ýÿ^Šš4é–
ueMdÛujÝYSjªÞ6¹(‚¢õ{mbn›bâgË¹9 Ém‚Ù8«â!Z)¼íÖ½Ývq<ÙR%O€#å„„åíÚZ2Œíãó«ÒÀWâÈôãial=s0C
Œš;¯:û;x{8ÎÂÊÃŒ10›NÞÕ%œ)½Ñm eÍEØ„ÕCÓUA|•Pó(àÊ«ÙóÿáÄÛuVÇ;RÑ1_ÇAæTgÐÊ¿øïìŒîø¯ãÎŸ~/>®þ°È3«µŽÜâBnÒ°‰+;Ôà8ˆÜ_ÿ+OÇÎ3é¼%æË¡/_ÂQÜzl÷ƒM=à—A¤Ñ1	‰#�º‚—œ9ÞEI¨&ã;Žô§ëTJ	;¡¼5u}ó‚L ª¨¨ÔÓFœÍUíEêªç ¸s´�qW·)@j‚ØF›UAºß‘¾©ZUaJ¥mnT™˜I^‚áÒŸXém!ù»Ln.jÊÛÙ(ø{ü²$eçÀ@éöàÿHãXgÌG÷;|;Ñ©´ÖWÓÓÁ@ñ3E ¾5êo>öô¹¥¢�ND”’³Ò–JŒ×(£Ú9ÐÛ ‹s²Ê‚`ëkNð¯×PÄ§a¿ö(�UL);ëï(´RRƒÍ"›{`¦7�–»§‹cÛÉF:®!à„ž×Ô¶¸E’&0ÇÄ£º?µœYó=Ù4^¥R;m UÊë Å^íAº|â„oJÆ%ýì�ýxn´Ûªz·Ó*à!5WACU�5UeÁX¡g¶{¯ªµšhSjmš.ØLÙ¨Xš‘U•Õ�
ó7jÿH÷áË¿þ`±îÒu¸îód¥=&ã¿ŽˆŠ,á$ŒÄÕjS�uC¡ñÖ�…ã¤   »  »  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  $<?xml version="1.0"?><Features nextValidID="20"><Feature recentID="19" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="2076" maxFusedRunOn="2076" detectionMode="exactProteinMatch"><Segment range="2047-2073" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="18" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="2076" maxFusedRunOn="2076" detectionMode="exactProteinMatch"><Segment range="2017-2043" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="17" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="2076" maxFusedRunOn="2076" detectionMode="exactProteinMatch"><Segment range="1987-2013" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="16" name="lac operator" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5003-5019" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;lac&lt;/i&gt; repressor encoded by &lt;i&gt;lacI&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;The &lt;i&gt;lac&lt;/i&gt; repressor binds to the &lt;i&gt;lac&lt;/i&gt; operator to inhibit transcription in &lt;i&gt;E. coli&lt;/i&gt;. This inhibition can be relieved by adding lactose or isopropyl-Î²-D-thiogalactopyranoside (IPTG).&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="15" name="M13 rev" directionality="2" type="primer_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4979-4995" color="#a020f0" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;common sequencing primer, one of multiple similar variants&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="14" name="CAP binding site" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5072-5093" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;E. coli&lt;/i&gt; catabolite activator protein&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;CAP binding activates transcription in the presence of cAMP.&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="lac promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment name="-10" range="5027-5033" color="#ffffff" type="standard"/><Segment range="5034-5051" color="#ffffff" type="standard"/><Segment name="-35" range="5052-5057" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for the &lt;i&gt;E. coli lac&lt;/i&gt; operon&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2751-2799" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="AmpR promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="7001-7105" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4809-4930" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3623-3758" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="430-633" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3443-3772" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="50-429" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="f1 ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3001-3429" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5381-5969" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="WPRE" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2097-2685" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;woodchuck hepatitis virus&amp;nbsp;posttranscriptional regulatory element&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="NeoR/KanR" directionality="1" translationMW="29048.78" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3839-4633" color="#ccffcc" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="1" name="AmpR" directionality="2" translationMW="31558.16" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="6931" readingFrame="-1" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment range="6140-6931" color="#ccffcc" type="standard" translated="1"/><Segment name="signal sequence" range="6932-7000" color="#ccffcc" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="Zdhhc23-m" directionality="1" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="2076" maxFusedRunOn="2076"><Segment range="706-1980" color="#ffcc00" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  ?<Notes>
<UUID>133751de-e061-46cb-a9a0-62e6e87ef9e0</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<Created UTC="5:0:4">2019.1.23</Created>
<LastModified UTC="3:40:34">2023.7.11</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
</Notes>
  	<StrandColors><TopStrand><ColorRange range="699..704" colors="green"/><ColorRange range="1980..1985" colors="green"/></TopStrand><BottomStrand><ColorRange range="699..704" colors="green"/><ColorRange range="1980..1985" colors="green"/></BottomStrand></StrandColors>  /     ×  ò        ò)ª3Ž³œFg2‡hi¡ä¦–ImiÀ-¤­“öf¯2�—§	X?>?\óö‡-e‡&+öIsÖ@z½¡ËXjp•ã÷ ÒvÔ‰¶cÔœÿæ‡-aÂVÏƒi�Òv¦êùè4�¹É¤¶Îiöc
 ÒvÖ dÂ¡íÀ½K½ÿhrÖ**ƒ}V×êõX²]{Ïö‡5`0�Èœ ¹™M¸92¥zS Ÿ°oy/H‚¬÷Ø Kà4ì4PLüÌ÷‚{|Î <òÈ/�8>r#€>ßüàx?è×ƒ98é´ãµ¸à5È#ºûÎÁ¿M¬ !Ž0ø@à:x§Ò=SÐ�~É ·ŽããÈˆÛç,‡Ûx³æ€ãˆ€ëÙiðþ¾"ïŽ·¸à‹ã½Û´Ž9óø´ú8Ðýí?¹Ý îøâ�àíŽ{t5H»ƒô¨þ¨‚r"Þ(ˆ#€ãªöŽ8ë t}ø€ìßxæ€ß�uøÐÓøìà?’à®ªäû¾£àF»«ÑïB€º!ëûgŸ†˜×¦úa‰øiŽNo¦¿GœÙ!ñ›±Ö×î�V¢	®—˜£¾©ÎbsŽ¥�¨›cš:ü˜:¶«¾ú&Vø(âî¦J ü¢Ð× È"7ˆ¨áÍ÷‚€6�}ø´ï«Àz³«ÿ¿š=Ãí³Ï�£óŽ@;(áÖ¼‚(°8rú½ƒŽÏˆ£ß�®3ËëŽrþ°þÖôÁúúüÃã�ãºó.³ë?´q,¿¨>ÿ>p^ÜÖ|ó9‡eTtYW7(*+es ¬/Ð87¸±Ÿ÷ÄÚ õœüÊºú¯÷ýÿõ+?@ìÓ×,ãÙ4n3N î@	¿ÜÏâL3iLÃ ‚œÍ29Þ�LþLüï«:ºþ¾®Ïr³Ã«üµ;•°¿©¼jHêpß±ÿU^†�!‚·$€öÏá‘ÂªÏê KÜ®¥’º+Õà]wµþnÂæº¡©”¨«š
UXN—Uj\Å¥® Xˆ´¤�RÿC¿ÓCE&5M�»ZKM}�RÿC¿ÓCE&5M�»ZKM}’üÿ—¼ý¿?åï?Jóö»ÏöZª¦¦4CÄ<û�¸NkÑI!:ª>Cª5TïÀN‰›Ú¬†ÔGA„*Í†…Ô`hÜÐ®ðó  D9¬9‡€Ýtu°ã¸cÏ"¼8´Í ÏÂº¨µ‹Â?……ãAÄ4Ì9²qÀÊú3N#±Ê-áLàãš� Ðnø¶íú;ãÄT›Û`á�c8ÙÎ†ðçãö±÷ÔÅvÍ±17'°`SÂè±´nM´³=<^+=Ô36?1ì²Ø1�Ž�m‚X<ê¸Û ðà"9´“(9ü†háDè0Å€áó¯²:œ&Ï;ñ¬Ó6Ï®lúèq+®î ¬Åañõ1Ï×ãÛq±¯|óë˜T(°[*¼<8o½3 nØàJë?×¢¦�:e‚�YSY6ÝZ·VTÚª·�®J ¨½^ÛX›¦Ø¸™òÇîNDè2[`¶N*øˆVŠo;u¯w]œO6T‰Sàùa!9{v–Œ£;xüêô°ø²=8ÚX[\ÌÂ£&€ÎëÎ¾ÎÞÎ3°²°ãL&Ó·µC	g
ot[@sAQv!5PôÕCÐ_%T<Ê82ªöC¼ÿøq6ÝU±ÎÔ´BWñÐy•ô2¯þ;û#;¾+Çøó§ÁŸ‹Ï«¿¬2êíc·8�›´¬"BÊÎõ8"7ÿÊÓñóŒúo	y²èK×ð”w›=àÓOx%Ði4LBbCçD®… ƒåçw‘AÒj	¸Îã…=)úÁU‚Nèo]_|à“*ª*54Ñ§3EUA»QFú†ê¹À.í \UíÊP ¶¦ÕPn·äoªV•XR©[[•&fW ¸t§Ö:[HC~nÓ‹š²¶öJ>ÿ,‰yÆp:}¸?Ò8ÖóýÎßôjm5•ôôðP<LÑH/�z›Ï½½.ih£ÀS‘%$¬ô¥’£5Ê(öŽt6È"Üì² ˜:ÚÓ¼+õÆÔ1)ØoýŠ#US
NúÂûÆÊ-” óH¦ÞØ)ƒMãe®éâØöòQŽ«ˆx!'µõ-®d‰Œ1ñ(î�Ã-g–|ÏvM©TŽÛhrºÀ1W»PnŸ8¡Ò±‰{#^­6êž­ôÊ¸MUÐPÕcÍU@Y@ÇpV(Yížëê­fšÚ›@¦‹¶vj&¤Ueud¼ÍÚ¿ÅR=ørÇÀFïÆÿ˜,{´�n;†<Ù)OI¸ïã¢"�8I#15Z”ç]CPè|u£aE¸é   »    !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  $<?xml version="1.0"?><Features nextValidID="20"><Feature recentID="19" name="AmpR" directionality="2" translationMW="31558.16" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="6508" readingFrame="-1" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment range="5717-6508" color="#ccffcc" type="standard" translated="1"/><Segment name="signal sequence" range="6509-6577" color="#ccffcc" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="18" name="NeoR/KanR" directionality="1" translationMW="29048.78" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3416-4210" color="#ccffcc" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="17" name="WPRE" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1674-2262" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;woodchuck hepatitis virus&amp;nbsp;posttranscriptional regulatory element&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="16" name="ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4958-5546" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="15" name="f1 ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2578-3006" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="14" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="50-429" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3020-3349" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="430-633" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3200-3335" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4386-4507" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="AmpR promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6578-6682" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2328-2376" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="lac promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment name="-10" range="4604-4610" color="#ffffff" type="standard"/><Segment range="4611-4628" color="#ffffff" type="standard"/><Segment name="-35" range="4629-4634" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for the &lt;i&gt;E. coli lac&lt;/i&gt; operon&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="CAP binding site" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4649-4670" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;E. coli&lt;/i&gt; catabolite activator protein&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;CAP binding activates transcription in the presence of cAMP.&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="M13 rev" directionality="2" type="primer_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4556-4572" color="#a020f0" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;common sequencing primer, one of multiple similar variants&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="lac operator" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4580-4596" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;lac&lt;/i&gt; repressor encoded by &lt;i&gt;lacI&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;The &lt;i&gt;lac&lt;/i&gt; repressor binds to the &lt;i&gt;lac&lt;/i&gt; operator to inhibit transcription in &lt;i&gt;E. coli&lt;/i&gt;. This inhibition can be relieved by adding lactose or isopropyl-Î²-D-thiogalactopyranoside (IPTG).&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1653" maxFusedRunOn="1653" detectionMode="exactProteinMatch"><Segment range="1564-1590" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="2" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1653" maxFusedRunOn="1653" detectionMode="exactProteinMatch"><Segment range="1594-1620" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="1" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1653" maxFusedRunOn="1653" detectionMode="exactProteinMatch"><Segment range="1624-1650" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="0" name="Zdhhc24-m" directionality="1" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1653" maxFusedRunOn="1653"><Segment range="706-1557" color="#ffcc00" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  ><Notes>
<UUID>133751de-e061-46cb-a9a0-62e6e87ef9e0</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<Created UTC="5:0:4">2019.1.23</Created>
<LastModified UTC="3:38:4">2023.7.11</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
</Notes>
  	<StrandColors><TopStrand><ColorRange range="699..704" colors="green"/><ColorRange range="1557..1562" colors="green"/></TopStrand><BottomStrand><ColorRange range="699..704" colors="green"/><ColorRange range="1557..1562" colors="green"/></BottomStrand></StrandColors>  /¦     m  J        J)ª3Ž³œFg2‡hi¡ä¦–ImiÀ-¤­“öf¯2�—§	X?>?\óö‡-e‡&+öIsÖ@z½¡ËXjp•ã÷ ÒvÔ‰¶cÔœÿæ‡-aÂVÏƒi�Òv¦êùè4�¹É¤¶Îiöc
 ÒvÖ dÂ¡íÀ½K½ÿhrÖ**ƒ}V×êõX²]{Ïö‡5`0�Èœ ¹™M¸92¥zS Ÿ°oy/H‚¬÷Ø]¸×Wû×QÓÿDˆ�Ó?·AÒëý�Ó;±A``N?ßÎôhƒàã¹û®³h:€/¢¿î�·Þ>89Ž�€n£ƒß¢ß‡Ž.öÆôÑ�XŒQ9îþ?nµóOMŒØ¶…�ã_˜Ç r3ÕÞ4Ï�e#&0ë}£R×^2æÃº¹Ý"¸êh¾;àŽ=é‹¬�+¨µÿc²}}w¨RèQ}Üˆ*"º>8ÿˆýøöø?ƒÏã¶úà>:¹Óøè=øî:÷jnXƒu;}ù…�²4ß/NÐSTýÔ�-�üÔ#ÚÐF®v~´ö#/Dþàô9M6•�[ëô«£ßÔ=HßyþûíÞãïpo_ôUDÃ&F�Ð¸è;÷�Ð§ï“Ï;ÓºÛ†½ô�OÒ68 î43çžÃm8KØF½ ýÏ€Ò<Þ?ÐO@,D¸çCr³ãŠ¨„üM Äü~0Ç�»gŸ†˜×¦úa‰øiŽNo¦¿GœÙ!ñ›±Ö×î�V¢	®—˜£¾©ÎbsŽ¥�¨›cš:ü˜:¶«¾ú&Vø(âî¦J ü¢Ð× È"7ˆ¨áÍ÷‚€6�}ø´ï«Àz³«ÿ¿š=Ãí³Ï�£óŽ@;(áÖ¼‚(°8rú½ƒŽÏˆ£ß�®3ËëŽrþ°þÖôÁúúüÃã�ãºó.³ë?´q,¿¨>ÿ>p^ÜÖ|ó9‡eTtYW7(*+es ¬/Ð87¸±Ÿ÷ÄÚ õœüÊºú¯÷ýÿõ+?@ìÓ×,ãÙ4n3N î@	¿ÜÏâL3iLÃ ‚œÍ29Þ�LþLüï«:ºþ¾®Ïr³Ã«üµ;•°¿©¼jHêpß±ÿU^†�!‚·$€öÏá‘ÂªÏê KÜ®¥’º+Õà]wµþnÂæº¡©”¨«š
UXN—Uj\Å¥® Xˆ´¤�RÿC¿ÓCE&5M�»ZKM}�RÿC¿ÓCE&5M�»ZKM}’üÿ—¼ý¿?åï?Jóö»ÏöZª¦¦4CÄ<û�¸NkÑI!:ª>Cª5TïÀN‰›Ú¬†ÔGA„*Í†…Ô`hÜÐ®ðó  D9¬9‡€Ýtu°ã¸cÏ"¼8´Í ÏÂº¨µ‹Â?……ãAÄ4Ì9²qÀÊú3N#±Ê-áLàãš� Ðnø¶íú;ãÄT›Û`á�c8ÙÎ†ðçãö±÷ÔÅvÍ±17'°`SÂè±´nM´³=<^+=Ô36?1ì²Ø1�Ž�m‚X<ê¸Û ðà"9´“(9ü†háDè0Å€áó¯²:œ&Ï;ñ¬Ó6Ï®lúèq+®î ¬Åañõ1Ï×ãÛq±¯|óë˜T(°[*¼<8o½3 nØàJë?×¢¦�:e‚�YSY6ÝZ·VTÚª·�®J ¨½^ÛX›¦Ø¸™òÇîNDè2[`¶N*øˆVŠo;u¯w]œO6T‰Sàùa!9{v–Œ£;xüêô°ø²=8ÚX[\ÌÂ£&€ÎëÎ¾ÎÞÎ3°²°ãL&Ó·µC	g
ot[@sAQv!5PôÕCÐ_%T<Ê82ªöC¼ÿøq6ÝU±ÎÔ´BWñÐy•ô2¯þ;û#;¾+Çøó§ÁŸ‹Ï«¿¬2êíc·8�›´¬"BÊÎõ8"7ÿÊÓñóŒúo	y²èK×ð”w›=àÓOx%Ði4LBbCçD®… ƒåçw‘AÒj	¸Îã…=)úÁU‚Nèo]_|à“*ª*54Ñ§3EUA»QFú†ê¹À.í \UíÊP ¶¦ÕPn·äoªV•XR©[[•&fW ¸t§Ö:[HC~nÓ‹š²¶öJ>ÿ,‰yÆp:}¸?Ò8ÖóýÎßôjm5•ôôðP<LÑH/�z›Ï½½.ih£ÀS‘%$¬ô¥’£5Ê(öŽt6È"Üì² ˜:ÚÓ¼+õÆÔ1)ØoýŠ#US
NúÂûÆÊ-” óH¦ÞØ)ƒMãe®éâØöòQŽ«ˆx!'µõ-®d‰Œ1ñ(î�Ã-g–|ÏvM©TŽÛhrºÀ1W»PnŸ8¡Ò±‰{#^­6êž­ôÊ¸MUÐPÕcÍU@Y@ÇpV(Yížëê­fšÚ›@¦‹¶vj&¤Ueud¼ÍÚ¿ÅR=ørÇÀFïÆÿ˜,{´�n;†<Ù)OI¸ïã¢"�8I#15Z”ç]CPè|u£aE¸é   »  l  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  $<?xml version="1.0"?><Features nextValidID="20"><Feature recentID="19" name="Zdhhc1-m" directionality="1" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="2253" maxFusedRunOn="2253"><Segment range="706-2157" color="#ffcc00" type="standard" translated="1"/><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="18" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="2253" maxFusedRunOn="2253" detectionMode="exactProteinMatch"><Segment range="2224-2250" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="17" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="2253" maxFusedRunOn="2253" detectionMode="exactProteinMatch"><Segment range="2194-2220" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="16" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="2253" maxFusedRunOn="2253" detectionMode="exactProteinMatch"><Segment range="2164-2190" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="15" name="lac operator" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5180-5196" color="#31849b" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;The &lt;i&gt;lac&lt;/i&gt; repressor binds to the &lt;i&gt;lac&lt;/i&gt; operator to inhibit transcription in &lt;i&gt;E. coli&lt;/i&gt;. This inhibition can be relieved by adding lactose or isopropyl-Î²-D-thiogalactopyranoside (IPTG).&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;lac&lt;/i&gt; repressor encoded by &lt;i&gt;lacI&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="14" name="M13 rev" directionality="2" type="primer_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5156-5172" color="#a020f0" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;common sequencing primer, one of multiple similar variants&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="CAP binding site" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5249-5270" color="#31849b" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;CAP binding activates transcription in the presence of cAMP.&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;E. coli&lt;/i&gt; catabolite activator protein&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="lac promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment name="-10" range="5204-5210" color="#ffffff" type="standard"/><Segment range="5211-5228" color="#ffffff" type="standard"/><Segment name="-35" range="5229-5234" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for the &lt;i&gt;E. coli lac&lt;/i&gt; operon&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2928-2976" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="AmpR promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="7178-7282" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4986-5107" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3800-3935" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="430-633" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3620-3949" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="50-429" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="f1 ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3178-3606" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="direction"><V text="RIGHT"/></Q></Feature><Feature recentID="3" name="ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5558-6146" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="direction"><V text="LEFT"/></Q></Feature><Feature recentID="2" name="WPRE" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2274-2862" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;woodchuck hepatitis virus&amp;nbsp;posttranscriptional regulatory element&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="1" name="NeoR/KanR" directionality="1" translationMW="29048.78" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="4016-4810" color="#ccffcc" type="standard" translated="1"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="0" name="AmpR" directionality="2" translationMW="31558.16" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="7108" readingFrame="-1" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment range="6317-7108" color="#ccffcc" type="standard" translated="1"/><Segment name="signal sequence" range="7109-7177" color="#ccffcc" type="standard" translated="1"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  ><Notes>
<UUID>133751de-e061-46cb-a9a0-62e6e87ef9e0</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<Created UTC="5:0:4">2019.1.23</Created>
<LastModified UTC="3:31:5">2023.7.11</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
</Notes>
  	<StrandColors><TopStrand><ColorRange range="699..725" colors="green"/><ColorRange range="2136..2162" colors="green"/></TopStrand><BottomStrand><ColorRange range="699..725" colors="green"/><ColorRange range="2136..2162" colors="green"/></BottomStrand></StrandColors>  -Í     £  #        #)ª3Ž³œFg2‡hi¡ä¦–ImiÀ-¤­“öf¯2�—§	X?>?\óö‡-e‡&+öIsÖ@z½¡ËXjp•ã÷ ÒvÔ‰¶cÔœÿæ‡-aÂVÏƒi�Òv¦êùè4�¹É¤¶Îiöc
 ÒvÖ dÂ¡íÀ½K½ÿhrÖ**ƒ}V×êõX²]{Ïö‡5`0�Èœ ¹™M¸92¥zS Ÿ°oy/H‚¬÷ØM;D‹àjø+ˆòak®!HQçoAÕ©nžµ„Ð¿·›Näv ~øaEàQ×ý}†„ÐÓÄc©�¡½ÏÎvú}|ƒlý U'ÓPG¨)âû"'ˆEôõŽ¿h>­¿BöS¹ãýHØ‰ÝýKmG}·p`Ïž°Þ
¿·cºØ#oÄŸÔGã×Ò¢?C¹Â­FöñƒçÓ�;ÔóÓ^µôµk>ÄŸÙÇ'á¦5é¾˜b~c“›é†/Ñç6H@üfìuµû�§U¨…F‡‚k¥æ(ïªs˜�œã©cê&ØæŽ¿&­ªï¾‰•¾
8»©„ˆ?(´5È2�â*8s_ýà £ß~-;êð¬êÿïæ�pÁ{lóãèüã�ÐÃŠxu¯ Š,N¾¯`ã³â(÷àkŒÀrúãœ¿¬?µ½0~¾¿0øãÃ¸Ãî¼Ë¬úÏíKïêÏ¿Ï�\ C—…wuŸüÎaÃYUUÍÀŠÊŠÙ\À+ôî,gýñö€=g?2®¾«ýÿýJÀ…Ð;4õË ÃCøöMŒÓ€;�o÷3ø“ÚS0Àˆ §3L‡Îw£Ó?“?;êÎ®¿¯«³Ü¬ðêÿ-Nåloê@¯’:œ7ìÕW¡¤`­É =³ødpª³ú‡(÷+©d�îŠõx]í›°¹®¨jeª jÃæ‚•V†¥ÕZ—1ikˆ"-) T¿ÐïôÐÑI�ScnÖ’Ó_B T¿ÐïôÐÑI�ScnÖ’Ó_d¿?åï?oÏù{ÏÒ¼ý®óýƒ‡–ª©©�ñ>ãîšôRHAª��ê�U;ð¢fö«áµÐaÊ³a¡u74+¼<èkaà7]l8îóÈ¯-3@3ð®ª-GÇâð�áaxÐq3lƒƒÜp2¾ŒÓˆìr‹xS@x8æ€Å#À4¾-»~Žøñ&öØ8cXÃ6s¡¼9øý¬}õ1]³lLMÉìðº,m�Åm ìÏOŠÏCµÍ�ÇA»,‡öcã£Å›`�V:®¶Çˆ<8ƒÎmdÊ!š8Q:1`8|ëìŽ§	³Îük4Í³ë›>ºJë„À{€+1X|}LsõøöÜF¬kß<úæ
¬Ê¯ÏïLÀ¶8ºÏßõè©£N™`§VTÖM·V­Õ•6ª­ãk’ˆ*/W¶Ö&é¶.&|±û“‘:–Ø-“Š¾"¢›ÎÝkÝ×gÁM•"Tø>XHN^Ý¥£(ÎÞ?:½,~,�N6–Ã×3 D0¨É 3ºó¯³·‡³Œì,¬8Ã	´ííPÂYÂ›ÝÐ\ÐT]ˆMT=5PôÉU2Žª½�ï?þM·Ulsµ-ƒüteF}«ÿ�NþÈÎïŠñþ<éðgâóêïëLƒ:»XíÎ$&í+�²³½Nˆ�Åÿò´ü|ã>›Â^lºõü%Ç¦Ïx4ÓÞ	tM˜�Â9Ñ+¡H ùyÃ�äPtš‚n3¸áOJ~°UD “ºÃWWß8$Â
ªŠ�M4iÌÑUPnÔQ¾¡º®p‡;H{r”¨-„iµT­ùê•¥VªVÖåI™„•è.)õŽ–Òß›´Æâæ¬­½’�‡¿Ë"F^qœŸnôŽ5†|Äs·Ã½›Me}=<4Rã^¦óïoKšZ(ðäII+=)d¨ÍrŠ=£�²·;,¨&¶´ï
ýqµJvÿbˆÕTÂ“¾°¾ñ²‹E%(<Ò)·¶
`ÓxÙkºx¶=¼”cªâIí}Kk„Y"c|J;£ðËYÀeŸ3Ý“EêU#¶Ú\®°UîÔ§Î(Fô¬b_ÞÈß×†ëMº§«}2®Ut5XóUPP1ÜŠ{gºú«Y¦…6¦Ð)¢í„Á�š…‰©Y]Y ¯3v¯ñT�~±Á°»ñ¿æí'[Žá�6JSÒn;øèˆ BÎHÌMV¥9×PÔ:hØQn:  »  E  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  $<?xml version="1.0"?><Features nextValidID="20"><Feature recentID="19" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1446" maxFusedRunOn="1446" detectionMode="exactProteinMatch"><Segment range="1417-1443" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="18" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1446" maxFusedRunOn="1446" detectionMode="exactProteinMatch"><Segment range="1387-1413" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="17" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1446" maxFusedRunOn="1446" detectionMode="exactProteinMatch"><Segment range="1357-1383" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="16" name="lac operator" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4373-4389" color="#31849b" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;The &lt;i&gt;lac&lt;/i&gt; repressor binds to the &lt;i&gt;lac&lt;/i&gt; operator to inhibit transcription in &lt;i&gt;E. coli&lt;/i&gt;. This inhibition can be relieved by adding lactose or isopropyl-Î²-D-thiogalactopyranoside (IPTG).&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;lac&lt;/i&gt; repressor encoded by &lt;i&gt;lacI&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="15" name="M13 rev" directionality="2" type="primer_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4349-4365" color="#a020f0" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;common sequencing primer, one of multiple similar variants&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="14" name="CAP binding site" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4442-4463" color="#31849b" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;CAP binding activates transcription in the presence of cAMP.&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;E. coli&lt;/i&gt; catabolite activator protein&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="lac promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment name="-10" range="4397-4403" color="#ffffff" type="standard"/><Segment range="4404-4421" color="#ffffff" type="standard"/><Segment name="-35" range="4422-4427" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for the &lt;i&gt;E. coli lac&lt;/i&gt; operon&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2121-2169" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="AmpR promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6371-6475" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4179-4300" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2993-3128" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="430-633" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2813-3142" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="50-429" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="f1 ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2371-2799" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="direction"><V text="RIGHT"/></Q></Feature><Feature recentID="4" name="ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4751-5339" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="direction"><V text="LEFT"/></Q></Feature><Feature recentID="3" name="WPRE" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1467-2055" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;woodchuck hepatitis virus&amp;nbsp;posttranscriptional regulatory element&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="NeoR/KanR" directionality="1" translationMW="29048.78" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3209-4003" color="#ccffcc" type="standard" translated="1"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="1" name="AmpR" directionality="2" translationMW="31558.16" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="6301" readingFrame="-1" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment range="5510-6301" color="#ccffcc" type="standard" translated="1"/><Segment name="signal sequence" range="6302-6370" color="#ccffcc" type="standard" translated="1"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="0" name="CSNK2B" directionality="1" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1446" maxFusedRunOn="1446"><Segment range="706-1350" color="#ffcc00" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  ?<Notes>
<UUID>133751de-e061-46cb-a9a0-62e6e87ef9e0</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<Created UTC="5:0:4">2019.1.23</Created>
<LastModified UTC="2:32:51">2023.7.11</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
</Notes>
  +Ö     ÿ  ³         ³)ª3Ž³œFg2‡hi¡ä¦–ImiÀ-¤­“öf¯2�—§	X?>?\óö‡-e‡&+öIsÖ@z½¡ËXjp•ã÷ ÒvÔ‰¶cÔœÿæ‡-aÂVÏƒi�Òv¦êùè4�¹É¤¶Îiöc
 ÒvÖ dÂ¡íÀ½K½ÿhrÖ**ƒ}V×êõX²]{Ïö‡5`0�Èœ ¹™M¸92¥zS Ÿ°oy/H‚®4fôÝ ÃÎÄŸÙÇ'á¦5é¾˜b~c“›é†/Ñç6H@üfìuµû�§U¨…F‡‚k¥æ(ïªs˜�œã©cê&ØæŽ¿&­ªï¾‰•¾
8»©„ˆ?(´5È2�â*8s_ýà £ß~-;êð¬êÿïæ�pÁ{lóãèüã�ÐÃŠxu¯ Š,N¾¯`ã³â(÷àkŒÀrúãœ¿¬?µ½0~¾¿0øãÃ¸Ãî¼Ë¬úÏíKïêÏ¿Ï�\ C—…wuŸüÎaÃYUUÍÀŠÊŠÙ\À+ôî,gýñö€=g?2®¾«ýÿýJÀ…Ð;4õË ÃCøöMŒÓ€;�o÷3ø“ÚS0Àˆ §3L‡Îw£Ó?“?;êÎ®¿¯«³Ü¬ðêÿ-Nåloê@¯’:œ7ìÕW¡¤`­É =³ødpª³ú‡(÷+©d�îŠõx]í›°¹®¨jeª jÃæ‚•V†¥ÕZ—1ikˆ"-) T¿ÐïôÐÑI�ScnÖ’Ó_B T¿ÐïôÐÑI�ScnÖ’Ó_d¿?åï?oÏù{ÏÒ¼ý®óýƒ‡–ª©©�ñ>ãîšôRHAª��ê�U;ð¢fö«áµÐaÊ³a¡u74+¼<èkaà7]l8îóÈ¯-3@3ð®ª-GÇâð�áaxÐq3lƒƒÜp2¾ŒÓˆìr‹xS@x8æ€Å#À4¾-»~Žøñ&öØ8cXÃ6s¡¼9øý¬}õ1]³lLMÉìðº,m�Åm ìÏOŠÏCµÍ�ÇA»,‡öcã£Å›`�V:®¶Çˆ<8ƒÎmdÊ!š8Q:1`8|ëìŽ§	³Îük4Í³ë›>ºJë„À{€+1X|}LsõøöÜF¬kß<úæ
¬Ê¯ÏïLÀ¶8ºÏßõè©£N™`§VTÖM·V­Õ•6ª­ãk’ˆ*/W¶Ö&é¶.&|±û“‘:–Ø-“Š¾"¢›ÎÝkÝ×gÁM•"Tø>XHN^Ý¥£(ÎÞ?:½,~,�N6–Ã×3 D0¨É 3ºó¯³·‡³Œì,¬8Ã	´ííPÂYÂ›ÝÐ\ÐT]ˆMT=5PôÉU2Žª½�ï?þM·Ulsµ-ƒüteF}«ÿ�NþÈÎïŠñþ<éðgâóêïëLƒ:»XíÎ$&í+�²³½Nˆ�Åÿò´ü|ã>›Â^lºõü%Ç¦Ïx4ÓÞ	tM˜�Â9Ñ+¡H ùyÃ�äPtš‚n3¸áOJ~°UD “ºÃWWß8$Â
ªŠ�M4iÌÑUPnÔQ¾¡º®p‡;H{r”¨-„iµT­ùê•¥VªVÖåI™„•è.)õŽ–Òß›´Æâæ¬­½’�‡¿Ë"F^qœŸnôŽ5†|Äs·Ã½›Me}=<4Rã^¦óïoKšZ(ðäII+=)d¨ÍrŠ=£�²·;,¨&¶´ï
ýqµJvÿbˆÕTÂ“¾°¾ñ²‹E%(<Ò)·¶
`ÓxÙkºx¶=¼”cªâIí}Kk„Y"c|J;£ðËYÀeŸ3Ý“EêU#¶Ú\®°UîÔ§Î(Fô¬b_ÞÈß×†ëMº§«}2®Ut5XóUPP1ÜŠ{gºú«Y¦…6¦Ð)¢í„Á�š…‰©Y]Y ¯3v¯ñT�~±Á°»ñ¿æí'[Žá�6JSÒn;øèˆ BÎHÌMV¥9×PÔ:hØQn:  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  "Ã<?xml version="1.0"?><Features nextValidID="19"><Feature recentID="18" name="AmpR" directionality="2" translationMW="31558.16" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="5677" readingFrame="-1" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment range="4886-5677" color="#ccffcc" type="standard" translated="1"/><Segment name="signal sequence" range="5678-5746" color="#ccffcc" type="standard" translated="1"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="17" name="NeoR/KanR" directionality="1" translationMW="29048.78" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="2585-3379" color="#ccffcc" type="standard" translated="1"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="16" name="WPRE" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="843-1431" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;woodchuck hepatitis virus&amp;nbsp;posttranscriptional regulatory element&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="15" name="ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4127-4715" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="14" name="f1 ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1747-2175" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="50-429" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2189-2518" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="430-633" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2369-2504" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3555-3676" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="AmpR promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5747-5851" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1497-1545" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="lac promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment name="-10" range="3773-3779" color="#ffffff" type="standard"/><Segment range="3780-3797" color="#ffffff" type="standard"/><Segment name="-35" range="3798-3803" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for the &lt;i&gt;E. coli lac&lt;/i&gt; operon&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CAP binding site" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3818-3839" color="#31849b" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;CAP binding activates transcription in the presence of cAMP.&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;E. coli&lt;/i&gt; catabolite activator protein&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="M13 rev" directionality="2" type="primer_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3725-3741" color="#a020f0" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;common sequencing primer, one of multiple similar variants&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="lac operator" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3749-3765" color="#31849b" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;The &lt;i&gt;lac&lt;/i&gt; repressor binds to the &lt;i&gt;lac&lt;/i&gt; operator to inhibit transcription in &lt;i&gt;E. coli&lt;/i&gt;. This inhibition can be relieved by adding lactose or isopropyl-Î²-D-thiogalactopyranoside (IPTG).&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;lac&lt;/i&gt; repressor encoded by &lt;i&gt;lacI&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="822" maxFusedRunOn="822" detectionMode="exactProteinMatch"><Segment range="733-759" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="1" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="822" maxFusedRunOn="822" detectionMode="exactProteinMatch"><Segment range="763-789" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="822" maxFusedRunOn="822" detectionMode="exactProteinMatch"><Segment range="793-819" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  ?<Notes>
<UUID>133751de-e061-46cb-a9a0-62e6e87ef9e0</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<Created UTC="5:0:4">2019.1.23</Created>
<LastModified UTC="1:32:30">2023.7.10</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
</Notes>
  5        ¶         ¶)ª3Ž³œFg2‡hi¡ä¦–ImiÀ-¤­“öf¯2�—§	X?>?\óö‡-e‡&+öIsÖ@z½¡ËXjp•ã÷ ÒvÔ‰¶cÔœÿæ‡-aÂVÏƒi�Òv¦êùè4�¹É¤¶Îiöc
 ÒvÖ dÂ¡íÀ½K½ÿhrÖ**ƒ}V×êõX²]{Ïö‡5`0�Èœ ¹™M¸92¥zS Ÿ°oy/H‚®4fôÝ ÃÎÄUyfÑ�tW–ÒQ©U)jñ™!ñ›±Ö×î�V¢	®—˜£¾©ÎbsŽ¥�¨›cš:ü˜:¶«¾ú&Vø(âî¦J ü¢Ð× È"7ˆ¨áÍ÷‚€6�}ø´ï«Àz³«ÿ¿š=Ãí³Ï�£óŽ@;(áÖ¼‚(°8rú½ƒŽÏˆ£ß�®3ËëŽrþ°þÖôÁúúüÃã�ãºó.³ë?´q,¿¨>ÿ>p^ÜÖ|ó9‡eTtYW7(*+es ¬/Ð87¸±Ÿ÷ÄÚ õœüÊºú¯÷ýÿõ+?@ìÓ×,ãÙ4n3N î@	¿ÜÏâL3iLÃ ‚œÍ29Þ�LþLüï«:ºþ¾®Ïr³Ã«üµ;•°¿©¼jHêpß±ÿU^†�!‚·$€öÏá‘ÂªÏê KÜ®¥’º+Õà]wµþnÂæº¡©”¨«š
UXN—Uj\Å¥® Xˆ´¤�RÿC¿ÓCE&5M�»ZKM}�RÿC¿ÓCE&5M�»ZKM}’üÿ—¼ý¿?åï?Jóö»ÏöZª¦¦4CÄ<û�¸NkÑI!:ª>Cª5TïÀN‰›Ú¬†ÔGA„*Í†…Ô`hÜÐ®ðó  D9¬9‡€Ýtu°ã¸cÏ"¼8´Í ÏÂº¨µ‹Â?……ãAÄ4Ì9²qÀÊú3N#±Ê-áLàãš� Ðnø¶íú;ãÄT›Û`á�c8ÙÎ†ðçãö±÷ÔÅvÍ±17'°`SÂè±´nM´³=<^+=Ô36?1ì²Ø1�Ž�m‚X<ê¸Û ðà"9´“(9ü†háDè0Å€áó¯²:œ&Ï;ñ¬Ó6Ï®lúèq+®î ¬Åañõ1Ï×ãÛq±¯|óë˜T(°[*¼<8o½3 nØàJë?×¢¦�:e‚�YSY6ÝZ·VTÚª·�®J ¨½^ÛX›¦Ø¸™òÇîNDè2[`¶N*øˆVŠo;u¯w]œO6T‰Sàùa!9{v–Œ£;xüêô°ø²=8ÚX[\ÌÂ£&€ÎëÎ¾ÎÞÎ3°²°ãL&Ó·µC	g
ot[@sAQv!5PôÕCÐ_%T<Ê82ªöC¼ÿøq6ÝU±ÎÔ´BWñÐy•ô2¯þ;û#;¾+Çøó§ÁŸ‹Ï«¿¬2êíc·8�›´¬"BÊÎõ8"7ÿÊÓñóŒúo	y²èK×ð”w›=àÓOx%Ði4LBbCçD®… ƒåçw‘AÒj	¸Îã…=)úÁU‚Nèo]_|à“*ª*54Ñ§3EUA»QFú†ê¹À.í \UíÊP ¶¦ÕPn·äoªV•XR©[[•&fW ¸t§Ö:[HC~nÓ‹š²¶öJ>ÿ,‰yÆp:}¸?Ò8ÖóýÎßôjm5•ôôðP<LÑH/�z›Ï½½.ih£ÀS‘%$¬ô¥’£5Ê(öŽt6È"Üì² ˜:ÚÓ¼+õÆÔ1)ØoýŠ#US
NúÂûÆÊ-” óH¦ÞØ)ƒMãe®éâØöòQŽ«ˆx!'µõ-®d‰Œ1ñ(î�Ã-g–|ÏvM©TŽÛhrºÀ1W»PnŸ8¡Ò±‰{#^­6êž­ôÊ¸MUÐPÕcÍU@Y@ÇpV(Yížëê­fšÚ›@¦‹¶vj&¤Ueud¼ÍÚ¿ÅR=ørÇÀFïÆÿ˜,{´�n;†<Ù)OI¸ïã¢"�8I#15Z”ç]CPè|u£aE¸é   !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  ! <?xml version="1.0"?><Features nextValidID="18"><Feature recentID="17" name="Factor Xa site" directionality="2" translationMW="473.54" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="1316" readingFrame="-1" consecutiveTranslationNumbering="1" maxRunOn="933" maxFusedRunOn="933" detectionMode="exactProteinMatch"><Segment range="1317-1328" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Factor Xa recognition and cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="16" name="lac operator" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3752-3768" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;lac&lt;/i&gt; repressor encoded by &lt;i&gt;lacI&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;The &lt;i&gt;lac&lt;/i&gt; repressor binds to the &lt;i&gt;lac&lt;/i&gt; operator to inhibit transcription in &lt;i&gt;E. coli&lt;/i&gt;. This inhibition can be relieved by adding lactose or isopropyl-Î²-D-thiogalactopyranoside (IPTG).&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="15" name="M13 rev" directionality="2" type="primer_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3728-3744" color="#a020f0" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;common sequencing primer, one of multiple similar variants&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="14" name="CAP binding site" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3821-3842" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;E. coli&lt;/i&gt; catabolite activator protein&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;CAP binding activates transcription in the presence of cAMP.&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="lac promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment name="-10" range="3776-3782" color="#ffffff" type="standard"/><Segment range="3783-3800" color="#ffffff" type="standard"/><Segment name="-35" range="3801-3806" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for the &lt;i&gt;E. coli lac&lt;/i&gt; operon&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1500-1548" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="AmpR promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5750-5854" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3558-3679" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2372-2507" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="430-633" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2192-2521" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="50-429" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="f1 ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1750-2178" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4130-4718" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="WPRE" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="846-1434" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;woodchuck hepatitis virus&amp;nbsp;posttranscriptional regulatory element&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="NeoR/KanR" directionality="1" translationMW="29048.78" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="2588-3382" color="#ccffcc" type="standard" translated="1"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="1" name="AmpR" directionality="2" translationMW="31558.16" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="5680" readingFrame="-1" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment range="4889-5680" color="#ccffcc" type="standard" translated="1"/><Segment name="signal sequence" range="5681-5749" color="#ccffcc" type="standard" translated="1"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="3xMyc" directionality="1" translationMW="3573.98" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="825" maxFusedRunOn="825" detectionMode="exactProteinMatch"><Segment range="733-822" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;3 tandem Myc epitope tags&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
  ˆ<?xml version="1.0"?><Primers nextValidID="2"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/><Primer recentID="1" name="R1" sequence="CTCACTATAAGTCCTCCTCGGAAATTAACTTTTGCTCTAAATCTTCTTCACTGATTAGTTTCTGTTCCAAATCTTCCTCTGATATTAGTTTTTGTTCC" description="&lt;html&gt;&lt;body&gt;&lt;/body&gt;&lt;/html&gt;"><BindingSite location="731-828" boundStrand="1" annealedBases="CTCACTATAAGTCCTCCTCGGAAATTAACTTTTGCTCTAAATCTTCTTCACTGATTAGTTTCTGTTCCAAATCTTCCTCTGATATTAGTTTTTGTTCC" meltingTemperature="69"><Component hybridizedRange="731-828" bases="CTCACTATAAGTCCTCCTCGGAAATTAACTTTTGCTCTAAATCTTCTTCACTGATTAGTTTCTGTTCCAAATCTTCCTCTGATATTAGTTTTTGTTCC"/></BindingSite><BindingSite location="761-828" boundStrand="1" annealedBases="CTCACTATAAGTCCTCCTCGGAAATTAACTTTTGCTCTAAATCTTCTTCACTGATTAGTTTTGTTCC" meltingTemperature="62"><Component hybridizedRange="773-828" bases="CTCACTATAAGTCCTCCTCGGAAATTAACTTTTGCTCTAAATCTTCTTCACTGATT"/><Component bases="AGTTTCTGTTCCAAATCTTCCTCTGATATT"/><Component hybridizedRange="768-772" bases="AGTTT"/><Component bases="T"/><Component hybridizedRange="761-766" bases="TGTTCC"/></BindingSite><BindingSite simplified="1" location="731-828" boundStrand="1" annealedBases="CTCACTATAAGTCCTCCTCGGAAATTAACTTTTGCTCTAAATCTTCTTCACTGATTAGTTTCTGTTCCAAATCTTCCTCTGATATTAGTTTTTGTTCC" meltingTemperature="69"><Component hybridizedRange="731-828" bases="CTCACTATAAGTCCTCCTCGGAAATTAACTTTTGCTCTAAATCTTCTTCACTGATTAGTTTCTGTTCCAAATCTTCCTCTGATATTAGTTTTTGTTCC"/></BindingSite><BindingSite simplified="1" location="761-828" boundStrand="1" annealedBases="CTCACTATAAGTCCTCCTCGGAAATTAACTTTTGCTCTAAATCTTCTTCACTGATTAGTTTTGTTCC" meltingTemperature="62"><Component hybridizedRange="773-828" bases="CTCACTATAAGTCCTCCTCGGAAATTAACTTTTGCTCTAAATCTTCTTCACTGATT"/><Component bases="AGTTTCTGTTCCAAATCTTCCTCTGATATT"/><Component hybridizedRange="768-772" bases="AGTTT"/><Component bases="T"/><Component hybridizedRange="761-766" bases="TGTTCC"/></BindingSite></Primer><Primer recentID="0" name="F1" sequence="TCGAGGAACAAAAACTAATATCAGAGGAAGATTTGGAACAGAAACTAATCAGTGAAGAAGATTTAGAGCAAAAGTTAATTTCCGAGGAGGACTTATAGTGAGGGCC" description="&lt;html&gt;&lt;body&gt;&lt;/body&gt;&lt;/html&gt;"><BindingSite location="727-832" boundStrand="0" annealedBases="TCGAGGAACAAAAACTAATATCAGAGGAAGATTTGGAACAGAAACTAATCAGTGAAGAAGATTTAGAGCAAAAGTTAATTTCCGAGGAGGACTTATAGTGAGGGCC" meltingTemperature="71"><Component hybridizedRange="727-832" bases="TCGAGGAACAAAAACTAATATCAGAGGAAGATTTGGAACAGAAACTAATCAGTGAAGAAGATTTAGAGCAAAAGTTAATTTCCGAGGAGGACTTATAGTGAGGGCC"/></BindingSite><BindingSite simplified="1" location="727-832" boundStrand="0" annealedBases="TCGAGGAACAAAAACTAATATCAGAGGAAGATTTGGAACAGAAACTAATCAGTGAAGAAGATTTAGAGCAAAAGTTAATTTCCGAGGAGGACTTATAGTGAGGGCC" meltingTemperature="71"><Component hybridizedRange="727-832" bases="TCGAGGAACAAAAACTAATATCAGAGGAAGATTTGGAACAGAAACTAATCAGTGAAGAAGATTTAGAGCAAAAGTTAATTTCCGAGGAGGACTTATAGTGAGGGCC"/></BindingSite></Primer></Primers>
  ><Notes>
<UUID>554b079e-04cd-46e5-910a-3c8d9ddfc533</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<Created UTC="5:0:4">2019.1.23</Created>
<LastModified UTC="8:15:15">2020.4.4</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
</Notes>
  *T      ú  ž         ž)ª3Ž³œFg2‡hi¡ä¦–ImiÀ-¤­“öf¯2�—§	X?>?\óö‡-e‡&+öIsÖ@z½¡ËXjp•ã÷ ÒvÔ‰¶cÔœÿæ‡-aÂVÏƒi�Òv¦êùè4�¹É¤¶Îiöc
 ÒvÖ dÂ¡íÀ½K½ÿhrÖ**ƒ}V×êõX²]{Ïö‡5`0�Èœ ¹™M¸92¥zS Ÿ°oy/H‚®4fôÝ ÃÎÄuGØp†™Q¶±çPaÆI!ñ›±Ö×î�V¢	®—˜£¾©ÎbsŽ¥�¨›cš:ü˜:¶«¾ú&Vø(âî¦J ü¢Ð× È"7ˆ¨áÍ÷‚€6�}ø´ï«Àz³«ÿ¿š=Ãí³Ï�£óŽ@;(áÖ¼‚(°8rú½ƒŽÏˆ£ß�®3ËëŽrþ°þÖôÁúúüÃã�ãºó.³ë?´q,¿¨>ÿ>p^ÜÖ|ó9‡eTtYW7(*+es ¬/Ð87¸±Ÿ÷ÄÚ õœüÊºú¯÷ýÿõ+?@ìÓ×,ãÙ4n3N î@	¿ÜÏâL3iLÃ ‚œÍ29Þ�LþLüï«:ºþ¾®Ïr³Ã«üµ;•°¿©¼jHêpß±ÿU^†�!‚·$€öÏá‘ÂªÏê KÜ®¥’º+Õà]wµþnÂæº¡©”¨«š
UXN—Uj\Å¥® Xˆ´¤�RÿC¿ÓCE&5M�»ZKM}�RÿC¿ÓCE&5M�»ZKM}’üÿ—¼ý¿?åï?Jóö»ÏöZª¦¦4CÄ<û�¸NkÑI!:ª>Cª5TïÀN‰›Ú¬†ÔGA„*Í†…Ô`hÜÐ®ðó  D9¬9‡€Ýtu°ã¸cÏ"¼8´Í ÏÂº¨µ‹Â?……ãAÄ4Ì9²qÀÊú3N#±Ê-áLàãš� Ðnø¶íú;ãÄT›Û`á�c8ÙÎ†ðçãö±÷ÔÅvÍ±17'°`SÂè±´nM´³=<^+=Ô36?1ì²Ø1�Ž�m‚X<ê¸Û ðà"9´“(9ü†háDè0Å€áó¯²:œ&Ï;ñ¬Ó6Ï®lúèq+®î ¬Åañõ1Ï×ãÛq±¯|óë˜T(°[*¼<8o½3 nØàJë?×¢¦�:e‚�YSY6ÝZ·VTÚª·�®J ¨½^ÛX›¦Ø¸™òÇîNDè2[`¶N*øˆVŠo;u¯w]œO6T‰Sàùa!9{v–Œ£;xüêô°ø²=8ÚX[\ÌÂ£&€ÎëÎ¾ÎÞÎ3°²°ãL&Ó·µC	g
ot[@sAQv!5PôÕCÐ_%T<Ê82ªöC¼ÿøq6ÝU±ÎÔ´BWñÐy•ô2¯þ;û#;¾+Çøó§ÁŸ‹Ï«¿¬2êíc·8�›´¬"BÊÎõ8"7ÿÊÓñóŒúo	y²èK×ð”w›=àÓOx%Ði4LBbCçD®… ƒåçw‘AÒj	¸Îã…=)úÁU‚Nèo]_|à“*ª*54Ñ§3EUA»QFú†ê¹À.í \UíÊP ¶¦ÕPn·äoªV•XR©[[•&fW ¸t§Ö:[HC~nÓ‹š²¶öJ>ÿ,‰yÆp:}¸?Ò8ÖóýÎßôjm5•ôôðP<LÑH/�z›Ï½½.ih£ÀS‘%$¬ô¥’£5Ê(öŽt6È"Üì² ˜:ÚÓ¼+õÆÔ1)ØoýŠ#US
NúÂûÆÊ-” óH¦ÞØ)ƒMãe®éâØöòQŽ«ˆx!'µõ-®d‰Œ1ñ(î�Ã-g–|ÏvM©TŽÛhrºÀ1W»PnŸ8¡Ò±‰{#^­6êž­ôÊ¸MUÐPÕcÍU@Y@ÇpV(Yížëê­fšÚ›@¦‹¶vj&¤Ueud¼ÍÚ¿ÅR=ørÇÀFïÆÿ˜,{´�n;†<Ù)OI¸ïã¢"�8I#15Z”ç]CPè|u£aE¸é   !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  !H<?xml version="1.0"?><Features nextValidID="18"><Feature recentID="17" name="AmpR" directionality="2" translationMW="31558.16" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="5656" readingFrame="-1" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment range="4865-5656" color="#ccffcc" type="standard" translated="1"/><Segment name="signal sequence" range="5657-5725" color="#ccffcc" type="standard" translated="1"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="16" name="NeoR/KanR" directionality="1" translationMW="29048.78" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="2564-3358" color="#ccffcc" type="standard" translated="1"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="15" name="WPRE" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="822-1410" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;woodchuck hepatitis virus&amp;nbsp;posttranscriptional regulatory element&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="14" name="ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4106-4694" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="f1 ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1726-2154" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="50-429" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2168-2497" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="430-633" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2348-2483" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3534-3655" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="AmpR promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5726-5830" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="3xFLAG" directionality="1" translationMW="2730.72" type="CDS" allowSegmentOverlaps="0" cleavageArrows="798" consecutiveTranslationNumbering="1" maxRunOn="801" maxFusedRunOn="801" detectionMode="exactProteinMatch"><Segment range="733-798" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;three tandem FLAGÂ® epitope tags, followed by an enterokinase cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1476-1524" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="lac promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment name="-10" range="3752-3758" color="#ffffff" type="standard"/><Segment range="3759-3776" color="#ffffff" type="standard"/><Segment name="-35" range="3777-3782" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for the &lt;i&gt;E. coli lac&lt;/i&gt; operon&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="CAP binding site" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3797-3818" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;E. coli&lt;/i&gt; catabolite activator protein&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;CAP binding activates transcription in the presence of cAMP.&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="M13 rev" directionality="2" type="primer_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3704-3720" color="#a020f0" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;common sequencing primer, one of multiple similar variants&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="1" name="lac operator" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3728-3744" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;lac&lt;/i&gt; repressor encoded by &lt;i&gt;lacI&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;The &lt;i&gt;lac&lt;/i&gt; repressor binds to the &lt;i&gt;lac&lt;/i&gt; operator to inhibit transcription in &lt;i&gt;E. coli&lt;/i&gt;. This inhibition can be relieved by adding lactose or isopropyl-Î²-D-thiogalactopyranoside (IPTG).&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="Factor Xa site" directionality="2" translationMW="473.54" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="1292" readingFrame="-1" consecutiveTranslationNumbering="1" maxRunOn="909" maxFusedRunOn="909" detectionMode="exactProteinMatch"><Segment range="1293-1304" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Factor Xa recognition and cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  =<Notes>
<UUID>70bcc161-158a-4f5f-9630-d4c4e88666d6</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<Created UTC="5:0:4">2019.1.23</Created>
<LastModified UTC="8:9:43">2020.4.4</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
</Notes>
  Pý7zXZ  æÖ´F !   t/å£áŠ&] Ë‡ØÎf‘ƒÊý{3Ôé·Ú(1v%f M*	mj÷)p80çÌ*iÚ	´NY]Qó“�úF7î&ƒÕ!Ò÷ÀnÉ;_xœÊÓNW5ÿJ}ýV{åˆV« ÆcKY1±œÏ˜ŠÍv~i~ZÂ˜7šO’ŸýË°Á·€oÌvá~ØÜ6TPÇÕo·Á’3”QÏâ_—{a’ƒuÌx•ÍË©ªïµIÊÁ%‘b<Îgcp×f�`EÒÚ�«ƒé´±o¯À¸6•b²–
›®e¾Û¦ÔüÑ^ˆëóèûÉ7`×Æ»¯ÁæbRÏv+M,Îå;Ó‘=.8	MoSÑSœ([kiÌcU>":v­4ÊDd™Ëœ-ÐÕbÒ‰#×�p
ïÇÞë ‡—U–I
Ð#îx/¹L 
’[²š×,ªä¾JðÚ™þg	™Ñ2Cê³l“üBM€:±AíDEÈú×�ŸÃoÙ}¸ 	OþAÒxLø½áÎ˜ RC�\(x"õÄ`¶�~Ï-‰A€ÄíÌ�ä¬¯úM ®'òÍ*4Õ>¬SJpnëbÊÑ8ë“
ù\SlSëÞ~•®Tù™Šc$cÊõ}gïÞTæ­"Œ_àm.ºÎŸÌ1™ÆMUêJÊ™zµÝfYV®é� 'î\+ ‘çCvÜ	*J·aËÍ+g jˆ$Á&ˆ˜åýõUÃ/3õg¼3ERbKÐÿ±#eûÅç~EEîêRà"gÀâ?¯þÎQæÐ¨_4DÍÞ”ëèP¾b+†çé+_÷¸¿
W8aÙÖ8Á·ƒ¸¦÷C�lt’ù©kûM„™¦±›€aP½ôÄú¯�ø¼Cò\ÃíýG3ZAºk÷æT¹/˜‡éñÂçß:
ìY–|ÉöÈ`ñ") I‰?ì­7Sg¥2n]J¾INõË,|½LÈE!VHéÇœŽ ?</×ñZî9sþJÁE¨.®†
µbP¤H¡æ“0‰.�µ½�P]»‡£¤3Ã9íYâ,îˆÝ'¸vÔ8LÁÑ"�á82ë›þÑ{h6‹€¢…°¨N®›Müœ'(Cc•¤£ û7)Ã[±ÎÖß¹“„'0QCÌóµ�½û�þÇú¾Ç4ó axxë¼\ê“h-û¸ÖC9³šÀ‰êÙÃÍwCØ£Ãº²” äâT3]%âçs_â<`î ^IÕ†w`æU'­Ý'7}°^½fúŠ€ÄùýÃý0GzeÉöÚÀOÉî=Få©
?üb¡å\7�þscš}?*bÊ^àÃ9ôîcÙî=qò~úr²Ç!˜+Ìvï¦1ö%©eˆVJÔccË¾<ã³\"z”¡%\ð1§wEti1x1¯2-3!Ž©yÅÙ	‚JÔ­Â±=Š�ÚØò�p·èü‡8Q$½ÇûÔ2;¯õ\¹|¡kz–]°Ñ°ç!BØõ”­qÌ¢G‹£W1¬b‹µµT›ku°ešáèÿ\.?>)ÍI9ˆ¥2´JÛ Ç·C2¿_;µûjíÕ‚:øQíÿ¾¾°hbA+›2±Ä,Ï7Ÿ×ÕH“ýáÁô¦HÊd×y)�6¬Eã‡~µ6í|1"Öt“¦»ÿ>"RÇÃª§Ú&ûƒXV!Âð¸×z7}Â·©÷t¦U\UBƒfþPçW¥±Âø-P�r»}•–²]¤¨™ ç	Æ/}HœWÌñ “2†Ù÷; [ŸI®5˜ttáfž¥'7�*òSon¶ï~·z§Î¸"išW]Þ;«2—¡›‰ã%µW¾½¨nsáûâêÞ&Ÿ¯Þá¢ìXHp
VXåQœÇ&î6ÓÖC;ƒYBõFá5=•É–'uò–�º˜ $âdæG¦çœ	"´#ÊK¨‰«ÕÝã.ÿ9O'Õ	¶>vM=^ÕvÐý'äùëâ®±²8´R‡Áï ¦ªðÛ/[Ô6¿d¹¶—k¹ò\ˆaÍVÆ3Ü%tÊ“š/Ø0 HzÅt½)UW¶· �c¾øá9ÅùÊ+ˆVÒê‹±ÕÔ«ó ~.‚Å°ý*¬ ] S§yç¹r_¿Jwtäô/ÍNùá‡Üq%*5x˜óŒ~q–»ô+)îXŸñb�ëvµN(†[l(,û„¬â;\ä4¼ˆk)MŸEU8�„Hñ4âŸ«xeÐ» ÏBT}k:Fpý#j§“tn]ú–½q:)‘ó1ý'1™¯Ž*à¨(,BJ‹Ô)Ÿøpx•eóYî˜ÊPô¨µJÀÓeŒÏWøŒ±On:˜È"„Yøšo&jŒÝ¤ÖwÐuæ/ô™Fg™fj:|	MP�*¢Pn¯Ï�*H•Ø¨ b{Ô*�Iz¢JðÑ|8˜<
ª/—fL“–×¹(—/]ÒÉ™ië"‘½[7œ%¡"ÝÍÜTŠ‚�Á¨‘&è]+Œf®ÁAXÓ=1œ&”yRÝ+¿sÑó¼küºåLtà�­"C¯Fœ+º8ÁãÞÊ)ÊÄ{€²µ· Éºƒ#æf)A•ÞÔ‰WÎõ�O¨áÛA.HÿáŠFº÷Ú¾2Æ›¦Ë %"�dóê]Ú¼YöÍ&ÝéßAê©a3i§S7{ÞÖ�—‹p¢ÿ�ˆ†fÍqõzŸSùõªÀ¹^:øU�Æ•úhj ¶¯®Az�ßCÂ«RÒŸ>Ÿ°Æüô=¢Í¨ÈŠžÛ4å‰i×›#Œñg;ì¸C´|C6Ñ÷íãÌé'q.ÿœ˜•‚d|öJýu²ý0äðø”õó†ÁÝ¶t¸%sZŠsÿN*ÈñÆÛ}4àj&]rK¼s3©�õ¾#¥û]_Y;ìæ§�b†@äH?Y«xÑfí¼ab÷#
F�jH²[Bû²ÅXU±?w†°nA­þ™çDQg¯¿¡‚ÔÛ\Ë|H)– bÙ8ª«X³]î7,¦µðöè:¹@Ö—˜As¢ÂÐíëLGÖdnÌË¥uÜä,öM}8ãñd^#Û³ÆË‡J‹SË–‡Á±WÉ4LíÀ!&Öýý?ž¿Ô¨ç�±ÛØYÔÕö[j¡H9 :ižÝ3‹‹W‘ƒ±ãÿ·ËÎo¤è‡ÆF#-@D>�#�LûV‰ëV9ž–È+,#roúÄîãÄ–Á®!Lv\3…7¤Á çûD™'Ï… ¼ýw-"ÿc;’»?ÉÕ#Ï^],„?7¤ÞŽ»Â¸gU5…Ò»D£É9a{«ƒG:ûòþBˆ%:Çu°»û<ãÏÄ¯9¡³“Ø Õä´VÉ!o�ðOµMØhTA
¼ãÉ�EoÊÑÈëÉ¤ŒÂó:H[ùbÙÊKø¤R�d„å‡ð"�ý^¹ËÌÝ#{µÜâÑˆÖ A³#}bÎ#tÌyƒ4fƒ&÷²~ª¿­™ÆÙ��)æÖ ½˜+MŸÎ#”.‡fœäù¯û´£`TL³)Žå¿ë÷RâR½ZØ‘;eÅôdï—ÚŸ
¶ÇÈ¼)aà)UŽG«oÿ·.«¶Íg�ÃùGÑÁTÒ‘'_$eXà1;‘þ@iHu·qÔâjÒ.I‹U`VC�Œ
{òûD�Ý#váA|ò‡òT5ŽlÆÞÑˆõ‡gÒŸ¥#‚Cµá�°¥aZ‘Ò'¿™ÊýN¼j©]ËTˆ�¼Û¡‚4�4ÀÅRÌ)qát]/M¹l1ŒðœjÒÁH¸[ÓÆªK³�Ñ¥úv–¤éV>·)
¨Y¿0ôX™.t?!ÔNux›£Å%T²yÄÝåÁ…“§¿¨±~à¶Wï½çf¸À}K—5Þáf ì`¤»«Å}ü"¼r'Y1õÎ¢®ºq�ø}¢²…¾ {^¸8�âpDŒr9Ô|5…¬q^WxqÒ³N«½D]4Íç…°)  •.´ªÝîô…JnôÂ#´lò�ÔªÑbÑûf¿Ý�ÛŸ:Òõ‚§¨ÁµŽß„¿¤Hî„8¶M¨rw�Àã]íÞ¯WëÞ,z»—‘>¯Á‡Õž(ócœñÆ~Ë=kõÁ‘h‘Å KYv¢IÞìãxêØR£#I�Ëžo +Ï'
²DfhN¿#2
¬%®Ñµ‚Y;ÍëÀä0é¿ñç¬¸®#+ŠÔ§–“(þ@ xô\¢ï×°Ï‚uâ<À1úéã9Ù*<þÄTÀPlñþõÝkuñaSà`z’4,!úAˆ“tÃ¸¾„~)“þ´x‘ßªöcxž„Q.èX’ñÓê3ŸT­Åð85º£‘r=7 OŒ¼
å~Ð¸[@™¿ý:»F‚åå•m‚9ò$50†“Ñ‰càäR�êÅÖ’E‘-.®ÕxyèLX7ØÌ£ŠrÕ*ZHFØ¢ëÏuü=x’€º"åNûÈ�í°�£�½\D4L{l‹!ÎºV~‡tº¨tmœÏstjü<€+‰’èçÏãsù®”Y¢(‹�—¯
´#«Žfô›ÖÖ½£–=ò`ÎAñ	wBè³ÚàE(ÄæJ:Ë©�k+f\¿'ê­¤‡/µóIl#FOùô h=~#7‡+µûþ”ò™.Q‰6L�ý¾0ýG–þ÷ìà€D!±½+»&ðÅú^^Œ2±¤Toõá‰7ÐEÝÑ¾ÐÔ+^oí0ÙoaSºÎ¶ûBÖþð>wOq&Þ- O"¦¸«}b¥½Â* ®™ªqÄLóm<¶†Y]BÈ\ÒÞ~G¾u_4ÛçÓ
lq8ÿå¦êžxò³!4×©Q»Ì°9ÜLø,ÅÞ__W}¨y¸H�ßÈéé=ÏRðò‹ÉHŠµ¡sgC™ð’ƒ‡m©d‚9!'uµÅ=e`Éª±�IŽÁ°m„¹Eµ˜à“ø¸emoQ'�o2S#ñèT&(h(QM~MÖ·áÏ·>PŸà‘1r”h”äK8Àîr‹e~GT@rä!¯‹Ùì45ç,÷•™²j#ÃþâI©?ù©ä´•ü‰hÛÒ`ø¢]ãb‹ÚµµãÄgLX#UNÞÕ@°P3­¢DØÒ‘ Šÿcs7ªyAi£ƒ$Z
WÄêiW£ã?°†ôOÜ¡1'^£kB6nŒÊ>¶*oË“T‘‰mk«+éH¬A¿CáÍ¼ØÌFü¾ F-°B§QÐ+â…‘‡ml*H²µ,2^²%åBw_›1´Ô¢Ï¹†HLä/<¹ì�gv~ªÒeéB~d¦ee
Â¹#IíïÉ´i>ÑF@žäF)síóAôþ©×�·hý	ÄdÛîÚEÀš6æº*õ<žù÷QiCëI!mX’lsE/�ªë18–K�C‡‚ÞÆ¡î\º–ž,ÑÑÇLkQvdÓþíÀóTÈ4¸ßÝ[d’ªï«gw7Û´#3�Yê«T¢D+Ä}ãèÔ“¡º†Í¯ÝòÍ–¸y �m$yÀ‹ßQ7X1³ƒöogÚeçƒÏ±ŠYâw ž0Ñ{¥ÑV6¥s¿˜ýD„š±£2iYIc*CjÜ»2,¡2Þ|_^æ.*å7™—‘\ã²„l¶æ�‡;òÿ“ý»sü"Ì“›×PþqVô=lÎž~qßùmÄéw>ËŸ3dbH?Q¾Æ–³=µ¿ñú=~ÃúR!$<oU�z'Aˆ6›ûà¤„~ðè4#þ
ZúëóÙê‰bƒ9·ƒeLûˆ˜LÓô6<8Õ·©«Øì°Ó¤-Ê^ën!¿
åDÞÚ\o“µi:T¢n½Ò¸ÜoŠH½ˆÊdK"û¤ä96>Q£p8çÆ.f‘gQá·,/J;»Ìú÷WTãnøó4¶‰O{r‰nL;¶ôÂ÷n§m˜-[ÙYŒ¤áUq,”¯µ¬žÑ!B“·mH0>l«˜ó C�î™Ä»·à‰!Ã¦]ní[‹µÕ2í¿–èv™û&b«èCÁ…«¹ç‘bø¾Y9ž„‰ª¢éÀ¿#Ø¢ô-aÕ/DHî Þcy“þš`ðoKcªhß1ã<�âÊ¶våÎÃÃ’¢	óº©ÞÜ›p¥1ªåf‰‡Ž§zx‚§�€0IsŠu‘Jøùœqó#NyP;ÃÉÁwÔ¢ý`�ÒécýfÑ€+Û^)i-‰ñrÆ­yëYK»ÅD¨K6@º+(5üã<¨ºæ'Cy/£ÕšWxXi³^ŽEAúp ×›I³±o–’aŒ`� À�'?Oà£òNh‡-Îyü:58É�Fƒ H˜G^ÉìZ�Ø¼}¤ÜæB!*þà;]EåRh†«¹ÆKÑ×ž)h%iæxù�›k>z=ºXP,¯éX:‘)ÿ	ïø¸0yµ6Pn¶Êd`Ÿ�FÝþ“< ³JjTaFê�óí˜™)ôyÉÄwCË°¯Œ6Iå ¾ÃyG^\³ÓMvÌ²›­4Mç+è®É²JÂÒ®Þ¸†‡¤ÿbpG±ñI1Q6Ö‘I­¿±à´Tx/Í
‰¼ÏÒÃºðØ„CK	»Ž"½rTÄBW—ù£G#ksB�¤êó�¦k5cO•jršÆÁÒ¨Te¡†¦'<t†cß!8øh‘Q…|øÜE]Ê›5�õ%`6hÅq–0¨Qß./Wï¹‚ŸÜJîÊ›m’Kræ¹Ýr3ÿrjfŒë7OñpÜK(»«‚®Šþóþ�é~þ²ügMk¤3Im/½<)æ‰M¶´z¬èd�:nÍ÷l¼âÇžŸOÜxAa°›óãb
"”¬£™K®/>Ê’¶[:)}mƒ÷8 $‹U{æÁFñ×%ÐÚ›ïä™miE`Œ±ñxÿN½kàÂèWðÈ*ŒóWkûu«ÎÃ#¾�ÎG@Ù)¶—©]SxÂç?{w%ë³.¹\Ì@”3NW¤u|UUäÍÿ–ƒß´ŽëhÁÀô¨E¸šs‰Ä+&›Nh“^¾EßR Ôýþ?}´KIH+ÂÊÿeœU·:^ËÇyŠqÌ,„Y”Š–§#9„’ïÓÆÚ¬AâÑ“7V	nLÌ¼b¥�þ?w¹¡³Í;âp"Ôg+�þHTõ5-ý09áþá¸ÏS£7¢éäNDô¥—+ev�QÐ y%LNŽrVî‘Ä&Nq/ÔC†´à8 ¬’£rŠRË¦­öñYd•/{o§è"àp’N‹A [Æ=ßF	ÉmG&róã³ç°!ép2Â!ZÊÏ½Ÿ§Àð!}ÞŒMÿüEz*[.{œì=Ÿ4?…®5)Ã–{-5€Ž‹$?¥fÙ•^Íg�1¦Ê“ÎãG7wðûke2yŽlQjôÞCêZKjÑ2rZÈlº“æ­ýO¯†$™‡C&6?ž{Ï§’xck{lÛŠ‡+Õ»ÁB¾´³×Ï0ÝÖïon¿ü›@™á>‡æ)]a½
ì$”�FR�Ñ�ºçJn=]^G¤Ièâç ,/ƒ'âä©ÁÉ×Ñ&Â4î(…’HÞò¢nÂ¬tÜS@ù|HZô`mO1
>pH    Ë‚{î¤+J÷ «,§” ãaCÈ±Ägû    YZ   -<AlignableSequences trimStringency="Medium"/>  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  (Š<?xml version="1.0"?><Features nextValidID="20"><Feature recentID="0" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1797" maxFusedRunOn="1797" detectionMode="exactProteinMatch"><Segment range="1768-1794" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="translation"><V text="YPYDVPDYA"/></Q></Feature><Feature recentID="1" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1797" maxFusedRunOn="1797" detectionMode="exactProteinMatch"><Segment range="1738-1764" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="translation"><V text="YPYDVPDYA"/></Q></Feature><Feature recentID="2" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1797" maxFusedRunOn="1797" detectionMode="exactProteinMatch"><Segment range="1708-1734" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="translation"><V text="YPYDVPDYA"/></Q></Feature><Feature recentID="3" name="lac operator" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4724-4740" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;lac&lt;/i&gt; repressor encoded by &lt;i&gt;lacI&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;The &lt;i&gt;lac&lt;/i&gt; repressor binds to the &lt;i&gt;lac&lt;/i&gt; operator to inhibit transcription in &lt;i&gt;E. coli&lt;/i&gt;. This inhibition can be relieved by adding lactose or isopropyl-Î²-D-thiogalactopyranoside (IPTG).&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="M13 rev" directionality="2" type="primer_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4700-4716" color="#a020f0" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;common sequencing primer, one of multiple similar variants&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CAP binding site" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4793-4814" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;E. coli&lt;/i&gt; catabolite activator protein&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;CAP binding activates transcription in the presence of cAMP.&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="lac promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment name="-10" range="4748-4754" color="#ffffff" type="standard"/><Segment range="4755-4772" color="#ffffff" type="standard"/><Segment name="-35" range="4773-4778" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for the &lt;i&gt;E. coli lac&lt;/i&gt; operon&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2472-2520" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="AmpR promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6722-6826" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4530-4651" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3344-3479" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="430-633" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3164-3493" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="50-429" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="14" name="f1 ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2722-3150" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="15" name="ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5102-5690" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="16" name="WPRE" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1818-2406" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;woodchuck hepatitis virus&amp;nbsp;posttranscriptional regulatory element&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="17" name="NeoR/KanR" directionality="1" translationMW="29048.78" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3560-4354" color="#ccffcc" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="translation"><V text="MIEQDGLHAGSPAAWVERLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVADRYQDIALATRDIAEELGGEWADRFLVLYGIAAPDSQRIAFYRLLDEFF*"/></Q></Feature><Feature recentID="18" name="AmpR" directionality="2" translationMW="31558.16" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="6652" readingFrame="-1" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment range="5861-6652" color="#ccffcc" type="standard" translated="1"/><Segment name="signal sequence" range="6653-6721" color="#ccffcc" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="translation"><V text="MSIQHFRVALIPFFAAFCLPVFA,HPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW*"/></Q></Feature><Feature recentID="19" name="Zdhhc3" directionality="1" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1797" maxFusedRunOn="1797"><Segment range="706-1701" color="#ffcc00" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="translation"><V text="MMLIPTHHFRDIERKPEYLQPEKCAPPPFPGPAGAMWFIRDGCGIACAIVTWFLVLYAEFVVLFVMLVPSRDYAYSIINGIVFNLLAFLALASHCRAMLTDPGAVPKGNATKEFIESLQLKPGQVVYKCPKCCSIKPDRAHHCSVCKRCIRKMDHHCPWVNNCVGENNQKYFVLFTMYIALISLHALIMVGFHFLHCFEEDWTKCSSFSPPTTVILLILLCFEALLFLIFTSVMFGTQVHSICTDETGIERLQRTKQPREQSGSWKSVQEAFGGNFSLNWFNPFTRPCQPETPIDKGLVRQVSSLSDVDNMETAESQLEATKDRDSVEVLDE"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  §<Notes>
<UUID>d4b4376f-b9bd-4b57-b59b-3a57c77aab41</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pCMV-Zdhhc3(mouse)-3Ã—HA-Neo</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created UTC="5:0:4">2019.1.23</Created>
<LastModified UTC="23:55:44">2025.9.20</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
</Notes>
  Y     K         
?????                                                                                                       ÿ d      DO  d               E              ÿÿÿÿYô? P                                                                                                                                                             	<StrandColors><TopStrand><ColorRange range="699..704" colors="green"/><ColorRange range="1701..1706" colors="green"/></TopStrand><BottomStrand><ColorRange range="699..704" colors="green"/><ColorRange range="1701..1706" colors="green"/></BottomStrand></StrandColors>   3<?xml version="1.0"?><EnzymeVisibilities vals=""/>
   )<?xml version="1.0"?><CustomEnzymeSets/>
